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This dissertation will focus on the role of the two majorly abundant protein kinases 
CAMK2A and CAMK2B present in the brain. I have decided to highlight not all but only 
certain aspects of the literature on CAMK2A and CAMK2B for three reasons.
First, CAMK2A has already been profoundly studied considering the vast body of 
literature on this protein subunit. CAMK2B however, has not been given the same level 
of attention as its highly homologous protein isoform CAMK2A. As such, a substantial 
part of the introduction of this dissertation will try to summarize all current knowledge 
on this relatively unknown protein subunit CAMK2B. 
Second, this dissertation will try to elucidate the unique and common functions of 
CAMK2A and CAMK2B, thereby helping in understanding the full spectrum of the CAMK2 
protein in neuronal function. Both protein subunits arose from a common ancestral 
gene, making these two proteins highly homologous. Therefore, for many functions in 
the brain it is not known which are carried out by CAMK2A, which are carried out by 
CAMK2B or which are carried out by both.
Third, as a result of this high homology, dissociating between these two proteins using 
pharmacological inhibitors has so far proved impossible. Regardless, CAMK2 inhibitors 
are widely used to unravel novel functions of CAMK2. Thorough knowledge of these 
inhibitors is important to distinguish between direct effects of the drugs versus off-
target effects. Therefore, the introduction of this dissertation will try to summarize the 
knowledge on most current drugs available for CAMK2 and assert their specificity.
On a different note, the use of the words CAMK2A, CAMK2B and CAMK2 can be confusing, 
both for outsiders as well as among experts in the field. To clarify, this dissertation will 
refer to CAMK2 as the entire holoenzyme, either containing both CAMK2A and CAMK2B 
(heteromeric holoenzyme) as well as only CAMK2A (homomeric holoenzyme). If certain 
traits can be ascribed to single subunits of the holoenzyme, the specific name of that 








“Nothing in biology makes sense except in the light of evolution”  
Theodosius Dobzhansky
1.1 A BILLION-YEAR-OLD GENE
Ca2+/Calmodulin-dependent protein kinase II (CAMK2) is a protein that can be transcribed 
from 4 different genes which are estimated to have evolved from a common ancestral 
gene over 1 billion years ago (Ryan and Grant, 2009). CAMK2 is thought to have arisen at 
the start of the kingdom of Metazoa (Ryan and Grant, 2009) and has gradually evolved 
and acquired a variety of functions in a plethora of species.
As a result, the CAMK2 gene can be found throughout the animal kingdom, with only 
one genetic copy in (among others): sponges (A. Queenslandica (Ryan and Grant, 2009) 
and Suberitus domuncula (Krasko et al., 1999)), nematodes (C. Elegans; in which CAMK2 
is referred to as uncoordinated (unc)-43 (Reiner et al., 1999)) and insects (D. melanogaster 
(Ohsako et al., 1993)), three copies in (among others): frogs (Xenopus laevis (Stevens et 
al., 2001)) and 4 copies in (among others): mice (Mus Musculus (Hanley et al., 1989)), 
chicken (Gallus Gallus (Li et al., 1998)), and humans. The multiple gene copies of CAMK2 
found in frogs and higher vertebrates most likely arose from duplication of a common 
ancestral CAMK2 gene (Tombes et al., 2003). These duplications in turn are thought to 
have arisen from two whole genome duplication events (paleopolyploidy) that have 
occurred in a common ancestor of chordates and echinodermata in the deuterostomes 
clade (McLysaght et al., 2002). Therefore, the different CAMK2 genes can be referred to 
as paralogs.
Today, the CAMK2 protein is mainly known for its neuronal and cardiac functions. 
Interestingly however, the ancestral CAMK2 protein may have started as a non-neuronal 
and non-cardiac protein, since species in the phylum porifera (sponges) that have 1 copy 
have neither nervous nor circulatory system. Therefore, the initial function of CAMK2 in 
calcium homeostasis might have been much broader than its current specific functions 




The four protein isoforms known in higher vertebrates are CAMK2A, CAMK2B, CAMK2G 
and CAMK2D (A for alpha, B for beta, G for gamma and D for delta), all coming from 
the 4 paralog genes Camk2a, Camk2b, Camk2g and Camk2d located on different 
chromosomes (Table 1). Camk2b and Camk2g are the most closely related of these, and 
it is likely that Camk2a arose later in evolution as it is not present in amphibians (Tombes 






















Table 1. Overview of CAMK2 proteins and their chromosomal location in mice and humans
Taken together, it can safely be assumed that in higher vertebrates the four CAMK2 
paralogs have each developed to fulfill unique roles. On the other hand, considering 
their divergence from a common ancestral gene, an argument can also be made that 
certain functions present in the ancestral gene have been conserved in two, three or 
maybe all four paralogs. 
1.2 CAMK2 STRUCTURE, DOMAIN ORGANIZATION AND 
REGULATION
CAMK2 is quite an unusual protein, in the sense that it can auto-assemble into a larger 
protein, called a holoenzyme. This can be done using only proteins transcribed from 
one gene (homomers), or with a mixture of proteins coming from different CAMK2 
genes (heteromers). In this section, the structure of this holoenzyme will be discussed 
as well as the domain organization and the regulation of a single CAMK2 protein.
1.2.1 CAMK2 Structure
As mentioned above, CAMK2 can form a holoenzyme. More specifically, it can form a 
dodecameric holoenzyme, coming from the Greek dodeca (twelve) and meric (part of ), 




(Colbran and Brown, 2004; Chao et al., 2011). The holoenzyme is made of two rings of 6 
subunits each, placed on top of each other in a doughnut-like shape (Rosenberg et al., 
2005) (Figure 1).
CAMK2A and CAMK2B can form heteromeric oligomers (Shen et al., 1998). The same 
study mentioned but did not show that CAMK2G and CAMK2D can also form heteromeric 
holoenzymes with CAMK2A and CAMK2B, although later reports suggested that 
CAMK2G can move to the nucleus without translocation of any of the other isoforms 
(Ma et al., 2014). One does not necessarily exclude the other, as CAMK2G can detach 
from CAMK2A or CAMK2B upon translocation to the nucleus. Exchange of subunits 
between holoenzymes has been observed as well, but so far only for CAMK2A subunits 
(Stratton et al., 2013). Nevertheless, it is still not definitively clear whether CAMK2G and 
CAMK2D can form heteromers with CAMK2A and CAMK2B. 
1.2.2 Domain organization and regulation
The CAMK2 protein can be divided into multiple functional domains. These domains 
can be found in all 4 isoforms. Considering yet again that these genes have come from a 
common ancestral gene, it is perhaps not surprising that all 4 CAMK2 isoforms are highly 
homologous in their domain organization. In rats for example, it has been found that 
there is an 89-93% sequence homology between two of these domains (the catalytic 
and regulatory domain which will be discussed below) (Tobimatsu and Fujisawa, 1989).
Basically, all CAMK2 isoforms contain a catalytic domain, a regulatory domain, a variable 
domain and an association domain (Figure 1). The catalytic domain contains the ATP- 
and substrate-binding sites and interaction sites for anchoring proteins. This domain 
can also catalyze the phosphotransferase reaction (Lisman et al., 2002). The regulatory 
domain consists of an autoinhibitory domain, which contains a segment that closely 
resembles protein substrates. Under basal conditions, this so-called pseudosubstrate 
segment binds to the substrate binding region (S-site) of the catalytic domain. This 
way, activity of the enzyme is inhibited (Smith et al., 1992). Upon binding of Ca2+/
Calmodulin, binding of the pseudosubstrate segment to the S-site can be relieved. 
The variable domain is responsible for most differences between the isoforms. This is 
where differences in affinity for Ca2+/Calmodulin and inserts for targeting of CAMK2 to 
subcellular localizations can be found. Finally, the association domain at the C-terminal 
of the kinase is responsible for the assembly of multiple CAMK2 subunits into a hetero- 
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Figure 1. CAMK2 domain organization, regulation and structure. a. Domain 
organization of CAMK2 including the most important phosphorylation sites 
(indicated with T). b. The autoinhibitory and catalytic domains form a gate that 
regulates activity. The enzyme is inhibited when the gate is closed because the 
autoinhibitory domain binds to the catalytic domain at the S and T sites (top). The 
binding of Ca2+/calmodulin releaves the autoinhibitory domain and activates CAMK2 
(middle). The NMDA (N-methyl-D-aspartate) receptor NR2B subunit can bind to the 
T site, keeping the gate open and the enzyme active even after the dissociation of 
calmodulin (bottom left). In the presence of Ca2+/calmodulin, the Thr286 site can be 
phosphorylated by a neighbouring subunit. This is also sufficient to keep the enzyme 
autonomously active even after dissociation of calmodulin (bottom right). 
c. Three-dimensional structure of CAMK2. (Left) This view shows only one of the 
hexameric rings formed by the catalytic regions of six subunits. (Right) Stereo view 
of CAMK2 seen from a perspective perpendicular to that shown left. The association 
domains of the 12 subunits form the gear-like structure. Adapted from Lisman et al., 




Figure 1. CAMK2 domain organization, regulation and structure. (A) Domain organization 
of CAMK2 including the most important phosphorylation sites (indicated with T). (B) The 
autoinhibitory and catalytic domains form a gate that regulates activity. The enzyme is 
inhibited when the gate is closed because the autoinhibitory domain binds to the catalytic 
domain at the S and T sites (top). The binding of Ca2+/calmodulin releaves the autoinhibitory 
domain and activates CAMK2 (middle). The NMDA (N-methyl-D-aspartate) receptor NR2B 
subunit can bind to the T site, keeping the gate open and the enzyme active even after the 
dissociation of calmodulin (bottom left). In the presence of Ca2+/calmodulin, the Thr286 
site can be phosphorylated by a neighbouring subunit. This is also sufficient to keep the 
enzyme autonomously active even after dissociation of calmodulin (bottom right). (C) Three-
dimensional structure of CAMK2. (Left) This view shows only one of the hexameric rings formed 
by the catalytic regions of six subunits. (Right) Stereo view of CAMK2 seen from a perspective 
perpendicular to that shown left. The association domains of the 12 subunits form the gear-like 
structure. Adapted from Lisman et al., Nature Reviews Neuroscience, 2002 and Kolodziej et al., 
J. Biol. Chem., 2000.
But what are the roles of these domains in regulating the activity of CAMK2? Under 
basal conditions, access to the substrate-binding site (S-site, on the catalytic domain) 
on CAMK2 is blocked by the pseudosubstrate segment of the protein (Braun and 
Schulman, 1995a; Colbran and Brown, 2004; Coultrap and Bayer, 2012) (Figure 1). 
CAMK2 is activated upon influx of calcium into the cell. Four calcium ions can bind the 
protein Calmodulin, which in turn will bind to the Ca2+/Calmodulin footprint present on 
the pseudosubstrate segment of the CAMK2 isoforms (R296 to A309 for CAMK2A, R297 
to A310 in the other three isoforms (V310 in CAMK2G)) (Vallano, 1989). Binding of Ca2+/
Calmodulin to this footprint releases the pseudosubstrate segment from the catalytic 
domain, making the catalytic domain available to phosphorylate different substrates. 
When two neighboring subunits have bound Ca2+/Calmodulin and their catalytic 
domains are available for phosphorylation, one catalytic domain can phosphorylate 
the neighboring subunit in the regulatory domain at threonine 286 (T286) (Miller 
and Kennedy, 1986; Hanson et al., 1994). Phosphorylation of T286 (T287 in CAMK2B, 
CAMK2G and CAMK2D) greatly enhances the affinity for Ca2+/Calmodulin, a mechanism 
referred to as CaM-trapping. This trapping of Ca2+/Calmodulin can keep the CAMK2 
holoenzyme activated more easily. However, when calcium levels in the cell drop to 
basal levels Ca2+/Calmodulin can detach from CAMK2. Phosphorylated T286 will render 
the CAMK2 subunit autonomously active as it will function to keep the pseudosubstrate 
segment relieved from the catalytic domain. This autonomous activity, also referred to 
as Ca2+-independent activity, is ~40-80% compared to the maximal activity (when Ca2+/
Calmodulin is bound (Patton et al., 1990; Coultrap et al., 2010). When Ca2+/Calmodulin 
is no longer bound, it allows phosphorylation of yet another site, TT305/6 (TT306/7 in 
the other three isoforms). This site is located within the footprint for Ca2+/Calmodulin 
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binding, thus phosphorylation of this site prevents Ca2+/Calmodulin from binding, 
thereby inhibiting Ca2+/Calmodulin-dependent activation of CAMK2. If further loss 
of phosphorylation at T286 occurs, the pseudosubstrate segment will attach to the 
catalytic domain thereby inhibiting the enzyme and only upon dephosphorylation of 
TT305/6 can CAMK2 be activated again (as reviewed in (Lisman et al., 2002)).
1.3 CAMK2 LOCALIZATION, SYNAPTIC FUNCTIONS AND 
NEURONAL EXCITABILITY
1.3.1 Localization
Localization of CAMK2 can be described on multiple levels. This can be done on the 
basis of expression within a cell, within brain regions or even the complete organism. 
Differences in localization can occur upon activation of CAMK2 and there is even a 
difference in localization between Camk2a and Camk2b messenger RNA (mRNA). All 
these differences in localization are briefly described here. 
CAMK2A and CAMK2B are the most abundant CAMK2 isoforms in the brain. CAMK2A 
is mainly expressed in excitatory neurons of the hippocampus and cortex (Jones et 
al., 1994; McDonald et al., 2002; Zou et al., 2002), whereas CAMK2B can be found in 
both excitatory and inhibitory neurons and in oligodendrocytes. Besides the brain, 
CAMK2B can also be found in skeletal muscle cells and pancreas islet cells (Bayer et al., 
1998; Rochlitz et al., 2000; Cahoy et al., 2008; Martinez-Lozada et al., 2014). The other 
two isoforms, CAMK2G and CAMK2D, can be found throughout the body and have 
important functions in cardiac tissue. These functions in cardiac tissue are beyond the 
scope of this thesis and will not be discussed here. Recently, CAMK2G was also found to 
have an important role in neuronal tissue (Ma et al., 2014). 
Differences in localization between CAMK2’s most prominent neuronal subunits, 
CAMK2A and CAMK2B, can also be described in terms of a ratio between the two in 
different brain regions. For example, CAMK2A and CAMK2B are expressed at a ratio 
of 3:1 in hippocampus (Bennett et al., 1983; Miller and Kennedy, 1985; Brocke et al., 
1999) whereas in the cerebellum the inverse ratio is found (Miller and Kennedy, 1985). 
In general, CAMK2A levels are much lower in pons and midbrain compared to forebrain 
and hippocampus (Erondu and Kennedy, 1985). However, these ratios should be 
interpreted with caution, since ratios on the level of brain region (e.g. hippocampus) 
do not at all represent the levels of CAMK2A and CAMK2B at the level of single cells. 
Hippocampal region CA1 for example is known to have varying levels of CAMK2A 




even be detected (Brocke et al., 1995), implying that CAMK2A is not always present in 
excitatory hippocampal CA1 pyramidal cells. Also for the cerebellum, ratios of 1:4 for 
CAMK2A and CAMK2B have been found, but upon closer inspection CAMK2A is only 
expressed in cerebellar Purkinje cells, where ratios of CAMK2A and CAMK2B are 1:1. 
CAMK2B on the other hand can be found throughout all neuronal cell types of the 
cerebellum (Conlee et al., 2000; Hansel et al., 2006). 
Within their respective cell types, CAMK2A and CAMK2B can be found in dendrites and 
in spines. Concentrations of CAMK2 are particularly high in a region within spines called 
the postsynaptic density (PSD). Activation or deactivation of the protein however can 
change the ratios of expression between dendrite and PSD (Shen and Meyer, 1999). 
Upon activation, CAMK2 detaches from actin and moves to the PSD, a localization shift 
that is reversed upon deactivation. Moreover, autophosphorylation can increase the 
time CAMK2 remains in the PSD (Shen and Meyer, 1999). Therefore, as we will see later, 
mutations of CAMK2 that interfere with the activation of the protein not only disable 
activation but also change the localization of the protein (Shen and Meyer, 1999; 
Elgersma et al., 2002).
Under basal condition, CAMK2 concentration is twice as high in spines as in the shaft 
(Merrill et al., 2005; Feng et al., 2011) which upon activation can only further increase. 
In spines, up to 2-6% of total protein is made up of CAMK2. The density of CAMK2 on 
average is 80 holoenzymes per 0,1µm2 of PSD (Chen et al., 2005; Cheng et al., 2006) with 
up to ~240 holoenzymes in large mushroom-shaped spines (Feng et al., 2011). 
Interestingly, there are also differences in localization of mRNA between CAMK2A 
and CAMK2B. Camk2a mRNA is present at the spines and can provide a quick local 
translation mechanism after LTP induction to increase levels of CAMK2A. In contrast to 
Camk2a mRNA, Camk2b mRNA is not found in spines (Burgin et al., 1990; Benson et al., 
1992; Mayford et al., 1996b).
1.3.2 Presynaptic functions
CAMK2 can be found on both sides of the synapse where it has numerous functions. Most 
of the functions are beyond the scope of this thesis. Therefore, I will limit the summary to 
presynaptic and postsynaptic functions in light of presynaptic or postsynaptic plasticity.
CAMK2, even though it was originally discovered as a presynaptic protein and named 
Synapsin I kinase (DeLorenzo et al., 1979; Kennedy and Greengard, 1981; Kennedy et al., 
1983), is mostly known for its postsynaptic role. However, CAMK2 also has important 
roles presynaptically. Most research on a presynaptic role for CAMK2 has been performed 
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on Camk2a mutant mice in the well-studied CA3-CA1 synapse in the hippocampus, 
where it is involved in neurotransmitter release and short-term synaptic plasticity, 
but not in basal synaptic transmission and paired-pulse facilitation (PPF) (Llinás et al., 
1985; Lin et al., 1990; Nichols et al., 1990; Chapman et al., 1995; Hinds et al., 2003; Hojjati 
et al., 2007; Jiang et al., 2008; Pang et al., 2010). The role of presynaptic CAMK2B still 
remains elusive, as well as the presynaptic role of the holoenzyme CAMK2 in long-
term potentiation (LTP). Studies so far have been using pharmacological approaches 
to investigate the function of presynaptic CAMK2. In one study using organotypic 
cultures of hippocampal slices blocking presynaptic CAMK2 in the CA3-CA3 synapse, 
LTP was reduced by 50% (Lu and Hawkins, 2006). Another study showed in dissociated 
hippocampal neurons that pharmacologically blocking presynaptic CAMK2 prevented 
the induction of LTP (Ninan and Arancio, 2004). These studies show an important role 
for presynaptic CAMK2 in the induction of LTP. A drawback of using inhibitors however 
is that they cannot distinguish between different isoforms like CAMK2A or CAMK2B. 
Additionally, inhibitors may fail to elucidate the full function of CAMK2 because they 
only block enzymatic activity, whereas it is known that CAMK2 can also have structural 
roles (Hojjati et al., 2007; Borgesius et al., 2011). In Chapter 4 we have used a genetic 
approach to elucidate the presynaptic role of CAMK2A and CAMK2B in the CA3 area of 
the hippocampus.
1.3.3 Postsynaptic functions
CAMK2 is both necessary (Silva et al., 1992b) and sufficient (Lledo et al., 1995) to induce 
LTP postsynaptically. Upon activation by Ca2+/Calmodulin and further autonomous 
activation by T286 autophosphorylation, CAMK2 can move to the PSD (Shen and Meyer, 
1999). There, CAMK2 can bind the NMDA-receptor (NMDAr). More specifically, after T286 
phosphorylation, a site opposite to T286, the T-site, can bind GluN2B (Bayer et al., 2001) 
or the NR1 subunit (Leonard et al., 1999) (Figure 1). It can bind specifically near S1303 
in NR2B (in a way that does not require T286 phosphorylation) or near amino acids 839 
and 1120 which does require autophosphorylation (Bayer et al., 2001). This way, CAMK2 
is strategically placed at the primary site of calcium entry into spines to control synaptic 
strength. CAMK2 bound to the NMDAr via the T-site can persist for more than 30 minutes 
after removal of calcium (Bayer et al., 2006). Interfering with the binding of CAMK2 to 
the NMDAr near S1303 greatly reduces the duration (and thereby the maintenance) of 
LTP (Barria and Malinow, 2005).
But how does CAMK2 strengthen synaptic transmission? Multiple mechanisms are 
known. First, the AMPA-receptor (AMPAr) subunit GluA1 contains a phosphorylation site, 




enhances channel conductance by 50% (Mammen et al., 1997; Barria et al., 1997a; 
Derkach et al., 1999; Kristensen et al., 2011). Second, autophosphorylated CAMK2 that 
binds to the NMDAr organizes a structural process along with many AMPAr anchoring 
proteins that will lead to an increase of AMPA receptors docking in the PSD (Lisman 
and Zhabotinsky, 2001). Additionally, a member of the transmembrane AMPA-receptor 
regulatory proteins stargazin (TARP g-2), an auxiliary protein on extrasynaptic AMPA 
receptors, can be phosphorylated (Tomita et al., 2005; Opazo et al., 2010). As a result, 
extrasynaptic AMPA receptors are trapped at the synapse by binding of stargazin to 
PSD95, a protein highly abundant in the PSD (Opazo et al., 2012). In summary, CAMK2 
can increase synaptic strength both by increasing AMPAr channel conductance per 
channel and by increasing the total number of AMPA receptors in the spine. In both 
ways, CAMK2 will greatly enhance postsynaptic sensitivity for presynaptic signals.
CAMK2 has also been implicated in regulating long-term depression (LTD), which 
involves the weakening of synapses (Stevens et al., 1994). During prolonged weak 
stimuli, known to induce LTD, CAMK2 phosphorylates GluA1 on S567 (Coultrap et al., 
2014). Phosphorylation of GluA1 on this site can reduce synaptic GluA1 localization 
(Lu et al., 2010), thereby weakening the synapse. This form of LTD is NMDA-receptor 
dependent and requires autonomous activity of CAMK2 (i.e. T286/7 phosphorylation) 
(Coultrap et al., 2014). Direct binding of CAMK2 to the NMDA-receptor can be reduced 
by the induction of LTD (Aow et al., 2015). CAMK2 is also known to phosphorylate GABA-
receptors and can thereby change the strength of inhibitory synapses (Wei et al., 2004; 
Houston et al., 2008). Other forms of LTD, such as group I metabotropic glutamate 
receptor-mediated long-term depression mGluR-LTD may also depend on CAMK2. The 
role of CAMK2 in this form of LTD is still unclear since blocking CAMK2 using KN62 can 
either facilitate (Schnabel et al., 1999) or inhibit group I mGluR-LTD (Mockett et al., 2011). 
1.3.4 CAMK2 and intrinsic neuronal excitability
Besides synaptic plasticity, neuronal excitability can also be controlled by CAMK2. For 
example, CAMK2A-T286A mutant mice show increased intrinsic excitability in CA1 
pyramidal neurons (Sametsky et al., 2009). According to this study CAMK2A functions 
to downregulate CA1 intrinsic neuronal excitability following synaptic stimulation 
(Sametsky et al., 2009). Another study found a role for CAMK2 in downregulating intrinsic 
excitability after induction of LTP. This was done by stimulating the Schaffer-collaterals 
while simultaneously depolarizing postsynaptic CA1 neurons. This downregulation 
requires CAMK2 activity, postsynaptic Ca2+ influx, NMDA-receptors, backpropagating 
action potentials, protein synthesis and increased I
h
 (Fan et al., 2005). CAMK2-mediated 
downregulation of intrinsic excitability has also been observed in vestibular nucleus 
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neurons (Nelson et al., 2005) and medium spiny neurons in the striatum (Klug et al., 
2012). In contrast, one report found that stimulating synaptic inputs correlating with 
postsynaptic neuronal spikes in CA1 pyramidal cells elicited both LTP and lowered the 
threshold for action potential generation, thereby increasing intrinsic excitability using 
a CAMK2-dependent mechanism (Xu et al., 2005). With the exception of the last study, 
CAMK2 seems to have an inhibiting function on excitability, but the exact mechanisms 
involved are yet to be elicited. 
Most of the abovementioned studies have used pharmacological inhibition to study the 
role of CAMK2 in excitability. Surprisingly, Camk2 mutants have only rarely been used 
to address CAMK2’s function in neuronal excitability and unitary synaptic transmission. 
In Chapter 5 we address these issues by using an inducible knockout mouse for both 
CAMK2A and CAMK2B.
1.3.5 Regulation of receptors by CAMK2
Receptors can function as gateways to conduct signals across the biological membrane 
of a cell. Many receptors in the brain are important for signaling with the extracellular 
environment including other neurons. CAMK2 is known to bind to and regulate 
multiple receptors. An overview of these receptors found so far is depicted in Table 2. 
Even though CAMK2 has been found to interact with receptors in cardiac tissue (e.g. see 
(Maier, 2011) and (Respress et al., 2012) or for review see (Bers and Grandi, 2009)) and 
in pancreatic cells (Kline et al., 2013), this section will only focus on neuronal receptors. 
In long-term potentiation, one of the most important channels known to be 
phosphorylated by CAMK2 is the AMPA receptor. As mentioned above, CAMK2 can 
phosphorylate the AMPA receptor subunit GluA1 on S831, which will increase channel 
conductance (Barria et al., 1997a; 1997b). Loss of autophosphorylation in the T286A 
knock-in mutant does not reduce phosphorylation at this GluA1 site, probably due to 
Ca2+-dependent activity of CAMK2 or by PKC, which can competitively phosphorylate 
GluA1 at S831. Both Serine 845 (S845), a PKA-dependent phosphorylation site on 
GluA1, and S831 regulate LTP and LTD as has been demonstrated in mutants where 
the Serines were mutated to Alanines (S831A and S845A), to prevent phosphorylation 
at these sites (phospho-deficient mutants) (Lee et al., 2003). Interestingly, single 
mutants (S831A or S845A) have normal LTP and only S845A mutants show impaired 
LTD whereas S831A mutants do not (Lee et al., 2010), indicating that S831 and S845 act 
in concert to induce LTP. However, S831 and S845 phosphorylation as one of the crucial 
steps in the mechanisms of LTP has been called into question by the discovery that 
mainly in adulthood only 1% of AMPA receptors at synapses is phosphorylated in the 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































glycine (Hosokawa et al., 2015). Further research is warranted to clarify this important 
discrepancy. Recently S567 was identified as another phosphorylation site on GluA1 
which can be phosphorylated by CAMK2 both in vitro and in vivo (Lu et al., 2010). 
Of equal importance in the mechanisms of LTP and also regulated by CAMK2 is 
the NMDA receptor. As mentioned earlier, CAMK2 can bind two sites on the NMDA 
receptor subunit GluN2B. First, CAMK2 can bind near S1303 which does not require 
T286 phosphorylation (Strack and Colbran, 1998; Barria and Malinow, 2005). Second, 
CAMK2 can bind between amino acids 839 to 1120 in a way that does require T286 
autophosphorylation (Bayer et al., 2001). Binding of CAMK2 to the GluN1 subunit has 
been described as well (Leonard et al., 1999).
CAMK2 can also bind to both members of group I metabotropic glutamate receptors 
(mGluR1 and 5), which are known to increase NMDA receptor activity (for review, see 
(Mao et al., 2014)). CAMK2 can phosphorylate mGluR1 at T871 (Jin et al., 2013b) and can 
bind to the C-terminal of mGluR5, although the exact binding sequence is still unknown 
and no phosphorylation sites have been found so far (Jin et al., 2013a). Interestingly, 
Calmodulin can also bind to the same C-terminal region on mGluR5, but it cannot 
bind to mGluR1 (Choi et al., 2011). On mGluR5, this can create competition for binding 
between CAMK2 and Calmodulin. Moreover, binding of CAMK2 to mGluR5, in contrast 
to mGluR1, is reduced upon activation of CAMK2 (Jin et al., 2013a). As mentioned above, 
the role of CAMK2 in DHPG-induced LTD, which acts through both mGluR1 and mGluR5, 
is unclear. In Chapter 4 we investigated the role of CAMK2A and CAMK2B in DHPG-
induced LTD.
Additionally, some members of the voltage-gated calcium channel family (VGCC) are 
also regulated by CAMK2. For example, CAMK2 can bind and phosphorylate both the 
Cavα1.2 and the Cavβ1.2 subunits (Hudmon et al., 2005; Grueter et al., 2008; Koval et 
al., 2010). Furthermore, CAMK2 can bind Cav1.3, belonging to the L-type VGCC mainly 
present on dendrites and soma, (Jenkins et al., 2010) thereby forming a crucial link 
in excitation-transcription coupling that is critical for learning and memory (Wang et 
al., 2017). CAMK2 can presynaptically bind Cav2.1, a P/Q-type VGCC (Jiang et al., 2008) 
and phosphorylate Cav2.2, an N-type VGCC in the C-terminus thereby enhancing 
interactions with SNARE protein complexes (Hell et al., 1994; Yokoyama et al., 2005) and 
postsynaptically phosphorylate Cav3.2 on S1198, a T-type VGCC (Welsby et al., 2003).
CAMK2 can bind and phosphorylate the dopamine D3 receptor (D3R) on S229 in mice, 
thereby negatively regulating dopamine signaling (Liu et al., 2009). In mice CAMK2 can 




channels on S438 and S459 thereby increasing surface expression of these channels and 
decreasing excitability of the cell (Varga et al., 2004). EAG (ether à go-go) channels are 
also phosphorylated by CAMK2 in Drosophila, enhancing current amplitude and slowing 
down inactivation of these channels (Wang et al., 2002). Finally, different subunits of the 
GABAA receptors can be phosphorylated on multiple sites in mice, mediating different 
functions such as increasing cell-surface expression and modulating channel activity (as 
reviewed in (Houston et al., 2009)).
1.4  DIFFERENCES IN CAMK2A AND CAMK2B FUNCTIONING
Despite the similarity between CAMK2A and CAMK2B (for examples, see (Hudmon 
and Schulman, 2002) and (Tobimatsu and Fujisawa, 1989)), few differences have been 
described as well. One of these examples is the binding of CAMK2B to actin, which will 
be discussed further in another section below. Studying differences of the isoforms of 
the CAMK2 family can be troubling, since pharmacologically there are no blockers that 
can target only one isoform specifically and knockout models for isoforms other than 
CAMK2A are still scarce. Despite these limitations some differences in functionality have 
been described. 
The first difference in functionality between CAMK2A and CAMK2B is their binding 
affinity for Calmodulin. The EC50 for Calmodulin, the effective binding at which 50% of 
maximum activity is achieved, is ~8 fold lower for CAMK2B homomers (15nM) than for 
CAMK2A homomers (130nM) (Brocke et al., 1999).
Second, in substrate specificity there are a few differences known between CAMK2A and 
CAMK2B. For example, the C-terminus of densin-180 selectively binds to CAMK2A (not 
to CAMK2B) (Robison et al., 2005). Another part more towards the N-terminus of densin 
binds both CAMK2A and CAMK2B (Jiao et al., 2011). CAMK2B specifically phosphorylates 
Cdc20-APC (Puram et al., 2011), while CAMK2A doesn’t. CAMK2B, but not CAMK2A, can 
phosphorylate actin under basal conditions, (O'Leary et al., 2006). Finally, CAMK2B binds 
Arc/Arg3.1 at low levels of Ca2+/Calmodulin (upon Ca2+/Calmodulin binding the affinity 
for Arc drops), but CAMK2A does not. 
Despite the high homology between CAMK2A and CAMK2B, the above-mentioned 
examples also indicate unique functions. The next to section of this introduction will 
focus on these differences. However, consideration of their shared involvement in 
learning and LTP and their overlap in substrates prompted the idea that they can also be 
redundant. For example, the reduction, but not the complete absence, of LTP in Camk2a 
knockout mice spawned the idea that the residual LTP was caused by CAMK2B. In 
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Chapter 4 we address this by using an inducible knockout mouse for both CAMK2A and 
CAMK2B. Furthermore, the simultaneous deletion of both CAMK2A and CAMK2B allows 
us to unravel new functions that were previously unknown due to this redundancy. 
1.5 CAMK2A
The literature on CAMK2A has expanded enormously ever since its discovery almost 40 
years ago. In light of the scope of this dissertation, this vast body of literature cannot be 
summarized completely. This summary of CAMK2A will only briefly address the different 
knockout and knock-in mutants that have been generated over the years. For a more 
detailed overview of CAMK2A I recommend excellent reviews such as (Lisman et al., 
2002; 2012; Hell, 2014).
CAMK2A is one of the most abundant protein kinases in the brain which is mostly 
present in the postsynaptic density of spines (Kennedy, 1997). Much of what we 
know of CAMK2A is due to the generation of knockout or knock-in mice. As early as 
1992, a Camk2a knockout mouse was generated, the first knockout mouse in the 
field of learning and memory. These knockout mice showed impaired spatial learning 
in the Morris watermaze and impaired LTP at the Schaffer-collateral pathway in the 
hippocampus (Silva et al., 1992a; 1992b). Additional Camk2a knockout mice have been 
generated that confirmed the LTP and hippocampal learning impairments (Hinds et al., 
1998; Elgersma et al., 2002). Interestingly, Camk2a knockout mice show reduced, but no 
complete absence of LTP. Further behavioral analysis revealed that Camk2a knockout 
mice also suffer from reduced fear-related responses, decreased aggression, increased 
pain sensitivity, increased startle response, increased vigilance and decreased mating 
(hardly any mating in knockouts) (Chen et al., 1994). 
More knock-in mouse mutants have been made for CAMK2A. The importance of T286 
phosphorylation was shown by mutating Threonine286 into a phospho-deficient alanine 
residue (T286A), thereby preventing autonomous activity of CAMK2A. These mice 
showed almost complete loss of NMDA-receptor-dependent LTP in the hippocampus 
and impairments in the Morris watermaze (Giese et al., 1998). Interestingly, the LTP 
impairment in the T286A mutant mice seemed greater than the impairment in the full 
knockout mutant. This could be explained by a dominant-negative effect of the T286A 
mutation, which can affect other isoforms present in the holoenzyme (e.g. CAMK2B). 
Another knock-in mutant created was the CAMK2A-T286D, with an aspartate instead of 
a threonine to mimic phosphorylation at this site. These mice also showed impairment 




learning in this knock-in mutant is thought to be caused by increased phosphorylation 
of TT305/6 which was found in vitro using these mutations, overruling the autonomous 
activity by inhibiting the enzyme (Pi et al., 2010). Perhaps not surprising, knock-in 
mutants for the inhibitory phosphorylation sites have been generated as well. In 
CAMK2A-TT305/5VA mice (phospho-deficient), CAMK2A can no longer be inhibited 
and these mice show more rigid and less fine-tuned learning and a lower threshold for 
LTP induction. Finally, in CAMK2A-T305D (phospho-mimic) mice CAMK2A can no longer 
bind Ca2+/Calmodulin and is therefore constantly in the inactive state. These mice show 
no learning and complete loss of LTP, which again can be explained by a dominant-
negative effect of CAMK2A, similar to what is seen in T286A mice (Elgersma et al., 2002). 
Not only is CAMK2A involved in LTP at the Schaffer-collateral pathway in the hippocampus, 
CAMK2A is also essential for experience-dependent plasticity (Glazewski et al., 1996). 
This type of plasticity can be induced in the barrel cortex by whisker deprivation. The 
autonomous activity of CAMK2A is especially important, as homozygous CAMK2A-
T286A mice have impaired experience-dependent plasticity (Glazewski et al., 2000). 
Even on the single cell level, using whole-cell electrophysiology, the loss of autonomous 
activity of CAMK2A results in impaired LTP (Hardingham et al., 2003). 
The use of knockout mice is an elegant tool to assess the molecular mechanisms 
underlying learning and memory. However, caution is warranted in the interpretations 
when using these mouse models. For example, even though expression of CAMK2A 
starts at P1 (Bayer et al., 1999), a developmental role for CAMK2A cannot be ruled out. It 
is possible that CAMK2A has a developmental role in the first postnatal days, which could 
cause the impairments in hippocampal learning and LTP seen in adult knockout mice. 
Second, it could be hypothesized that acute deletion has different effects compared to 
germline deletion. The latter could induce compensatory mechanisms, which might not 
be at play upon acute deletion. Third, the use of global knockout mice puts a restriction 
on spatial involvement of the candidate gene. For example, in the case of CAMK2A, it is 
unknown which brain regions are involved in the phenotypes present in global Camk2a 
mutant mice. In Chapter 2 we investigate these issues using a floxed Camk2a mutant 
mouse in which we induce genetic knockout of Camk2a in adult mice to dissect the 
temporal and region-specific requirements for CAMK2A.
1.6 CAMK2B
Even though CAMK2B was discovered relatively shortly after CAMK2A (Kennedy et al., 
1983), it was neglected for a long time likely due to the lack of a mouse model. However, 
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CAMK2B has been recently gaining attention in literature. CAMK2B has some very 
interesting and unique properties such as binding to actin thereby playing an important 
role in morphology of the cell. This part of the introduction will focus on everything 
known on CAMK2B: from the actin binding properties of CAMK2B to specific functions 
in LTP and homeostatic scaling. 
1.6.1 Actin Binding
One of the first functional differences found between CAMK2A and CAMK2B was their 
localization. When overexpressed separately, CAMK2A is mainly found to be cytosolic, 
whereas overexpression of CAMK2B co-localizes with PSD95 and the actin cytoskeleton 
(Shen et al., 1998). When overexpressed together, overexpression of both CAMK2A and 
CAMK2B changes the localization of CAMK2A to a similar distribution found for CAMK2B 
(Shen et al., 1998; Okamoto et al., 2004). This suggests that CAMK2B can determine the 
subcellular localization of CAMK2A. Indeed, when CAMK2B is removed, the localization 
of CAMK2A changes (Shen et al., 1998; Thiagarajan et al., 2002; Borgesius et al., 2011). 
The mechanism by which CAMK2B can target itself and CAMK2A to spines is by binding 
the major cytoskeleton protein actin. Actin is present in dendritic spines and it is 
involved in structural maintenance of spines and plasticity (Capani et al., 2001; Star et 
al., 2002; Okamoto et al., 2004; Hayashi and Majewska, 2005). CAMK2B can bind both 
polymeric F-actin (filamentous) (Fink et al., 2003; Okamoto et al., 2004; O'Leary et al., 
2006; Okamoto et al., 2007; Lin and Redmond, 2008) and free monomeric G-actin 
(globular) (Sanabria et al., 2009). 
CAMK2B is bound to actin in its basal state. Upon activation however, CAMK2B can 
detach from actin (Fink et al., 2003; O'Leary et al., 2006; Okamoto et al., 2007; Lin and 
Redmond, 2008). Various experiments have tried to assess the mechanisms of CAMK2B 
detachment. CAMK2B detachment from F-actin is regulated by an autophosphorylation 
event within the actin binding domain on at least two different putative sites: S331 and 
S371 (Martinez-Lozada et al., 2014). Absence of Ca2+/Calmodulin or mutations that 
interfere with CAMK2B activity result in a failure of CAMK2B to detach from actin. For 
example, expression of a CAMK2B protein with a mutation in its Calmodulin footprint 
(A303R), that prevents binding Ca2+/Calmodulin, or with a mutation in the catalytic 
domain (K43R), thereby lacking kinase activity, results in failure of CAMK2B to detach 
from actin (Lin and Redmond, 2008). Another mutant protein mimicking continuous 
autophosphorylation (T287D; similar to the T286D mutation in CAMK2A) reversely 
cannot bind actin (Lin and Redmond, 2008) and decreases dendritic branching (Puram 
et al., 2011). Finally, CAMK2 inhibitor KN93, which competes with Ca2+/Calmodulin 




monomeric CAMK2B, which lacks an association domain but still has the actin-binding 
domain intact, does not co-localize with actin. Therefore, the association domain and 
possibly oligomerization itself is also necessary for targeting CAMK2B to actin (Lin and 
Redmond, 2008).
Why is only CAMK2B able to bind actin, and not CAMK2A (but see (Khan et al., 2016))? 
The answer can be found in the variable domain of the protein, which in CAMK2B 
contains regions necessary for actin binding that are not present in CAMK2A. In 
general, CAMK2B contains three exons in the variable region (V) that are not present 
in the Camk2a gene (V1, V3 and V4). Two other exons in the variable region, V2 and 
V5, are not unique to CAMK2B as they are present in both CAMK2A and CAMK2B. V1 is 
most important for actin binding (O'Leary et al., 2006), but presence of V4 can further 
strengthen this binding. These exons in the variable region also give rise to alternative 
splice variants known to CAMK2B. Most prominently expressed in the adult brain in vivo 
is the full-length b splice variant (Brocke et al., 1995). This full-length splice variant is 
capable of binding actin (O'Leary et al., 2006). Other described splice variants are bM, bE 
, b’ and b’E. The E stands for embryonic, since these splice variants are expressed mainly 
during embryonic development (Brocke et al., 1995). The M in bM stands for muscular, 
because this splice variant is mainly found in skeletal muscles (Bayer et al., 1998). An 
overview of these splice variants along with the exons from the variable region that are 
translated into protein can be found in Table 3. In short, V1 is present in the full-length 
CAMK2B splice variant, but not in the bE and b’E. Therefore, these splice variants cannot 
bind actin (Brocke et al., 1995; O'Leary et al., 2006). V1 is also present in b’, but compared 
to full-length b it misses V4 and therefore binding of b’ to actin is decreased (Shen et al., 














pancreatic islet cells, hippocampus, cortex
pancreatic islet cells, hippocampus, cortex
Table 3. Overview of CAMK2B splice variants
βM muscular skeletal muscles, pancreatic islet cells, neurons weak  V1-V6 
Actin Binding Exonsb 
strong  V1-V5 
no binding  V2-V5 
moderate/strong V1-V3, V5 
no binding  V2, V3, V5
aAs has so far been described in literature
bAs expressed in the translated splice variant 
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1.6.2 CAMK2B and neuronal morphology 
1.6.2.1 CAMK2B and dendritic arborization and spine morphology
Since actin is a major constituent of the cytoskeleton of eukaryotic cells and the 
cytoskeleton is responsible for the morphology of these cells, actin-binding proteins 
like CAMK2B influencing the cytoskeleton can also regulate morphology, like dendritic 
arborization and spine density. Many studies have been conducted to elucidate the role 
of CAMK2B in morphology of neurons. The effects of changing expression of CAMK2B 
by either knockdown or overexpression on dendritic arborization vary among reports, 
as will become clear below. Not only the use of different techniques but also temporal 
differences in the manipulation performed can change the effect on morphology. 
For example, one report showed that overexpression of CAMK2B increases dendritic 
arborization and filopodia motility and knockdown of CAMK2B decreases arborization 
(Fink et al., 2003). According to another report knockdown of CAMK2B actually increases 
dendritic arborization (Puram et al., 2011). Since both studies use the same technique 
(primary neuronal cultures) the contrast in findings might lie in the difference in the time 
point the neurons were harvested from the rat brain to obtain cultured hippocampal 
neurons, E18.5 (Puram et al., 2011) versus postnatal day 6 or 10 (Fink et al., 2003). This 
effect of CAMK2B was only found in young cultures and not in adult cultures, implying 
that CAMK2B only has an effect on dendritic arborization within a critical window of 
development (Fink et al., 2003).
The effect of overexpression or knockdown of CAMK2B remains inconclusive with respect 
to spine density. Overexpressing CAMK2B in cultured hippocampal neurons increases 
spine density whereas knockdown decreases it (Fink et al., 2003). Overexpressing 
CAMK2B can increase mEPSC frequency, an effect likely to be mediated by an increase in 
dendritic branching or spine density (Thiagarajan et al., 2002). However, the knockdown 
effect on spine density is less consistent. Another study found that upon knockdown 
of CAMK2B in organotypic slices of the hippocampus spine density does not change 
but interestingly spine volume decreases and neck length increases, conversing mature 
spines into immature spines (Okamoto et al., 2007). 
To further complicate the issue, mice that are knockout for CAMK2B (Camk2b–/–) have 
normal gross morphology (Bachstetter et al., 2014) and show no changes in dendritic 
arborization, spine density, neck length and head width in cerebellar Purkinje cells 
(Van Woerden et al., 2009). Similarly in the hippocampus, spine density is unchanged 
in Camk2b–/– mice (Borgesius et al., 2011). It is possible that Camk2b–/– mice have 
no phenotype in arborization and spine density because the loss of CAMK2B is 




or knockdown within the neuronal cultures in vitro are perhaps not compensated due 
to their rapid onset. Another possibility is that morphology itself is regulated differently 
when neurons are in culture compared to in vivo. For example, there are clear differences 
between the extracellular environment in these two conditions and extracellular matrix 
proteins are known to influence morphogenesis (Rozario and DeSimone, 2010; Gordon 
et al., 2013). 
Overall, it seems clear that under certain in vitro conditions, CAMK2B can influence the 
morphology of neurons. In the knockout mouse models for CAMK2B, however, these 
observations have not been made. This could mean that in Camk2b knockout mice, 
compensatory mechanisms are at play. 
1.6.2.2 Gating mechanism for structural plasticity
What is the function of CAMK2B attachment to actin and detachment upon entry of 
calcium mentioned before and what does it mean for the morphology, organization 
and functioning of the spine? The detachment of CAMK2B allows actin regulatory 
proteins like cofilin and the Arp2/3 complex to act on the polymerization of actin. The 
activation of CAMK2B leads to a brief time window in which the actin cytoskeleton 
within a spine can be remodeled. Re-attachment of CAMK2B closes this time window 
and stabilizes the new F-actin structure for extended periods of time. In this model, 
CAMK2B acts as a negative regulator of actin remodeling in spines and as a molecular-
temporal gate for synaptic plasticity (Kim et al., 2015). However, actin detachment alone 
is not sufficient to induce structural changes to the cytoskeleton. Glutamate receptor 
signaling has to accompany this detachment in order for structural changes to occur. 
This way, coincidence detection underlies the structural plasticity changes, which can 
work as a double-verification step (Kim et al., 2015).
1.6.2.3 Other pathways in neuronal morphology regulated by CAMK2B
Next to providing a gating mechanism in spines, other mechanisms are known by which 
CAMK2B regulates morphology. Although much is still unclear, a small summary of all 
known pathways in which CAMK2B is involved will be discussed here. In granule neurons 
CAMK2B can phosphorylate NeuroD at Ser336 which regulates dendritic growth and 
maintenance (Gaudillière et al., 2004). CAMK2B can also bind to PCM1 using a unique 
centrosomal binding sequence (CTS) that is not present in CAMK2A. Using this CTS to 
bind to PCM1, CAMK2B can be targeted to the centrosome where it can phosphorylate 
Cdc20 on Ser51. Upon phosphorylation, Cdc20 will leave the centrosome, which will 
lead to dendrite retraction and pruning (Puram et al., 2011). Activation of group 1 
mGluR and subsequent activation of PKC has been shown to phosphorylate CAMK2B 
in cerebellar Purkinje cells promoting spine formation and elongation (Sugawara et al., 
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2017). In addition, Rem2 is also a substrate of CAMK2B. Phosphorylation of Rem2 by 
CAMK2B reduces dendritic branching (Ghiretti et al., 2013). CAMK2B can phosphorylate 
LIM-kinase1 (LIMK1) on Thr508 and thereby activate the cofilin-phosphorylating activity 
of LIMK1, which is part of a pathway involved in BDNF-induced enhancement of primary 
neurite formation (Saito et al., 2013). Taken together, CAMK2B can interact with multiple 
proteins to regulate neuronal morphology. However, it is still unclear whether these 
interactions are present throughout the brain or whether pathways through which 
CAMK2B can regulate morphology differ between cell types or brain regions. 
1.6.3 CAMK2B in different cell types
1.6.3.1 CAMK2B in interneurons
CAMK2B and CAMK2A are widely expressed throughout pyramidal cells in the cortex 
and the hippocampus, but in interneurons in these brain regions only CAMK2B is 
abundantly expressed and CAMK2A is not expressed at all (Liu and Jones, 1996; Sík et al., 
1998; Thiagarajan et al., 2002). Considering the important role for CAMK2A in mediating 
plasticity in both cortical and CA1 hippocampal pyramidal cells, the absence of CAMK2A 
in interneurons poses the question whether CAMK2B might be responsible for plasticity 
in interneurons. Especially interneurons in the stratum radiatum of the hippocampus 
are a likely candidate for CAMK2B to regulate plasticity since LTP expressed there from 
glutamatergic synapses is mostly NMDA receptor-dependent (Lamsa et al., 2005). 
Indeed, CAMK2 inhibitors KN62, KN93 and an autoinhibitory peptide blocks LTP in these 
interneurons (Wang and Kelly, 2001; Lamsa et al., 2007a). 
However, interneurons within the hippocampus can be quite diverse (Klausberger 
and Somogyi, 2008). Interneurons in the stratum radiatum as mentioned above are 
mostly expressing NMDA receptor-dependent LTP. However, most interneurons in the 
stratum oriens of the hippocampus are expressing NMDA receptor-independent LTP 
(Perez et al., 2001; Kullmann and Lamsa, 2007; Lamsa et al., 2007b). If CAMK2B is also 
important for plasticity in the latter group of interneurons, it poses the interesting 
question where the source of Ca2+ is coming from in these interneurons if not from 
the NMDA-receptor. Interestingly, these neurons have a high number of GluA2-lacking 
AMPA receptors, which are, next to sodium-permeable, also calcium-permeable (Matta 
et al., 2013). If indeed CAMK2B plays an important role in these interneurons, then the 
source of calcium needed to activate CAMK2B could well be the GluA2-lacking AMPA 
receptors. Importantly, there are LTP pathways known in pyramidal cells that involve 




the case for interneurons that express calcium-permeable AMPA receptors (Asrar et al., 
2009). Therefore, whether there is a role for CAMK2B in these cells in LTP remains to be 
uncovered. 
1.6.3.2 CAMK2B in oligodendrocytes
In addition to its abundant expression in excitatory and inhibitory cells, CAMK2B is 
also present in oligodendrocytes (Cahoy et al., 2008; Martinez-Lozada et al., 2014). 
There it regulates translation of proteins (Flores-Méndez et al., 2013), maturation 
of oligodendrocytes and myelination of axons (Waggener et al., 2013). Knockdown 
of CAMK2B mRNA restrains the establishment of an expanded process network that 
could be compared to the dendritic arborization in neurons (Waggener et al., 2013). 
Upon stimulation of oligodendrocytes with glutamate, CAMK2B becomes active and 
an autophosphorylation event occurs at S371 to further promote oligodendrocyte 
maturation (Martinez-Lozada et al., 2014). This phosphorylation event is also observed 
in neurons (Kim et al., 2015). Also, Camk2b–/– mice show decreased thickness of myelin 
sheath whereas Camk2bA303R/A303R mice have normal myelination, implying that CAMK2B, 
in contrast to oligodendrocyte maturation, has a structural role in myelination of axons 
(Waggener et al., 2013). 
1.6.4 CAMK2B in LTP and homeostatic scaling
1.6.4.1 CAMK2B in hippocampal LTP
Does CAMK2B have a similar role in LTP as CAMK2A in pyramidal neurons? CAMK2B 
seems to have a structural role in hippocampal CA1 neurons. Camk2b–/– mice have 
impaired hippocampus-dependent learning and LTP at the CA3-CA1 Schaffer-collateral 
pathway. In contrast, Camk2bA303R/A303R mice expressing mutant CAMK2B that can no 
longer bind Ca2+/Calmodulin show normal learning and LTP. One striking difference 
between these two mutants is that the Camk2bA303R/A303R mutant can still target CAMK2A 
to spines, which is most likely the explanation for the lack of a phenotype in these mice 
(Borgesius et al., 2011). 
It is interesting that Camk2bA303R/A303R mice do not show impaired hippocampus-
dependent learning even though the mutation in these mice prevents CAMK2B 
from detaching from actin (Borgesius et al., 2011). The question then arises whether 
structural LTP is still present in Camk2bA303R/A303R mice. According to (Kim et al., 2016), 
detachment from actin is essential for both electrophysiologically measured functional 
and structural LTP. It could therefore be hypothesized that CAMK2B-A303R mice have 
normal functional LTP but do not have the structural changes in spine size that are 
accompanied with it. 
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Perhaps CAMK2B-A303R mice are able to keep a gate at the spine neck by binding to 
actin. For example, CAMK2B with the length of its own homomere can bind two filaments 
of actin (Sanabria et al., 2009), which keeps these filaments relatively close, preventing 
diffusion of other proteins out of the spine (see also (Allison et al., 2000)). It could be 
hypothesized that the CAMK2B-A303R mice do not show a phenotype because of 
keeping this gate closed, whereas the CAMK2B knockout mice have a problem keeping 
this gate closed and as a result, CAMK2A can diffuse out of the spine.
1.6.4.2 CAMK2B in cerebellar LTP
Considering the high expression of CAMK2B in the cerebellum, it is perhaps not 
surprising that it has an important role in LTP there as well. Many studies have focused 
more specifically on the cerebellar Purkinje cells, the only cell type in the cerebellum 
that also expresses CAMK2A (Walaas et al., 1988). 
The plasticity rules are different in the cerebellum compared to the hippocampus 
(Bienenstock et al., 1982; Lev-Ram et al., 2002; Coesmans et al., 2004). At the parallel 
fiber-Purkinje cell synapse, phosphatases are responsible for LTP induction, whereas 
kinases are responsible for LTD induction (Coesmans et al., 2004; Belmeguenai and 
Hansel, 2005; Kakegawa and Yuzaki, 2005). Stimulation of the parallel fibers results 
in a low influx of calcium postsynaptically in Purkinje cells, which will activate mainly 
phosphatases. This low influx will allow phosphatases to outcompete kinases allowing 
phosphatases to induce LTP at the parallel fiber-Purkinje cell synapse. Upon stimulation 
of parallel fibers in combination with the climbing fiber, which will result in a high influx 
of calcium, kinases will outcompete phosphatases resulting in LTD at the parallel fiber-
Purkinje cell synapse. Note that for the cortex and hippocampus these rules are inversed, 
meaning that at low calcium levels phosphatases still outcompete kinases, but in these 
brain regions this results in LTD. High influx of calcium results in kinases outcompeting 
phosphatases leading to the induction of LTP.
Interestingly, deleting CAMK2A in the cerebellum using Camk2a–/– mutant mice impairs 
the induction of LTD. Upon low influx of calcium phosphatases will outcompete kinases 
leading to LTP. Upon high influx of calcium, phosphatases will still outcompete kinases 
due to the lack of the abundant kinase CAMK2A, and hence LTP will also be induced at 
higher calcium influx (Hansel et al., 2006). 
However, in Camk2b–/– mice, the loss of CAMK2B results in a complete reversal of the 
plasticity rules governed at the parallel fiber-Purkinje cell synapse (Van Woerden et 
al., 2009). First, low calcium influx caused by stimulating parallel fibers results in LTD. 




fiber results in LTP (Van Woerden et al., 2009). The latter observation can be explained by 
an overall lack of an abundant kinase, resulting in phosphatases outcompeting kinases 
at high levels of calcium influx, comparable to high calcium influx in Camk2a–/– mice. But 
that does not explain the former observation, where low influx of calcium results in LTD. 
The authors explain this observation by addressing an important function of CAMK2B: 
binding to actin (Okamoto et al., 2007). The lack of CAMK2B can result in more available 
CAMK2A not bound to actin in heteromeric holoenzymes that can mediate precocious 
kinase activity. Furthermore, previous experiments have shown that homomeric 
CAMK2A holoenzymes can move to the PSD 4 times faster than mixed CAMK2A/CAMK2B 
holoenzymes and 24-fold faster than homomeric CAMK2B holoenzymes (Shen et al., 
1998), which can explain the ready availability of CAMK2A in the absence of CAMK2B. 
This way, CAMK2B orchestrates the direction of plasticity at the parallel fiber-Purkinje 
cell synapse.
1.6.4.3 CAMK2B in homeostatic scaling 
CAMK2B and CAMK2A can also play an important role in homeostatic scaling. Blocking 
AMPA receptors for up to 24 hours increases the CAMK2B/CAMK2A ratio in neurons 
and increases expression of surface GluA1, mediated by enzymatic activity of CAMK2B, 
which in turn increases in mEPSC amplitude and frequency if the AMPA block is 
alleviated (Thiagarajan et al., 2002; Groth et al., 2011). Blocking all inhibition decreases 
the CAMK2B/CAMK2A ratio, and decreases the frequency and increases the amplitude 
of mEPSCs. Interestingly, the up and down regulation are reciprocal, the total levels of 
CAMK2 do not change. Because of this, excitatory neurons can regulate homeostatic 
scaling upon strong input by increasing levels of CAMK2A, which has an 8-fold weaker 
binding affinity for Ca2+/Calmodulin, and when input is low, increasing levels of 
CAMK2B, which has a stronger binding affinity for Ca2+/Calmodulin (Brocke et al., 1999; 
Thiagarajan et al., 2002). This provides a neuronal tuning mechanism to different levels 
of activity in the cell. This tuning mechanism has been suggested to work through the 
scaffolding protein GKAP (Shin et al., 2012). The question remains, how these tuning 
mechanisms play a role in vivo where the window of activity changes is narrower than 
in the conditions used in these papers, and the activity can vary more between different 
synapses within the same neuron. 
1.6.5 CAMK2B and the synaptic tag hypothesis
In 1997 Uwe Frey and Richard Morris postulated the idea of a ‘synaptic tag’ in long-term 
potentiation (Frey and Morris, 1997). Although the nature of this tag is still unclear, the 
authors stated that this tag will enable synapses that have undergone LTP to capture 
newly synthesized plasticity-related proteins to maintain increased synaptic strength 
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over the course of hours to days or even years. Interestingly, disruption of the actin 
cytoskeleton can disrupt this synaptic tag (Ramachandran and Frey, 2009). In addition, 
KN62 can prevent the establishment of this tag (Sajikumar et al., 2007). This would imply 
that CAMK2B could be involved in the formation of this tag since it binds actin and can 
be inhibited by KN62. Indeed, CAMK2B has been proposed to be at least part of this 
synaptic tag (Okuno et al., 2012; 2017), but not as a synaptic tag but rather by acting 
oppositely as an inversed synaptic tag by binding Arc (also called Arg3.1) at inactive 
synapses. Arc is an immediate early gene whose induction highly correlates with 
augmented neuronal activity (Link et al., 1995; Lyford et al., 1995; Guzowski et al., 1999; 
Ramírez-Amaya et al., 2005). Arc can bind inactive CAMK2B predominantly at synapses 
that have not been active for a while. Because of this, the binding of Arc with inactive 
CAMK2B can act as an inversed synaptic tag, creating a tag for inactive synapses to stop 
newly synthesized plasticity-related proteins from entering the synapse, keeping them 
only available for synapses that do not have this inverse synaptic tag (Okuno et al., 2012; 
2017) and have undergone LTP. 
1.6.6 CAMK2B in locomotion 
As discussed before, on a behavioral level, Camk2b–/– mice have hippocampus-dependent 
learning problems in contextual fear conditioning (Borgesius et al., 2011). Since CAMK2B 
has an important role in actin binding and plasticity, even inversing the plasticity rules in 
the cerebellum, a brain region important for motor control, the question rises whether 
knockout animals for Camk2b show outspoken motor phenotypes. Indeed, ever since 
the generation of the first Camk2b knockout mouse (Camk2b–/–) (Van Woerden et al., 
2009), it has become clear that CAMK2B has an important function in locomotion. 
Camk2b–/– mice show a reduced latency on the accelerating rotarod and an impairment 
to stay on the balance beam (Van Woerden et al., 2009). These phenotypes were later 
independently verified in another CAMK2B knockout mouse (Bachstetter et al., 2014) 
together with new phenotypes including lower weight in the first 3-9 weeks of age 
(but normal birth weight), increased fat mass at 12 weeks of age, decreased strength in 
the forelimbs in the grip strength test, decreased spontaneous activity in the running 
wheel, reduced anxiety related behavior and decreased nest building (Bachstetter et al., 
2014). Most of these phenotypes can be ascribed to the impaired locomotion in these 
mice. Since CAMK2B is expressed in abundance in major brain regions implicated in 
locomotion from early development, it is unclear whether these motor problems (i) have 
a developmental origin, i.e. an important role for CAMK2B during early development, (ii) 
are due to an important post-developmental role for CAMK2B in one or multiple brain 




try to dissect the spatiotemporal requirements of CAMK2B in locomotion by crossing 
the Camk2bf/f mouse with specific Cre-lines deleting the Camk2b gene in brain regions 
known to be important for locomotion. 
1.7  CAMK2 INHIBITORS
Because knockout mice for Camk2a and Camk2b were not always available, much 
research has used pharmacological inhibitors to elucidate the kinetic role of CAMK2 in 
the brain. However, it is of utmost importance that: (i) these inhibitors are applied at the 
right concentration (ii) these inhibitors are CAMK2-specific and (iii) off-target effects are 
known and considered. This section will focus on which CAMK2 inhibitors are mainly 
used in literature and which of these above issues have been addressed.
In recent years, multiple inhibitors for CAMK2 have been developed. Some are specific 
for CAMK2, whereas others inhibit a broader range of Ca2+/Calmodulin-dependent 
protein kinases. Potency can also vary significantly between drugs. An overview of the 
most used inhibitors for CAMK2 can be found in Table 4, divided into three different 
classes, along with their specificity and known off target effects. In short, the first class 
are the artificially developed drugs KN62 and KN93, the second class are peptides based 
on the autoinhibitory domain of CAMK2 like AIP and AC3-I and the third class consists of 
the group of endogenous proteins like CAMKIIN and newly developed peptides based 
on CAMKIIN.  
One of the first inhibitors developed was KN62 in 1990 (Tokumitsu et al., 1990). However, 
KN62 is hydrophobic which limits the application of this drug in vitro or in vivo, as it must 
be dissolved in DMSO, which can be harmful for the tissues or cultured cells. Therefore, 
in 1991, a new inhibitor, KN93, was developed which was dissolvable in water but still 
able to cross the cell membrane (Sumi et al., 1991). KN62 and KN93 both compete with 
Calmodulin in binding to CAMK2 (Tokumitsu et al., 1990; Sumi et al., 1991). Because of 
their competitive nature with Calmodulin, it could be expected that KN62 and KN93 
have off-target effects with other CaM binding proteins. Indeed, KN62 was found to 
block CAMK5 (Mochizuki et al., 1993) and CAMK4 in vitro (Enslen et al., 1994). 
Next to having these broader effects on closely related protein kinases, additional 
off-target effects of KN93 and KN62 are known. For example, KN62 and KN93 have an 
effect on basal activity levels of tyrosine hydroxylase (TH), the rate-limiting enzyme in 
catecholamine synthesis (Ishii et al., 1991; Sumi et al., 1991). These effects were also 
found by their respective inactive analogues KN04 and KN92 (Tombes et al., 1995) in a 






























































































































































































































































































































































































































































































































































































































































































that these effects were not mediated through CAMK2 but were indeed off-target. 
Furthermore, KN93 and its inactive analogue KN92 are both known to decrease CaV1.2 
and CaV1.3 currents, an effect not seen when using a more specific CAMK2 inhibitor, 
autocamtide-2-related inhibitory protein (AIP; will be further discussed below) (Gao et 
al., 2006). Moreover, KN62 is known to block P2X7 receptors, an effect also accomplished 
by the inactive analogue KN04 (Gargett and Wiley, 1997). Finally, KN93 and KN92 are 
known to block inward rectifying potassium channels (IKR) in mammalian ventricular 
myocytes (Hegyi et al., 2015).
In 1995 two more potent inhibitory drugs, autocamtide-2-related inhibitory protein 
(AIP) and autocamtide-3 inhibitor (AC3-I), were developed (Braun and Schulman, 1995b; 
Ishida et al., 1995). These drugs are >100 times more selective for CAMK2 than they 
are for PKC, PKA or CAMK4. Both AIP and AC3-I mimic the autoinhibitory domain of 
CAMK2A but have their phosphorylatable Thr286/287 substituted for an Alanine. They 
block CAMK2 by competing with substrates for binding to the catalytic domain. Off-
target effects have been described. For example, AC3-I can inhibit cellular actions of 
protein kinase D1 (PKD1) (Backs et al., 2009). A control peptide for AC3-I is available 
(AC3-C), but it is not as often used as KN92 or KN04 (Patel et al., 1999; Wu et al., 2009). 
AIP or AC3-I are sometimes modified by lipids to enhance cell membrane permeation, 
but some effects unrelated to CAMK2 inhibition were shown for these peptides as well 
(Wu et al., 2009).
A third class of CAMK2 inhibitors is a group of endogenous proteins that inhibit CAMK2 
with high affinity. Two small proteins have been identified, CaM-KIINa and CaM-KIINb, 
sometimes collectively called CAMKIIN, and both proteins can be found throughout the 
brain (Chang et al., 2001; Pellicena and Schulman, 2014). The a and b in these proteins 
do not relate to the CAMK2 isoforms as these proteins block all CAMK2 isoforms equally 
with an IC50 of 50nM (Chang et al., 2001). Further analysis of the core inhibitory domain 
of CAMKIIN led to the generation of CAMKIINtide, a 28 amino acid long peptide inhibitor 
(Chang et al., 1998). CAMKIIN and CAMKIINtide both block CAMK2 in the kinase domain, 
meaning that they can only block CAMK2 after it has been activated by Ca2+/Calmodulin 
or when it is autophosphorylated. Further adjustments of CAMKIINtide led to even more 
potent, more specific and shorter peptides, such as CN21a (Vest et al., 2007), CN19o with 
an IC50 < 0.4nM (Coultrap and Bayer, 2011) and CN17b (Gomez-Monterrey et al., 2013).
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1.8  CAMK2 IN BRAIN DISEASE
By the end of this introduction it should become clear that CAMK2 is involved in a 
plentitude of pathways. Therefore, it should not be surprising that CAMK2 is implicated 
in many brain diseases. Examples of diseases are epilepsy ((Churn et al., 2000; McNamara 
et al., 2006; Yamagata et al., 2006), reviewed in (Liu and Murray, 2012)), Alzheimer’s 
disease (Kummer et al., 2014) (reviewed in (Ghosh and Giese, 2015)), Parkinson’s disease 
(Picconi et al., 2004), depression (Li et al., 2013), bipolar disorder (Ament et al., 2015), 
alcohol addiction (Easton et al., 2013; Schöpf et al., 2015) and Angelman syndrome 
(Weeber et al., 2003; Van Woerden et al., 2007). 
Most studies did not differentiate between different isoforms. Therefore, it is not clear 
whether a single isoform or all isoforms of CAMK2 are involved in the pathophysiology 
of the disease. One exception is a study that found a role for CAMK2B in depression 
(Li et al., 2013). In congenitally learned helpless rats, an animal model for depression, 
CAMK2B protein is upregulated in the lateral habenula, a brain region implicated 
in depression (Li et al., 2013). Overexpression of CAMK2B in wildtype mice and rats 
results in depression-like behavior. Conversely, reducing CAMK2B levels in these rats 
rescues depression-like behavior, indicating that CAMK2B is an important mediator of 
depression-like behavior in the lateral habenula. Interestingly, CAMK2G is even more 
upregulated in this animal model, but was not further tested, so the role for CAMK2G in 
depression remains elusive (Li et al., 2013). Even though the mechanism for depression 
in this study is limited only to CAMK2B and not to CAMK2A, a potential role for CAMK2A 
in depression cannot be ruled out since it has been found to be down-regulated in the 
hippocampus and prefrontal cortex of humans with depression who committed suicide 
(Fuchsova et al., 2015). 
However, papers describing isolated deletions or mutations in one of the Camk2 genes 
in humans have been scarce. One paper described heterozygous deletion of human 
CAMK2A as part of a large deletion encompassing several genes in two persons with 
Treacher Collins syndrome with unexpected intellectual disability, where the deletion 
of CAMK2A could explain the intellectual disability (Vincent et al., 2014). 
Another missense mutation in CAMK2A, CAMK2A-E183V, was found and associated with 
autism-spectrum disorder (Iossifov et al., 2014). This CAMK2A-E183V mutation was later 
shown to decrease CAMK2A kinase activity and interactions with CAMK2 associated 
proteins and to increase CAMK2A turnover in cells (Stephenson et al., 2017). Moreover, 




synaptic transmission. CAMK2A-E183V knock-in mice also show aberrant behavioral 
phenotypes including hyperactivity, decreased social interaction and increased 
repetitive behaviors (Stephenson et al., 2017). 
In an evaluation of 100 patients with intellectual disability and an IQ <50 with unaffected 
parents, a missense mutation in CAMK2G (Arg292Pro) was found in one of these patients 
(de Ligt et al., 2012). CAMK2G being the first paralog found in intellectual disability in 
humans was somewhat surprising considering the strong abundance and specific 
neuronal expression of CAMK2A and CAMK2B compared to the lower expression of 
CAMK2G as well as its non-specificity in neurons. Recently however, new important roles 
for CAMK2G in the coupling of neuronal excitation to transcription are being unraveled, 
increasing our understanding of CAMK2G and possible pathophysiology if indeed the 
CAMK2G mutation turns out to be cause of the intellectual disability (Ma et al., 2014; 
Cohen et al., 2015; 2016).
Very recently, 19 rare de novo mutations were found in individuals with intellectual 
disability in both CAMK2A and CAMK2B and screened for their effect on CAMK2 function 
and neuronal migration. Some mutations increased CAMK2 autophosphorylation 
and others decreased it, but interestingly, all mutations that interfered with 
autophosphorylation also affected neuronal migration, implicating a tight regulation 
between autophosphorylation and development (Küry et al., 2017). With new genomic 
screening techniques becoming more affordable than ever, it will be very interesting to 
see what the future holds in store for us when it comes to CAMK2A, CAMK2B, CAMK2G or 
CAMK2D mutations in humans. 
1.9  SCOPE OF THIS DISSERTATION
This dissertation will focus on both CAMK2A and CAMK2B, on both their independent 
role in neuronal and cognitive functioning as well as their collective role. In Chapter 
2 we focus on the CAMK2A’s function in adulthood. Using an inducible Camk2a 
knockout mutant, we investigate the spatial and temporal requirements of CAMK2A in 
hippocampal-dependent learning and LTP. In Chapter 3 we use a similar approach with 
an inducible Camk2b knockout mutant, now investigating the molecular, spatial and 
temporal requirements of CAMK2B in locomotion. Finally, in Chapter 4 and 5 we use a 
similar approach with mice where both CAMK2A and CAMK2B are deleted throughout 
the brain, uncovering previously unknown functions of CAMK2 in survival (Chapter 4) 
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The alpha isoform of the calcium/calmodulin-dependent protein kinase II (aCaMKII) has 
been extensively implicated in molecular and cellular mechanisms underlying spatial 
and contextual learning in a wide variety of species. Germline deletion of Camk2a leads 
to severe deficits in spatial and contextual learning in mice. However, the temporal and 
region-specific requirements for αCaMKII have remained largely unexplored. Here, we 
generated conditional Camk2a mutants to examine the influence of spatially-restricted 
and temporally-controlled expression of αCaMKII. Forebrain-specific deletion of the 
Camk2a gene resulted in severe deficits in water maze and contextual fear learning, 
while mice with deletion restricted to the cerebellum learned normally. Furthermore, 
we found that temporally-controlled deletion of the Camk2a gene in adult mice is as 
detrimental as germline deletion for learning and synaptic plasticity. Taken together, we 
confirm the requirement for αCaMKII in the forebrain, but not the cerebellum, in spatial 
and contextual learning. Moreover, we highlight the absolute requirement for intact 
αCaMKII expression at the time of learning.
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INTRODUCTION
Mouse genetic studies with targeted mutations of the Camk2a gene have greatly 
contributed to establishing the causal link between synaptic plasticity and learning 
(Silva et al., 1992a; Silva et al., 1992b; Giese et al., 1998; Elgersma et al., 2002). However, 
the interpretation of results using germline knockout mice requires consideration 
of possible neurodevelopmental influences on the phenotype of adult mice, given 
the absence of gene expression not only at the time of learning but also throughout 
neural development. Perhaps most importantly for interpreting the extensive literature 
utilizing germline Camk2a knockout mice, it remains unclear how the absence of 
αCaMKII during the early postnatal period might adversely influence brain development, 
thereby leading to the observed deficits in spatial and contextual learning. In contrast, 
most current models of αCaMKII function in synaptic plasticity and learning posit its 
requirement at the time of learning, independent of any developmental influences 
(for review see (Elgersma et al., 2004)). Therefore, distinguishing between the potential 
developmental influences of αCaMKII versus its necessity at the time of learning remains 
a highly important question.
Many distinct brain regions have robust αCaMKII expression, for which germline Camk2a 
knockout mice have not provided a definitive experimental model to dissociate region-
specific influences. In the cortex and hippocampus, αCaMKII is exclusively found in 
glutamatergic pyramidal neurons (Benson et al., 1992; Jones et al., 1994; Sik et al., 1998), 
whereas in the striatum it is localized to GABAergic medium-spiny neurons (Benson et 
al., 1992; Takeuchi et al., 2002). Additionally, αCaMKII is expressed in cerebellar Purkinje 
cells, where it is required for intact parallel fiber-Purkinje cell long-term depression 
(LTD) (Hansel et al., 2006), a form of plasticity suggested to contribute not only to 
motor learning, but also to spatial and contextual learning (Lalonde and Strazielle, 
2003; Burguiere et al., 2005; Goddyn et al., 2006; Burguiere et al., 2010; Galliano et 
al., 2013). Therefore, examining the region-specific role of αCaMKII on learning offers 
unique insights into the functioning of this highly abundant synaptic protein, and more 
generally on the systems-level neurobiology of spatial memory.
In the current study, we engineered a conditional Camk2a allele in order to fully 
parameterize the contribution of αCaMKII to learning and memory, thereby permitting 
spatiotemporal control over deletion. We found that loss of αCaMKII in adulthood leads 
to similar deficits as observed in the global knockout, which lacks αCaMKII expression 
from conception. Moreover, we confirm the critical importance of αCaMKII in the cortex 
and hippocampus for intact spatial and contextual learning, while its expression in the 
cerebellum is dispensable. Taken together, the present study shows that in contrast to 
60
Chapter 2
cerebellar αCaMKII, the loss of forebrain αCaMKII has severe adverse effects on spatial 
learning in mice.  Furthermore, deletion of Camk2a in adulthood is sufficient to fully 
recapitulate the learning impairments of global knockout mice. This finding confirms 
the critical necessity of forebrain αCaMKII expression at the time of learning.
MATERIALS AND METHODS
Animals
The following mice were used in this study: Camk2a+/+ (WT), Camk2aflox (homozygously 
floxed Camk2a mice), Camk2aflox/L7-cre– and Camk2aflox/L7-cre+ (Purkinje cell-specific αCaMKII 
knockout), Camk2aflox/Emx-cre– and Camk2aflox/Emx-cre+ (telencephalon-restricted αCaMKII 
knockout), Camk2aflox/CreER– and Camk2aflox/CreER+ (global αCaMKII knockout with temporal 
control over gene deletion), and germline αCaMKII knockout mice (Camk2a–/–). All mice 
were backcrossed >10 times into the C57BL/6JOlaHsd background. 
Mice were group housed and maintained under a 12h light/dark cycle (lights on at 
07:00 A.M.), with ad libitum access to food and water. Behavioural testing was performed 
during the light phase. The experimenter remained blind to the genotype throughout 
the experiments and data analysis. All behavioural experiments were performed using 
littermates. Mice were between 2-5 months of age. Experimental group assignments 
were made in consideration of sex- and age-matching. All experiments were performed 
in accordance with the Dutch Animal Ethical Committee (DEC).
Generation of floxed Camk2a mice
Camk2a floxed mutant ES cells were generated as follows: a genomic clone of 
approximately 8 Kb encoding the Camk2a exon 2 (amino acids 22–53) was isolated 
by screening a mouse library. The targeting construct was made by inserting a PGK 
neomycin cassette flanked by LoxP sites into the EcoRI site approximately 1.2 Kbp 
downstream of exon 2. Another LoxP site was inserted into the SmaI site 60 bp upstream 
of exon 2. Targeted ES clones (61 out of 130) were identified by Southern blot analysis. 
PCR analysis revealed that 20 out of these 61 clones contained the additional 5’ LoxP 
site. The PGK neo cassette was removed by transient expression of Cre recombinase 
(pBS185, Gibco). Consequently, a mutant allele was created in which Camk2a exon 2 
was flanked by LoxP sites (Fig. 1A).
L7-cre
Heterozygous floxed αCaMKII mice were crossed with L7/pcp-2 Cre transgenic mice 
(RRID:IMSR_JAX:004146) (Oberdick et al., 1990; Barski et al., 2000). Male Camk2aflox/L7-
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cre+ mice from this F1 offspring were crossed with female Camk2aflox/L7-cre– mice to obtain 
the 2 experimental genotypes investigated: Camk2aflox/L7-cre– and Camk2aflox/L7-cre+. L7 is 
expressed in cerebellar Purkinje cells in utero. Therefore, in Camk2aflox/L7-cre+ mice, deletion 
of Camk2a is Purkinje-cell specific and occurs prior to the normal postnatal expression 
of αCaMKII (Smeyne et al., 1991).
Emx1-cre
Camk2aflox mice were crossed with Emx1-Cre transgenic mice (RRID:IMSR_RBRC01345) 
(Iwasato et al., 2004). Male Camk2aflox/Emx-cre+ mice from this F1 offspring were crossed with 
female Camk2aflox mice. Male Camk2aflox/Emx-cre+ mice from this F2 offspring were crossed 
again with female Camk2aflox to obtain the 2 experimental genotypes: Camk2aflox/Emx-
cre– and Camk2aflox/Emx-cre+. Emx1 is expressed in glutamatergic telencephalic neurons in 
utero (Simeone et al., 1992). Therefore, in Camk2aflox/Emx-cre+ mice, deletion of Camk2a is 
restricted to the telencephalon and occurs prior to the normal postnatal expression of 
αCaMKII.
CreER
CreER mice were generated by engineering a fusion protein between cre recombinase and 
the ligand binding domain of a tamoxifen-responsive mutant human estrogen receptor, 
driven by the widespread CMV early enhancer/chicken beta actin (CAG) promoter 
(RRID:IMSR_JAX:004682) (Hayashi and McMahon, 2002). Only upon tamoxifen binding 
will the CreER protein translocate into the nucleus and catalyse loxP recombination (Van 
Duyne, 2001). Therefore, tamoxifen administration in adulthood allows the normal 
endogenous expression of αCaMKII protein throughout development. For breeding 
of the experimental genotypes, male CreER+ mice were crossed with female Camk2aflox 
mice. The resulting F2 male Camk2aflox/CreER+ mice were crossed with female Camk2aflox 
mice to obtain the Camk2aflox/CreER+ and Camk2aflox/CreER– genotypes.
Tamoxifen injections for CreER experiments
Adult deletion of Camk2a was achieved using 4 injections of tamoxifen. Tamoxifen 
(Sigma-Aldrich) was dissolved in sunflower oil in a dilution of 20 mg/ml. Injections were 
performed once daily for 4 consecutive days at a dose of 0.10 mg/g of bodyweight. 
Behavioural testing was initiated four weeks after the first day of tamoxifen injection 
(Hayashi and McMahon, 2002).  Importantly, in order to control for any potential 
influence of tamoxifen itself, all mice (both Camk2aflox/CreER+ and Camk2aflox/CreER–) received 
tamoxifen injections. Notably however, previous studies have demonstrated that using 
this dosing regimen, the administration of tamoxifen has no discernible influence on 




All mice were handled for one minute daily beginning a week prior to the experiment. 
The water maze is a circular pool with a diameter of 1.2 meters, filled with an opaque 
mixture of water and white paint. Water temperature was maintained at 25-26 degrees 
Celsius. The escape platform had a diameter of 11 cm and was submerged 1 cm beneath 
the water surface. The swimming paths of the animals were captured by a closed-circuit 
video camera mounted directly above the centre of the pool and analysed using Smart 
version 2.0 (Panlab rib_00052). The room was illuminated by ceiling lamps set to a low 
level of light intensity. Visually-salient and readily-distinguishable distal cues were 
displayed on each wall of the room.
Mice were trained using two 60 s trials per day, with a 30 s inter-trial interval, for 
five consecutive days. During training, mice were placed on the platform for 30 s 
and subsequently placed into the pool at pseudo-random starting positions. After 
reaching the platform, the mice were allowed to remain for 30 s, before returning to 
their homecage. If a mouse was unable to locate the platform within 60 s, the trial was 
concluded and the mouse was gently placed on the platform by the experimenter, and 
remained there for 30 s. The platform location was in a fixed position throughout all trials. 
For each trial, latency, distance covered, mean swim speed and path were measured.
On day 5, a probe trial was performed one hour after the training, in which the platform 
was removed to assess spatial learning. During the probe trial, mice were placed in the 
pool at the opposite side of the platform position and were allowed to search for 60 
s. The amount of time spent in each quadrant and platform location crossings were 
measured for each probe trial. For statistical analysis, the time in the target quadrant 
was compared to the average of the other three quadrants.
Pavlovian fear conditioning
Mice were placed in a steel chamber (30 x 20 cm) with a grid floor, and clear plastic 
door and ceiling (Med Associates). On day 1, each mouse was placed inside the 
conditioning chamber for 180 s. A single foot-shock (2 s, 0.4 mA) was delivered following 
a placement-to-shock interval of 148 s. Twenty-four hours later, mice were returned to 
the same context for 180 s. Behaviour during training and testing was recorded using 
a closed-circuit video camera mounted directly in front of the chambers. Freezing 
behaviour, defined as the cessation of all movement except respiration, was quantified 
using an automated video-based algorithm with detection parameters calibrated by 
independent manual scoring (Anagnostaras et al., 2010).
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Western Blots
Mice were anaesthetised with isoflurane and decapitated. Cortex, hippocampus and 
cerebellum were rapidly dissected and frozen in liquid nitrogen. Tissue samples were 
homogenized using a dounce homogenizer in lysis buffer (0.1 M  Tris-HCL, pH 6.8; 4% 
SDS) containing protease and phosphatase inhibitor cocktails (Sigma-Aldrich). Protein 
concentrations were determined using the BCA method (Pierce), adjusted to 1 mg/
ml. 10 μg of protein was loaded per lane. The following antibodies were used: αCaMKII 
(1:10.000, Millipore Cat# MAB8699 RRID:AB_2067919), bCaMKII (1:10.000, Abcam 
Cat# ab34703 RRID:AB_2275072) and Actin (1:20000; EMD Millipore Cat# MAB1501R 
RRID:AB_94235). Samples were electrophoresed using 10% Bis-Tris gels (Bio-Rad) and 
blotted on nitrocellulose membranes (Bio-Rad). The membranes were blocked with 
5% non-fat dry milk in Tris Buffered Saline (TBS) with 0.1% Tween-20 (TBST). Blots 
were incubated in primary antibody, diluted in TBST with 2% dry milk, followed by 
incubation in secondary antibody (Affinipure goat anti-mouse, 1:3.000, AB_2307348). 
The blots were incubated in chemiluminescence reagent (ECL, Pierce) exposed to film 
and analysed with ImageJ-64 software (NIH).
Immunohistochemistry
Mice were deeply anaesthetized with pentobarbital and perfused transcardially 
with a series of Phosphate Buffered Saline (PBS) followed by freshly prepared 4% 
paraformaldehyde (PFA, Sigma). Brains were carefully removed and fixed for two hours 
in 4% PFA, followed by 24 h incubation in 0.1 M phosphate buffer (PB) and 10% sucrose. 
Brains were then embedded in gelatine blocks (10% gelatine, 10% sucrose), post-fixed 
in 10% formaldehyde and 30% sucrose for 3 h, and kept in 30% sucrose overnight at 
4ºC. The embedded brains were sectioned using a freezing microtome with a section 
thickness of 40 μm. Sections were processed free floating, with diaminobenzidine 
(0.05%) as the chromogen. 
Slices were rinsed, blocked in 3% H2O2 and PBS, rinsed again and kept at 80ºC in 10 mM 
sodium citrate for 20 min. After rinsing, slices were preincubated for one hour at room 
temperature in 10% normal horse serum (NHS), 0.5% Triton and PBS and kept overnight 
at 4ºC in 10% NHS, 0.5% Triton, PBS and AffiniPure Fab Fragment (donkey anti mouse, 
1:200, Jackson, rid_000053). Subsequently, sections were kept in 10% NHS, 0.5% Triton, 
PBS and primary antibody (αCaMKII, 1:9000, Millipore Cat# MAB8699 RRID:AB_2067919) 
for 48 h at 4ºC. After rinsing sections were kept for 2 h at room temperature in the 
secondary antibody (RAM-HRP, 1:200, AB_2307349), in 10% NHS, 0.5% Triton and PBS. 
Finally, slices were stained in 0.05 M PB, 0.05% diaminotenzidinetetrachloride (DAB) and 
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3% H202 for 2 min. Slices were then mounted on slides with chrome(III)potassiumsulfate-
dodecahydrate, dehydrated in alcohol (70%, 90%, 100%), cleared with xylene and cover 
slipped with Permount (Fisher Scientific).
Electrophysiology
Adult mice (15-20 weeks old) were anesthetized with isoflurane and decapitated after 
which the brain was taken out quickly and submerged in ice- cold oxygenated (95%) 
and carbonated (5%) artificial cerebrospinal fluid (ACSF) (<4.0°C). ACSF contained the 
following substances (in mM): 120 NaCl, 3.5 KCl, 2.5 CaCl2, 1.3 MgSO4, 1.25 NaH2PO4, 26 
NaHCO3 and 10 D-glucose. Using a vibratome 400 μm thick sagittal slices were made and 
hippocampi were dissected out afterwards. Hippocampal slices were allowed to recover 
in a bath of oxygenated and carbonated ACSF at room temperature for 1.5 hours. At 
onset of the experiment slices were placed submerged in a recording chamber that 
was continuously perfused at a rate of 2 ml/min with oxygenated and carbonated 30°C 
ACSF. All slices were recorded from with platinum (Pt)/iridium (Ir) electrodes. Bipolar 
Pt/Ir stimulating electrodes were used to stimulate the slice with a stimulus duration 
of 100 μs. Stimulating and recording electrodes were placed on the CA3-CA1 Schaffer-
collateral afferents and the dendrites of CA1 pyramidal cells in the stratum radiatum 
(150-200 μm from s. pyramidale), respectively. Upon placement of electrodes, slices 
were given 30 minutes to rest before onset of measurements. All PPF experiments were 
done at one-third of slice maximum. Long-term potentiation (LTP) induced using 100 
Hz tetanization (1 train of 1 second at 100 Hz) was also evoked at one-third of slice 
maximum. Theta burst LTP (4 trains of 4 stimuli at 100 Hz, 200 ms apart) were evoked at 
two-thirds of slice maximum. Unstable recordings were excluded and determinations 
were made blind to genotype. The magnitude of LTP was defined as the average of the 
last 10 measurements of the normalized fEPSP slope.
Data analysis and statistics
Hypothesis testing was performed using SPSS version 17 (SPSS Inc) as indicated in 
the results section. Outcomes are expressed as mean ± standard error (SE). Pairwise 
comparisons were performed using either ANOVA with Tukey’s post-hoc test, or two-
tailed t-tests, depending upon the experimental design and as specified in the text. 
Group sizes for each experiment are provided in the figure legends.
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RESULTS
Spatiotemporal deletion of αCaMKII
To investigate the temporal and region-specific contribution of αCaMKII to the learning 
deficits observed in global Camk2a–/– mice, we first generated a floxed allele of Camk2a 
in order to enable experiments using spatiotemporally-controlled deletion of αCaMKII 
(Fig. 1A). For each of the cre lines used: L7-cre (cerebellar Purkinje neurons), Emx1-
cre (glutamatergic pyramidal neurons of the cortex and hippocampus), CAG-CreER 
(tamoxifen-inducible global deletion), we first confirmed that the protein levels and 
immunohistochemical distribution of αCaMKII was consistent with the expected pattern 
of deletion as previously reported using other floxed lines. The conditional mutants were 
further compared to WT and global KO mice. As expected, Camk2aflox/L7-cre+ mice showed 
a selective loss of αCaMKII expression in cerebellar Purkinje neurons, the only cell type 
in the cerebellum that normally expresses αCaMKII (Walaas et al., 1988) (Fig. 1B,C). In 
Camk2aflox/Emx-cre+ mice, αCaMKII was deleted from cortex and hippocampus, but without 
any changes in the cerebellum. In line with previous reports (Iwasato et al., 2004), 
recombination was variable across distinct amygdala nuclei. Specifically, high levels of 
recombination were observed in the basolateral amygdala (BLA) relative to the lateral 
amygdala (LA) and posterodorsal medial amygdala nucleus (MePD). Also consistent 
with the Iwasato (2004) findings, we observe a very low residual staining of αCaMKII 
throughout the telencephalon, with a randomly scattered and sparse distribution of 
labeled neurons. In contrast, we observed complete tamoxifen-inducible deletion of 
αCaMKII in adult Camk2aflox/CreER+ mice. Importantly however, Camk2aflox mice lacking cre 
recombinase had no detectable alteration in their αCaMKII protein levels, confirming 
that the integrated loxP sites are not interfering with Camk2a gene expression (Fig. 1B, 
C).
Telencephalic, but not cerebellar, αCaMKII is required for spatial learning
Previous studies have demonstrated that Camk2a–/– mice are severely impaired in 
spatial learning using the hidden version of the Morris water maze (Silva et al., 1992a; 
Elgersma et al., 2002). However, the temporal and region-specific requirements 
for endogenous αCaMKII in spatial learning have not previously been determined. 
Therefore, we examined the impact of temporal and region-specific deletion of αCaMKII 
on water maze learning, using a 5 day (2 trials/day) training protocol previously shown 
to result in severe impairments in Camk2a–/– global knockout mice in which the same 
exon was already deleted in germline (Elgersma et al., 2002). In both groups latency 
times decreased equivalently (Fig. 2A, first panel; effect of genotype: F1,15 = 0.46, p = 
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Figure 1: Generation of spatial and temporal specific Camk2a knockout mice. (A) Schematic 
diagram for the generation of floxed Camk2a knockout mice (Genome) Wild-type Camk2a locus 
with exon 2 depicted as a black box. (Construct) Targeting construct used for introducing the 
LoxP sites and neomycin resistance (Neo) gene in the Camk2a locus. The LoxP sites flanking 
exon 2 and the Neo gene are depicted as triangles. (Recombined) Mutant Camk2a flox locus 
after homologous recombination and Cre recombination in ES cells and consequential deletion 
of the Neo gene. (Crossed) The mutant Camk2a knockout locus after crossing with Cre-positive 
mice and subsequent deletion of exon 2 in targeted cells.  (B) Western blots using antibodies 
for αCaMKII, bCaMKII and actin demonstrate that: (1) αCaMKII level is specifically decreased 
in the cerebellum of Camk2aflox/L7-cre+ mice, but not in cortex or hippocampus (left panel). (2) 
αCaMKII level is specifically decreased in the cortex and hippocampus  of Camk2aflox/Emx-cre+ 
mice, but not in the cerebellum (middle panel). (3) αCaMKII level is decreased in all structures 
of Camk2aflox/CreER+ mice (right panel). For all genotypes, Cre-negative mice are unaffected in 
their αCaMKII and bCaMKII expression levels. (C) αCaMKII stainings show: (1) normal staining in 
Camk2a+/+ mice (top left panel). (2) No staining in Camk2a–/– mice (top middle panel). (3) Specific 
αCaMKII deletion in Purkinje cells in Camk2aflox/L7-cre+ mice (top right panel). (4) Specific αCaMKII 
deletion in forebrain, but not cerebellar cells in Camk2aflox/Emx-cre+ mice (bottom left panel). (5) 
Specific αCaMKII deletion throughout the brain in Camk2aflox/CreER+ mice (bottom middle panel).  
(6) Normal staining in Camk2aflox/CreER– mice (bottom right panel). 
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that Camk2a–/– mice have a severe spatial learning deficit, reflected in no significant 
preference for the target quadrant compared to the other quadrants (t
7 
= 2.62, p = 0.80 
dependent samples t-test, Fig. 2B, first panel), whereas Camk2a+/+ mice clearly showed a 
significant preference for the target quadrant (
t8 
= 4.411, p = 0.002, dependent samples 
t-test; Fig. 2B, first panel). 
Previous studies have suggested that the cerebellum may contribute significantly to 
the acquisition of spatial learning (Lalonde and Strazielle, 2003; Burguiere et al., 2005; 
Goddyn et al., 2006) (but see also (Galliano et al., 2013)). Therefore, in order to examine 
the specific contribution of cerebellar αCaMKII on spatial learning in our water maze 
learning paradigm, we tested Camk2aflox/L7-cre+ mice and their Camk2aflox/L7-cre– control 
littermates on the hidden version of the Morris water maze. During training, latency 
times decreased equivalently in both genotypes  (Fig. 2A, second panel; effect of 
genotype: F
1,27 
= 0.408, p = 0.53, repeated measures ANOVA). Moreover, Camk2aflox/L7-cre+ 
mice are indistinguishable from their littermates in their capacity to locate the platform 
during the probe trial (average time in platform quadrant, Camk2aflox/L7-cre+: t
13 
= 2.868, p 
= 0.01, paired t-test; Camk2aflox/L7-cre–: t
14 
= 3.567, p = 0.003, paired t-test; Fig. 2B, second 
panel).  Therefore, cerebellar expression of αCaMKII does not appear to be required for 
spatial learning given that Camk2aflox/L7-cre+ mice have complete deletion of αCaMKII in 
the cerebellum, yet acquire spatial learning normally under conditions in which global 
Camk2a–/– mice are severely impaired.
We next examined the necessity for telencephalic αCaMKII during spatial learning, using 
Camk2aflox/Emx-cre+ mice and their Camk2aflox/Emx-cre– control littermates. Both groups of mice 
showed an overall similar reduction in their latency times across the training days (Fig. 
2A, third panel). Although a repeated measures ANOVA showed a significant difference 
between the groups (effect of genotype: F
1,26 
= 6.023, p = 0.02), post-hoc Tukey’s tests 
showed that a significant difference between the two groups was restricted to day 3 
(t
26 
= 3.171, p = 0.004), and no differences were observed in the initial or final training 
days. Moreover, consistent with the requirement of telencephalic αCaMKII for spatial 
learning, Camk2aflox/Emx-cre+ mice showed no significant preference for the target quadrant 
during the probe trial (t
12 
= 1.816, p = 0.09, paired t-test; Fig. 2B, third panel). In contrast, 
the Camk2aflox/Emx-cre– littermates demonstrated robust spatial learning of the hidden 
platform location (t
14 
= 4.656, p = 0.0004, paired t-test; Fig. 2B, third panel).  There was no 
significant difference in thigmotaxis (
t26 
= 0.107, p = 0.79, unpaired t-test), swimspeed (
t26 
= 1.882, p = 0.25, unpaired t-test), and pathlength (
t26 
= 1.904, p = 0.26, unpaired t-test) 
between the two groups. Together, our results suggest that under these commonly used 
experimental conditions, spatial learning is strongly dependent on αCaMKII expression 
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In addition to its region-specific requirements, we also considered how developmentally-
regulated expression of αCaMKII influences spatial learning. αCaMKII has been well 
demonstrated to function critically during NMDA-dependent LTP in the telencephalon, 
which is widely believed to be an indispensable form of plasticity underlying spatial 
learning. However, given that αCaMKII expression begins in the early postnatal period, 
the learning impairments observed in global Camk2a–/– mice might result from the 
absence of αCaMKII during early postnatal development, rather than being required 
specifically at the time of learning.  Therefore, we utilized the tamoxifen-inducible 
Camk2aflox/CreER+ mice and their Camk2aflox/CreER– littermates to achieve temporal control 
over the timing of αCaMKII deletion.  In particular, we reasoned that by inducing 
deletion only in adulthood, we could more directly examine the necessity for αCaMKII 
specifically at the time of learning, while controlling for any potentially confounding 
abnormalities that might arise from the absence of αCaMKII during early development. 
Therefore, adult Camk2aflox/CreER+ mice and their Camk2aflox/CreER– control littermates were 
given daily injections of tamoxifen (0.1 mg/g, i.p.) for four days to induce gene deletion. 
As shown in Figures 1B and 1C, tamoxifen-inducible deletion of αCaMKII in adulthood 
of Camk2aflox/CreER+ mice was highly efficient, and without any observed deletion in the 
absence of tamoxifen, thereby maintaining the full integrity of postnatal development.
During the training phase, Camk2aflox/CreER+ mice and their Camk2aflox/CreER– littermates 
demonstrated a similar reduction in latency times (effect of genotype: F
1,17 
= 1.982, p 
= 0.18, repeated measures ANOVA; Fig. 2A, last panel). However during the probe trial, 
Camk2aflox/CreER+ mice showed no significant preference for the target quadrant (t
9 
= 
1.593, p = 0.15, paired t-test; Fig. 2B, last panel), whereas their Camk2aflox/CreER– littermates 
demonstrated a search pattern that was highly localized to the location of the hidden 
platform (t
8 
= 2.511, p = 0.04, paired t-test; Fig. 2B, last panel). There was no significant 
difference in thigmotaxis (
t17 
= -0.538, p = 0.09, unpaired t-test), swimspeed (
t17 
= 0.409, p 
= 0.59, unpaired t-test), and pathlength (
t17 
= -0.140, p = 0.95, unpaired t-test) between 
the two groups. Therefore, αCaMKII is specifically required in adulthood at the time of 
learning for intact acquisition of spatial information, independent of its function during 
early postnatal development.
Regional and temporally-controlled deletion of αCaMKII on contextual 
fear learning
Contextual fear conditioning is a highly robust form of associative learning in which 
unsignaled aversive stimuli (e.g., footshock) are administered within a previously neutral 
context, in which a range of defensive behaviours (e.g., freezing) are subsequently elicited 
(Phillips and Ledoux, 1992, 1994). In addition to impaired spatial learning, Camk2–/– mice 
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also have been shown to have deficits in contextual conditioning (Silva et al., 1992a). 
Therefore, we sought to examine the temporal and region-specific requirements for 
αCaMKII expression during contextual fear learning.
Consistent with previous studies, we found that Camk2a–/– mice with a germline 
deletion of αCaMKII were severely impaired in contextual fear conditioning (Fig 3A; t
16 
= 4.454, p = 0.0004, unpaired t-test) when compared to their Camk2a+/+ littermates.  In 
contrast, Camk2aflox/L7-cre+ mice with cerebellum-specific deletion of αCaMKII showed 
similar contextual fear learning as their Camk2aflox/L7-cre– control littermates (Fig 3B; t
30 
= 
0.621, p = 0.57, unpaired t-test), suggesting that Purkinje cell expression of αCaMKII is 

























































Figure 3: Contextual fear learning is unaffected in the absence of cerebellar αCaMKII. (A) 
Compared to Camk2a+/+ mice, Camk2a–/– mice show no contextual fear learning. (B) Camk2aflox/
L7-cre+ mice show intact contextual fear learning, when compared to their Camk2aflox/L7-cre– 
control littermates. In contrast, Camk2aflox/Emx-cre+ mice (C), as well as Camk2aflox/CreER+ (D) mice 
show severe contextual fear learning deficits, when compared to their Cre-negative control 
littermates. Number of mice tested: Camk2a+/+: 9, Camk2a–/–: 9, Camk2aflox/L7-cre–: 15, Camk2aflox/
L7-cre+: 17, Camk2aflox/Emx-cre–: 17, Camk2aflox/Emx-cre+ : 21, Camk2aflox/CreER–: 10, Camk2aflox/CreER+: 11. Bars 
represent the amount of freezing behavior, which is used as an index for recollection of the 
context. Error bars represent standard error of the mean.
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Many previous studies have suggested that contextual fear learning requires NMDA-
dependent LTP in the cortex and hippocampus (Levenson et al., 2002) (Kiyama et al., 
1998). However, no previous studies have examined the telencephalic region-specific 
requirement for αCaMKII, despite being among the most widely hypothesized proteins 
underlying LTP and learning (as reviewed in (Coultrap and Bayer, 2012)).  Therefore using 
Camk2aflox/Emx-cre+ mice, we examined whether expression of αCaMKII specifically in the 
telencephalon was required for contextual conditioning.  Indeed, as predicted by the 
predominant models of synaptic plasticity and learning, Camk2aflox/Emx-cre+ mice showed 
a significant impairment in contextual fear learning, compared with their littermate 
controls (Fig. 3C; t
36 
= 3.773, p = 0.001; unpaired t-test).
In addition to the region-specific requirements for αCaMKII, we also examined the 
temporal requirement during contextual fear learning.  In particular, we aimed to 
examine whether the conditioning deficit in the global Camk2a–/– mice arises from a 
developmental abnormality or due to the absence of αCaMKII in adulthood at the time 
of learning. Therefore, we again utilized Camk2aflox/CreER+ mice to induce αCaMKII deletion 
selectively in adulthood, while sparing the potential impact of deletion during early 
development. Consistent with a requirement for αCaMKII expression at the time of 
learning, Camk2aflox/CreER+ mice with temporally-restricted adult deletion showed a severe 
impairment of contextual learning (Fig. 3D; t19 = 4.950, p = 0.0001, unpaired t-test). 
Long-term potentiation (LTP) is impaired in mice with adult deletion of 
αCaMKII
In addition to deficits in the Morris Water maze and contextual fear conditioning, 
Camk2a–/– mice also show an impairment in long-term potentiation (LTP) thought 
to underlie these hippocampal-dependent forms of learning (Silva et al., 1992b; 
Elgersma et al., 2002). Therefore, given the spatial and contextual learning deficits in 
Camk2aflox/CreER+ mice, we also performed field recordings in acute hippocampal slices 
to examine whether adult-restricted deletion also impaired synaptic plasticity. Efficacy 
of synaptic transmission was unaffected in the absence of αCaMKII (Fig. 4A). Fiber 
volley amplitude was not significantly different in Camk2aflox/CreER+ mice compared to 
their control littermates (effect of genotype: F
1,74 
= 2.37, p = 0.13, repeated measures 
ANOVA; Fig. 4A). Postsynaptic fEPSP slope was also independent of αCaMKII, consistent 
with previous studies using Camk2a–/– mice (effect of genotype: F
1,108 
= 2.97, p = 0.09, 
repeated measures ANOVA; Fig. 4A). Moreover, paired-pulse facilitation (PPF) was also 
unchanged in Camk2aflox/CreER+ mice (effect of genotype: F
1,59 
= 0.26, p = 0.61, repeated 
measures ANOVA; Fig. 4B).
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To examine whether the LTP impairment observed in Camk2a–/– mice is due to a 
critical role for αCaMKII during development and/or whether αCaMKII is necessary for 
the induction of LTP in adulthood, we used two independent protocols to induce LTP 
(100Hz and theta-burst protocols), given their distinct cellular mechanisms yet shared 
impairment in Camk2a–/– mice. Both stimulation protocols induced robust LTP in control 
littermates (Camk2aflox/CreER–; Fig. 4C,D). However, Camk2aflox/CreER+ mice with adult-specific 
deletion of αCaMKII showed impaired LTP in both the 100Hz (effect of genotype: F
1,29 
= 
16.88, p = 0.0003, repeated measures ANOVA; Fig. 4C) and theta-burst protocol (effect 
of genotype: F
1,52 
= 7.85, p = 0.007, repeated measures ANOVA; Fig. 4D). Taken together, 
these findings confirm that αCaMKII is specifically required in adulthood for both 

































































































Figure 4: CA3-CA1 Long-term potentiation is impaired upon deletion of αCaMKII in 
adulthood. (A) Camk2aflox/CreER+ mice show normal basal synaptic transmission (Camk2aflox/CreER+ 
n=37, n=55; Camk2aflox/CreER– n= 39, n=55 for number of slices showing fiber volley and fEPSP 
respectively). (B) Camk2aflox/CreER+ mice show normal paired-pulse facilitation (n=30 and n=31 for 
Camk2aflox/CreER+ and Camk2aflox/CreER– mice respectively). (C) Camk2aflox/CreER+ mice show impaired 
100Hz LTP at the CA3-CA1 synapse in the hippocampus (n=15 and n=16 for Camk2aflox/CreER+ and 
Camk2aflox/CreER– mice respectively). (D) Camk2aflox/CreER+ mice show impaired 4 Theta LTP at the 
CA3-CA1 synapse in the hippocampus (n=31 and n=23 for Camk2aflox/CreER+ and Camk2aflox/CreER– 
mice respectively). Error bars indicate S.E.M.
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DISCUSSION
Here we used conditional Camk2a mutants to examine the influence of spatially-restricted 
and temporally-controlled deletion of αCaMKII. The present series of experiments 
demonstrate that αCaMKII is required during adulthood in the telencephalon, but 
not the cerebellum, for both spatial and contextual learning as well as hippocampal 
LTP. Importantly, these results are entirely consistent with previous research showing 
that global germline deletion of αCaMKII leads to deficits in hippocampal-dependent 
learning and LTP (Silva et al., 1992a; Silva et al., 1992b; Elgersma et al., 2004).  However, 
no previous experiments had ever been able to control for the possibility that germline 
deletion of αCaMKII might have led to abnormalities in early brain development, rather 
than its requirement in adulthood at the time of learning. Moreover, given evidence in 
the literature regarding the influence of cerebellar Purkinje cell plasticity in spatial and 
contextual learning (Lalonde and Strazielle, 2003; Burguiere et al., 2005; Goddyn et al., 
2006), we also examined region-specific Camk2a deletion. 
Previous studies using inducible systems, such as (Mayford et al., 1996) and (Wang 
et al., 2003), investigated the necessity of αCaMKII during plasticity and learning by 
utilizing overexpression of a mutated temporally controlled and region specific Camk2a 
transgene. Although these studies show that enhanced levels of αCaMKII in forebrain, 
independent of its activity status, can interfere with learning and memory consolidation, 
they do not prove the requirement of endogenous αCaMKII for plasticity and learning. 
Temporal overexpression of the αCaMKII-T286D transgene, which is thought to have a 
dominant negative effect due to additional phosphorylation on the TT305/6 sites (Pi et 
al., 2010), caused changes in the frequency threshold for LTP induction, and disruption of 
several learning paradigms, which is reversed when turning off the transgene (Mayford 
et al., 1996). These experiments indicate a critical role for CaMKII signaling during 
learning. However since αCaMKII forms holoenzymes with bCaMKII, these studies do 
not rule out that the phenotype is caused by deregulation of the entire holoenzyme 
(rather than just αCaMKII) due to the dominant negative effect of the αCaMKII-T286D 
protein (Pi et al., 2010). Indeed, the dominant negative mutation αCaMKII-T305D  results 
in a much stronger deficit than Camk2a–/– mice (Elgersma et al., 2002). 
Temporal overexpression of αCaMKII-F89G (of which the activity can be regulated 
by specific inhibitors) in adult mice showed that increased CaMKII expression during 
training and the next 4 weeks had no effects on long-term contextual and cued-fear 
memories, as long as this level was not changed during consolidation or upon recall 
(Wang et al., 2003). Hence, these studies indicated that a constant level of CaMKII 
during the phases of acquisition, consolidation, or recall was critical for normal 
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learning, but did not address the requirement for endogenous αCaMKII for learning. 
In contrast, administering tatCN21 (a fusion peptide which inhibits stimulated and 
autonomous CaMKII activity) did not impair contextual fear memory expression when 
given one hour before testing (Buard et al., 2010). Importantly however, when tatCN21 
was administered one hour prior to training, acquisition was significantly impaired, 
confirming the necessity of CaMKII for intact learning and in full agreement with our 
findings.
Notably, we observed that mice with deletion restricted to the cerebellum demonstrated 
normal spatial and contextual learning, consistent with a recent study examining 
multiple lines of mice, each with distinct impairments in cerebellar transmission and 
plasticity, which found no evidence of cognitive impairments, including spatial and 
contextual learning (Galliano et al., 2013). Future studies should be aimed at further 
dissecting the regional and cell-type specific contributions of αCaMKII during learning, 
including the hippocampal subfields and amygdala nuclei.  Moreover, it will also 
be important to explore the differential contributions of αCaMKII during the various 
phases of memory, including acquisition, consolidation, reconsolidation, maintenance, 
and retrieval.
We have confirmed that the well-characterized learning deficits in Camk2a–/–mice 
are not merely due to absence of the protein during the developmental period. In 
the present study, mice with temporally-restricted deletion of αCaMKII in adulthood 
showed equivalent spatial and contextual learning deficits as observed in the global 
Camk2a–/– mutants who lack αCaMKII expression throughout postnatal development. 
Therefore, we conclude that temporally-controlled deletion of Camk2a in adult mice is 
as detrimental as germline deletion for spatial and contextual learning.
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Genetic approaches using temporal and brain region-specific restricted gene deletions 
have provided a wealth of insight in the brain regions and temporal aspects underlying 
spatial and associative learning. However, for locomotion such extensive studies are still 
scarce. 
Previous studies demonstrated that Camk2b–/– mice, which lack the β isoform of Calcium/
Calmodulin-dependent protein kinase 2 (CAMK2B), show very severe locomotion deficits. 
However, where these locomotion deficits originate is unknown. Here we made use of 
novel Camk2b mutants (Camk2bf/f and Camk2bT287A), to explore the molecular, temporal 
and brain region-specific requirements of CAMK2B for locomotion. At the molecular level 
we found that normal locomotion requires Calcium/Calmodulin mediated activation of 
CAMK2B, but CAMK2B autonomous activity is largely dispensable. At a systems level, we 
found that global deletion of Camk2b in the adult mouse causes only mild locomotion 
deficits, suggesting that the severe locomotion deficits of Camk2b–/– mice are largely of 
developmental origin. However, early onset deletion of Camk2b in cerebellum, striatum 
or forebrain did not recapitulate the locomotion deficits, suggesting that these deficits 
cannot be attributed to a single brain area. 
Taken together, these results provide the first insights into the molecular, temporal and 
region-specific role of CAMK2B in locomotion. 
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INTRODUCTION 
The Calcium/Calmodulin-dependent protein kinase II (CaMKII, from hereon called 
CAMK2) family members are pivotal to normal synaptic plasticity and learning in the 
hippocampus, cortex and cerebellum. The family consists of four different isoforms, 
(alpha, beta, gamma and delta) of which CAMK2A is the most studied (for review, see 
(Lisman et al., 2002; 2012; Hell, 2014)). In the last decade, the role of CAMK2B in the brain 
has gained attention largely due to the generation of new mutant mice (Van Woerden 
et al., 2009; Borgesius et al., 2011; Bachstetter et al., 2014; Gao et al., 2014).
In sharp contrast to CAMK2A, CAMK2B has been shown to play an important role in 
locomotion, since two independent CAMK2B mutants both show severe locomotion 
deficits (Van Woerden et al., 2009; Bachstetter et al., 2014). Like CAMK2A, CAMK2B is 
highly expressed in the brain (Cheng et al., 2006) and it has been shown that CAMK2B 
plays an enzymatic as well as a structural role in both hippocampal and cerebellar 
plasticity (Van Woerden et al., 2009; Borgesius et al., 2011). This structural role of 
CAMK2B comes from an additional domain within CAMK2B, the F-actin binding domain, 
which enables CAMK2B to cluster CAMK2A to the actin cytoskeleton (Shen et al., 1998; 
Shen and Meyer, 1999; Borgesius et al., 2011). Indeed, most hippocampal phenotypes 
observed in Camk2b–/– mutants require CAMK2B protein, but not its enzymatic function, 
since the Camk2bA303R mutants, in which CAMK2B cannot be activated, do not show an 
overt hippocampal phenotype (Borgesius et al., 2011). At the cerebellar parallel fiber–
Purkinje cell synapse, CAMK2B appears to have both a structural role as an enzymatic 
role (Van Woerden et al., 2009) but it is unknown to what extend the severe locomotion 
deficits seen in Camk2b–/– mice, arise from loss of the enzymatic or the structural role of 
CAMK2B. 
Expression of CAMK2B starts around E12.5, whereas expression of CAMK2A starts 
postnatal, around P1 (Bayer et al., 1999). According to this difference in temporal 
expression, one might expect that CAMK2B is involved in embryonic development, 
whereas CAMK2A is not. Indeed, it has been shown that deletion of CAMK2A in an 
adult brain gives a similar phenotype as germ-line deletion of CAMK2A with respect to 
learning and synaptic plasticity (Achterberg et al., 2014). Similar studies have not been 
performed for CAMK2B, but considering the early onset of expression, it is conceivable 
that germ-line deletion of CAMK2B results in a more severe phenotype compared to 
deletion in adult animals. 
Since CAMK2B has been shown to play an important role in controlling the direction of 
synaptic plasticity at the parallel fiber–Purkinje cell synapse (Van Woerden et al., 2009), 
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the Purkinje cells are a likely candidate for being responsible for the locomotion deficits 
observed in the Camk2b–/– mice. However, there are several other CAMK2B-expressing 
brain areas involved in motor control, such as motor cortex, several nuclei in brainstem, 
spinal cord and basal ganglia (e.g. striatum and subthalamic nucleus). Besides the 
hippocampus (Borgesius et al., 2011; Okuno et al., 2012), cerebellum (Van Woerden et 
al., 2009; Gao et al., 2014; Nagasaki et al., 2014) and lateral habenula (Li et al., 2013), 
CAMK2B function in different specific motor control areas has not been studied. 
For this study we generated an autophosphorylation-deficient CAMK2B mutant 
(Camk2bT287A) and made use of the previously described CAMK2B mutant which can 
no longer bind Calcium/Calmodulin (Camk2bA303R) (Borgesius et al., 2011) to study the 
structural and enzymatic role of CAMK2B in locomotion using the accelerating rotarod. 
Additionally, we generated a floxed Camk2b mutant to study the temporal and brain 
region-specific role of CAMK2B in motor behaviour. We show that Calcium/Calmodulin-
dependent activation of CAMK2B is essential for normal locomotion, but surprisingly, 
CAMK2B autonomous activity is largely dispensable. Additionally, we found that 
normal locomotion requires CAMK2B to be present during development, and that the 
locomotion deficits observed in the Camk2b mutant cannot be assigned to a single 
brain area. 
RESULTS
The role of Calcium/Calmodulin-dependent and autonomous activity of 
CAMK2B in locomotion
We have previously shown that Camk2b–/– mice (in which exon 11 was deleted) show 
severe locomotion deficits on the rotarod and the balance beam (Van Woerden et al., 
2009). Since CAMK2 can have both structural and enzymatic functions in the brain, 
we first set out to understand which molecular aspects of CAMK2B are important for 
normal locomotion.
Mutating Alanine 303 to Arginine (A303R) in CAMK2B, interferes with Calcium/
Calmodulin binding and activation of CAMK2B, and renders CAMK2B into a persistently 
F-actin bound state (Shen et al., 1998; Borgesius et al., 2011). To investigate whether this 
mutation has any effect on motor behaviour, we tested the Camk2bA303R/A303R mice on 
the rotarod. Even though this mutant has normal hippocampal learning and plasticity 
(Borgesius et al., 2011), Camk2bA303R/A303R mice showed a severe locomotion deficit, not 
being able to stay on the rod for more than 5-10 seconds (effect of genotype: F1,18=39.05, 
p<0.001; effect of time: F1,18=2.48, p=0.05; interaction: F1,18=2.44, p=0.05, repeated 
measures ANOVA; Fig. 1a).
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Figure 1. A crucial role for Calcium/Calmodulin-dependent activity, but not autonomous 
activity of CAMK2B in locomotion. Locomotion was tested using the accelerating rotarod. (A) 
Camk2bA303R/A303R mice (n=6) show a severe impairment in locomotion compared to Camk2b+/+ 
control littermates (n=14). (B) Schematic picture for the generation of the Camk2bT287A mutants. 
Exons are depicted as black boxes. The asterisk in exon 11 indicates the mutation at Thr287, 
where a new TspRI restriction site was introduced. The LoxP sites flanking the neomycin gene 
are depicted as triangles. The Diphtheria Toxin cassette (DTA) was cloned in the construct 
for positive selection. Recombined depicts the mutant Camk2bT287A locus after homologous 
recombination. ∆NEO depicts the mutant Camk2bT287A locus after Cre recombination. (C) 
Sequence of Thr287 in exon 11 showing the specific mutation made to induce Thr287Ala and 
introducing the TspRI restriction site used for genotyping. (D) Western blots probed with a 
phospho-specific antibody against ph-T287 reveal no detectable Thr287 phosphorylation in 
the hippocampus of Camk2bT287A/T287A mice. Note that the Thr287Ala mutation has no effect on 
ph-Thr286, CAMK2A, and CAMK2B protein levels. Actin levels are shown as loading control. 
(E) Camk2bT287A/T287A mice (n=14) show no impairment in locomotion compared to Camk2b+/+ 
control littermates (n=9). Error bars indicate SEM.
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The Camk2bA303R mutation interferes with the Calcium/Calmodulin dependent activity, 
as well as the autonomous (Calcium/Calmodulin independent) activity of CAMK2B. To 
specifically investigate the role of autonomous activity in locomotion, we generated 
an autophosphorylation-deficient CAMK2B mouse mutant in which Threonine 287 is 
substituted by an Alanine, thus blocking autonomous CAMK2B activity (Camk2bT287A/
T287A) (Fig. 1b and c). Protein quantification using western blot indeed revealed a near 
complete absence of T287-phosphorylated CAMK2B in Camk2bT287A/T287A mice without 
changes in T286-phosphorylated CAMK2A or total levels of both CAMK2A and CAMK2B 
(Fig. 1d; for quantification see Table 1).
Table 1. Overview of western blot quantification performed on the Camk2b mutants in 
percentage of controls. 




























































WT = wildtype; Het = heterozygous knockout; KO = knockout. Cre– = Cre-negative Camk2b mutant; Cre+ = Cre-positive 
Camk2b mutant. Number of samples is depicted in brackets.
Camk2bT287A/T287A mice showed a trend towards reduced locomotion compared to their 
wildtype littermates, however this difference was not significant (effect of genotype: 
F1,21=3.72, p=0.07; effect of time: F1,21=6.47, p<0.001; interaction: F1,21=0.71, p=0.59, 
repeated measures ANOVA; Fig. 1e). These results indicate, in contrast to the Calcium/
Calmodulin-dependent activation, the contribution of CAMK2B autonomous activity in 
normal locomotion is marginal. 
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Temporal involvement of CAMK2B in locomotion
Expression of CAMK2B starts during early development (E12.5) (Bayer et al., 1999), 
hence the motor deficits seen in the Camk2b–/– mice could very well be due to a crucial 
role for CAMK2B during development. To assess temporal contribution of CAMK2B in 
the severe locomotion deficits, we generated a novel floxed allele of Camk2b, with LoxP 
sites around exon 2 (containing the catalytic site) of the Camk2b gene (Camk2bf/f), which 
was crossed into the C57Bl/6 background (see Methods and Fig. 2a). To ensure that the 
locomotion deficits are also present in the C57Bl/6 background (the previous mutants 
were tested in an F2 129P2-C57Bl/6 hybrid background), we crossed the Camk2bf/f 
mice with a Cag-cre transgene, deleting exon 2 from germline (Camk2b∆ex2/∆ex2). Using 
immunocytochemistry and western blots, we confirmed the global deletion of CAMK2B 
in this line. As expected, Camk2b∆ex2/∆ex2 showed loss of CAMK2B without changes in the 
expression of CAMK2A (Fig. 2b and c; Table 1). Furthermore, Camk2b∆ex2/∆ex2 mice showed 
a severe locomotion deficit compared to their wildtype littermates (effect of genotype: 
F1,14=48.01, p<0.001, repeated measures ANOVA; Fig. 2d), which indicates that the motor 
deficits are present in both F2 129P2-C57Bl/6 hybrid  mice (Van Woerden et al., 2009) as 
well as congenic  (16 backcrosses) C57Bl/6 mice.
After having shown that our novel Camk2b mutant indeed recapitulates the severe 
locomotion deficit described before, we continued determining the developmental 
component of CAMK2B in the locomotion deficit. Therefore Camk2bf/f mice were crossed 
with CAG-CreER, giving us Tamoxifen-dependent temporal control over gene deletion. 
As expected, 12-14 week old Camk2bf/f;CAG-CreER mice showed loss of CAMK2B 4 weeks 
after 4 daily consecutive injections with Tamoxifen and showed no changes in levels of 
CAMK2A (Fig. 2b and c; Table 1). 
We tested 8-10 week old mice prior to Tamoxifen-induced deletion on the rotarod 
and found no difference between genotypes (effect of genotype: F1,38=0.53, p=0.47, 
repeated measure ANOVA), indicating that before Tamoxifen mediated gene deletion, 
the Camk2bf/f;CAG-CreER mice do not have a locomotion deficit (Fig. 2e, left). When 
tested 28 days after Tamoxifen-induced deletion, Camk2bf/f;CAG-CreER mice showed a 
clear locomotion deficit on the accelerating rotarod (effect of genotype: F1,38=24.25, 
p<0.001, repeated measures ANOVA; Fig. 2e, right), however, this phenotype was not 
as severe as upon germ-line deletion. To make sure that the milder phenotype was not 
caused by the initial rotarod testing before gene deletion, we induced Camk2b gene 
deletion in a naïve cohort of 8-10 week old mice, and tested the mice 4 weeks after 
gene deletion. Although these Camk2bf/f;CAG-CreER mice showed no improvement of 
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Figure 2. Temporal requirement of CAMK2B in locomotion. (A) Schematic overview of the 
generation of the floxed Camk2b and Camk2b∆Ex2/∆Ex2 mice. Camk2b locus and targeting construct 
with Exons 1, 2 and 3 depicted in black boxes. LoxP sites are indicated by the black triangles and 
the Frt sites are indicated by the grey ovals. The Diphtheria Toxin Cassette (DTA) was inserted 
for positive selection. Recombined depicts the mutant Camk2b locus after homologous 
recombination. Floxed depicts the Camk2bf/f mutant locus after transient expression of the 
Flp recombinase, resulting in a floxed locus without the neomycin cassette. ∆ex2 depicts the 
Camk2b∆Ex2 mutant locus after Cre-mediated deletion. (B) Immunohistochemistry stainings 
of CAMK2B, showing (Top to bottom, left to right): normal expression in WT mice and no 
expression in Camk2b∆ex2/∆ex2 mice; normal expression in Camk2bf/f mice and deletion throughout 
the brain in Camk2bf/f;CAG-CreER mice (C) Western blots using an antibody specific for CAMK2A 
and CAMK2B in Camk2b∆ex2/∆ex2 and Camk2bf/f;CAG-CreER mice and their control littermates. 
Actin levels are shown as loading control. Decreased levels of CAMK2B in Camk2bwt/∆ex2 mice 
and no detection of CAMK2B in Camk2b∆ex2/∆ex2 and Camk2bf/f;CAG-CreER mice in hippocampus, 
cortex and cerebellum with no changes in levels of CAMK2A. (D) Camk2b∆ex2/∆ex2 mice (n=8) 
show a significant impairment in locomotion compared to wildtype littermates (n=8). (E) 8-10 
week old Camk2bf/f;CAG-CreER mice (n=13) and their Camk2bf/f control littermates (n=17) were 
trained on the rotarod before (Day 1) and 4 weeks after Tamoxifen injections (Day 28). Before 
deletion, both genotypes performed equally. After deletion, Camk2bf/f;CAG-CreER mice showed 
a significant impairment of locomotion compared to Camk2bf/f control littermates as shown 
in the 5 trials given 28 days after the first injection. (F) 8-10 week old Camk2bf/f;CAG-CreER mice 
(n=8) show no impairment in locomotion compared to Camk2bf/f control littermates (n=8) 4 
weeks after Tamoxifen injections with no prior training. Error bars indicate SEM.
(overall effect of genotype: F1,14=4.01, p=0.06; effect of time: F1,14=6.48, p<0.001; 
interaction: F1,14=3.02, p<0.05 Fig. 2f ), performance at the first two trials was 
indistinguishable from control mice, which is markedly different from Camk2b∆ex2/∆ex2 
mice (Fig. 2d)
Taken together, deletion of CAMK2B in adulthood resulted in a much milder locomotion 
deficit compared to germline deletion of CAMK2B, indicating a significant developmental 
origin for the locomotion deficits seen in Camk2b∆ex2/∆ex2 mice. 
Brain areas contributing to the CAMK2B dependent rotarod deficits
Lesion studies in rodents have indicated that several brain areas are involved in 
locomotion, the most important being the cerebellum, striatum and motor cortex (for 
review see (Lalonde and Strazielle, 2007)). To our knowledge, the specific contribution 
of each of these brain areas to rotarod motor behaviour has not been systematically 
assessed through genetic lesions. CAMK2B is expressed in all these brain regions, 
therefore we used our conditional mutant to assess which brain area, if not all, is 
responsible for the severe rotarod phenotype seen in Camk2b∆ex2/∆ex2 mice. Knowing that 
loss of CAMK2B in the cerebellum reverses plasticity at the parallel fiber–Purkinje cell 
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synapse, we started with assessing the importance of the cerebellum in the rotarod 
phenotype. Camk2bf/f mice were crossed with two different cerebellum-specific Cre-
lines: L7-cre (specific for cerebellar Purkinje cells) and Gabaα6-cre (specific for cerebellar 
granule cells). Both Cre-lines express the CRE protein within the first postnatal week 
(Barski et al., 2000; Aller et al., 2003). 
Camk2bf/f;L7-cre mice showed selective loss of CAMK2B in cerebellar Purkinje cells (Fig. 
3a, b and c; Table 1) and Camk2bf/f;Gabaa6-cre mice showed selective loss of CAMK2B 
in cerebellar granule cells. Surprisingly, Camk2bf/f;L7-cre mice also showed a decrease 
in levels of CAMK2A in the cerebellum, whereas in Camk2bf/f;Gabaa6-cre mice CAMK2A 
levels were unaffected (Fig. 3a and c; Table 1). Importantly, Camk2bf/f mice lacking CRE 
recombinase did not show any detectible reduction of CAMK2B protein compared to 
Camk2b+/+ mice, indicating that the insertion of the LoxP sites did not interfere with 
Camk2b gene expression (Table 1). 
For the rotarod experiments with the L7-cre mice, we used all four genotypes obtained 
from crossings of heterozygous Camk2bf/+ (with and without cre) mice: Camk2bf/f;L7-
cre, Camk2bf/f, Camk2b+/+ and Camk2b+/+;L7-Cre. Finding no difference in locomotion 
Figure 3. Requirement of cerebellar CAMK2B in locomotion. Motor performance (1-
day paradigm; (D) and (F)) and learning (5-day paradigm; (E) and (G)) was tested using the 
accelerating rotarod. (A) Immunohistochemistry stainings of CAMK2B, showing (left to right): 
normal expression in Camk2bf/f mice; specific deletion in cerebellar Purkinje cells in Camk2bf/
f;L7-cre mice and specific deletion in the cerebellar granule cells of Camk2bf/f;Gabaa6-cre mice. 
(B) Immunofluorescent and immunohistochemical zoomed-in picture of the cerebellum of 
Camk2bf/f mice, Camk2bf/f;L7-cre and Camk2bf/f;Gabaa6-cre mice showing specific deletion in 
cerebellar Purkinje Cells in the Camk2bf/f;L7-cre mice and deletion in the granule cell layer (GCL) 
of Camk2bf/f;Gabaa6-cre mice, but not in Purkinje cells of the molecular layer (ML). (C) Western 
blots using an antibody specific for CAMK2A and CAMK2B in the different Camk2b mutants and 
their control littermates. (Left) Decreased levels of CAMK2A and CAMK2B in the cerebellum of 
Camk2bf/f;L7-cre mice. LoxP sites do not affect CAMK2A and CAMK2B levels. (Right) Decreased 
levels of CAMK2B in the cerebellum of Camk2bf/f;Gabaa6-cre mice with no changes in CAMK2A 
levels. Actin levels are shown as loading control. (D) Camk2bf/f;L7-cre mice (n=10) show no 
difference in performance compared to Camk2bf/f control littermates (n=12). Camk2b+/+;L7-cre 
(n=12) and Camk2b+/+ mice (n=15) do not differ in performance compared to Camk2bf/f;L7-cre 
and Camk2bf/f mice implying no effect of CRE or the flanked LoxP sites on rotarod performance. 
(E) Camk2bf/f;L7-cre mice (n=10) show an impairment in learning compared to Camk2bf/f control 
littermates (n=12). Camk2b+/+;L7-cre (n=12) and Camk2b+/+ mice (n=15) do not differ in learning 
compared to Camk2bf/f;L7-cre and Camk2bf/f mice implying no effect of CRE or the flanked 
LoxP sites on rotarod learning. (F) Camk2bf/f;Gabaa6-cre mice (n=8) show no impairment in 
performance compared to Camk2bf/f control littermates (n=8). (G) Camk2bf/f;Gabaa6-cre mice 
(n=8) and Camk2bf/f control littermates (n=8) show normal learning. Error bars indicate SEM.
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between the Camk2b+/+ and Camk2bf/f mice, we decided for subsequent experiments to 
cross homozygous Camk2bf/f mice (with and without cre), resulting in only Camk2bf/f and 
Camk2bf/f;cre offspring. Surprisingly, neither the cerebellar Purkinje cell nor granule cell 
specific Camk2b mutants showed a rotarod deficit on the one-day training paradigm 
(Fig. 3d and f; for statistics see Table 2). When tested for 5 consecutive days however (to 
assess motor learning), Camk2bf/f;L7-cre mice showed impaired motor learning (Fig. 3e; 
Table 2), whereas the granule cell specific mutants still showed no hint of any deficit 
compared to their littermate control mice (Fig. 3g; Table 2).
Since the loss of CAMK2B in cerebellar granule cells or Purkinje cells does not appear 
to contribute to the locomotion deficit as seen in Camk2b∆ex2/∆ex2 mice, we then focused 
on striatum and motor cortex. Camk2bf/f mice were crossed with Rgs9-cre (deletion 
specifically in most medium spiny projection neurons of the striatum (Rahman et 
al., 1999)) and Emx-cre (deletion in glutamatergic pyramidal neurons in cortex and 
hippocampus) transgenic mice to test respectively striatal and cortical involvement in 
the rotarod phenotype. Rgs9-cre is expressed from P8 onwards (Dang et al., 2006) and 
Emx-cre is expressed from E10.5 (Iwasato et al., 2004). Camk2bf/f;Rgs9-cre mice showed 
selective loss of CAMK2B in striatum (Fig. 4a and b; Table 1) and Camk2bf/f;Emx-cre mice 
showed selective loss of CAMK2B in glutamatergic pyramidal neurons in hippocampus 
and cortex with no changes in levels of CAMK2A in both mutants (Fig. 4a and b; Table 1). 
Importantly, none of the specific lines showed notable off-target deletion in other brain 
areas (data not shown).
Notably, neither the striatal nor forebrain-specific Camk2b mutants showed a rotarod 
deficit on the one-day training paradigm (Fig. 4c and e; for statistics see Table 2). When 
tested for 5 consecutive days these region-specific mutants still showed no deficits 
compared to their controls (Fig. 4d and f; Table 2). Interestingly, the Camk2bf/f;Emx-cre 
mice even showed a significantly enhanced locomotion (Fig. 4f; Table 2). 
Taken together these results show that selective deletion of CAMK2B in brain areas 
supporting locomotion, is not sufficient to recapitulate the locomotion deficits 
observed in either the Camk2b∆ex2/∆ex2 or the Camk2bf/f;CAG-CreER mice. This suggests that 
multiple brain areas are responsible for locomotion deficits observed in Camk2b∆ex2/∆ex2 
mice. The only mouse line showing a small but significant effect on motor learning (5 
day paradigm), but not motor performance (1 day paradigm), was the Purkinje cell 
specific knockout (Camk2bf/f;L7-cre). However, this effect is still marginal compared to 
Camk2b∆ex2/∆ex2 mice.
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Table 2. Overview of statistical analysis of rotarod performances and learning of Camk2b 
mutants. A 2-way repeated measures ANOVA was used to test for performance or learning 
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Figure 4. Requirement of striatal, hippocampal and cortical CAMK2B in locomotion. 
Motor performance (1-day paradigm; (C) and (E)) and learning (5-day paradigm; (D) and (F)) 
was tested using the accelerating rotarod. (A) Immunohistochemistry stainings of CAMK2B, 
showing (left to right): normal expression in Camk2bf/f mice; specific deletion in the striatum 
of Camk2bf/f;Rgs9-cre and specific hippocampal and cortical deletion in Camk2bf/f;Emx-cre mice. 
(B) Western blots using an antibody specific for CAMK2A and CAMK2B in the different Camk2b 
mutants and their control littermates. Actin levels are shown as loading control. Decreased 
levels of CAMK2B in striatal tissue of Camk2bf/f;Rgs9-cre mice (left). Decreased hippocampal and 
cortical levels of CAMK2B in Camk2bf/f;Emx-cre mice (right). No changes in levels of CAMK2A 
were observed in both mutants. (C) Camk2bf/f;Rgs9-cre mice (n=7) show no impairment in 
performance compared to Camk2bf/f control littermates (n=7). (D) Camk2bf/f;Rgs9-cre mice 
(n=7) and Camk2bf/f control littermates (n=7) show normal learning. (E) Camk2bf/f;Emx-cre mice 
(n=13) show no impairment in performance compared to Camk2bf/f control littermates (n=17). 
(F) Camk2bf/f;Emx-cre mice (n=13) and Camk2bf/f control littermates (n=17) show enhanced 
performance but no impairment in learning. Error bars indicate SEM.
DISCUSSION 
Using several novel as well as previously described Camk2b mouse mutants, we dissected 
the molecular, temporal and systems requirements for CAMK2B in locomotion. At the 
molecular level we showed that even though the autonomous activity of CAMK2B in 
locomotion is dispensable, the ability of CAMK2B to bind Calcium/Calmodulin is crucial 
for normal locomotion. At the developmental level we found that deletion of Camk2b 
in the adult mouse causes a much milder locomotion deficit compared to germ line 
Camk2b deletion. Finally, at a systems level we showed that early onset deletion of 
Camk2b in any of the major motor areas of the brain (cerebellum, striatum or forebrain) 
did not recapitulate the locomotion deficit of global Camk2b deletion. Taken together 
these results suggest that the locomotion deficits are mainly of a developmental origin, 
as well as a result of interplay between multiple regions (systems level). 
We showed here that loss of autophosphorylation of CAMK2B at the T287 site does not 
significantly affect rotarod behaviour, although a small trend could be seen. In contrast, 
mutating the Calcium/Calmodulin binding site of CAMK2B, such that it cannot bind 
Calcium/Calmodulin and rendering CAMK2B bound to actin (Camk2bA303R/A303R), led to 
a severe locomotion deficit. Whether the inability to bind Calcium/Calmodulin and 
becoming active, or the inability to be released from actin causes the deficits observed, 
remains to be investigated. CAMK2B forms heteromers with CAMK2A (Brocke et al., 
1999) and ratios of CAMK2A/CAMK2B can differ between cell types (Miller and Kennedy, 
1985; Brocke et al., 1999). It has been shown for the hippocampus (in dissociated 
neuronal cultures and using Camk2bA303R/A303R mice) that CAMK2B kinase activity is not 
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important for synaptic plasticity or hippocampal learning, but that CAMK2B is required 
for regulating the subcellular location of CAMK2A (Shen et al., 1998; Borgesius et al., 
2011). However, in Purkinje cells, CAMK2B not only regulates the subcellular localization 
of CAMK2A, but also plays an important enzymatic role in regulating the direction of 
plasticity at the parallel fiber–Purkinje cell synapse (Van Woerden et al., 2009). These 
different requirements likely reflect the differences in the CAMK2A/CAMK2B ratio in the 
different brain areas. Thus, when the relative expression level of CAMK2A is low, both 
the enzymatic and the non-enzymatic function of CAMK2B may be important, whereas 
in areas where CAMK2A is abundant, CAMK2B serves mainly to regulate the subcellular 
localization of CAMK2A. It would be interesting to investigate the CAMK2A/CAMK2B 
ratio in the specific motor areas of the brain to get more insight in which brain areas 
are involved in the severe locomotion deficits seen in the Camk2b–/– and Camk2bA303R/
A303R mice. Notably, Camk2bf/f;L7-cre mice showed a significant decrease in CAMK2A in 
western blot when only CAMK2B was deleted. A similar trend could be found in the 
cerebellum of Camk2bf/f;CAG-CreER and in Camk2b–/– mice (Van Woerden et al., 2009). 
These results imply that specifically in Purkinje cells, which are the only cells in the 
cerebellum expressing CAMK2A, CAMK2B stabilizes CAMK2A, and that absence of 
CAMK2B therefore results in reduced levels of CAMK2A. However, the exact mechanism 
behind this regulation requires further research. 
From a developmental point of view, we found that deleting most of Camk2b in the adult 
mice resulted in a significant locomotion impairment showing its necessity for normal 
motor behaviour. However, the phenotype was rather mild compared to the germ-
line knock out mouse, indicating that acute deletion of Camk2b does not dramatically 
affect neuronal function. These results indicate that the severe locomotion deficits of 
Camk2b–/– mice largely arise during development of the nervous system. Unfortunately, 
little is known about the role of both the CAMK2 isoforms in brain development. For 
CAMK2A, which starts to be expressed around P1, we recently showed that deletion 
of Camk2a in adulthood is as detrimental as a germline deletion of Camk2a for 
hippocampal learning and plasticity (Achterberg et al., 2014), indicating an important 
post-developmental role. CAMK2B however, starts to be expressed already during early 
embryonic development (around E12.5) (Karls et al., 1992; Bayer et al., 1999). Therefore 
it is likely that CAMK2B plays a significant role during development. Previous studies 
looking at the developmental role of CAMK2B have shown an important role for 
CAMK2B in neurite extension and spine formation in acute knock-down experiments in 
neuronal cultures (Fink et al., 2003). However, no morphological changes were found in 
the Camk2b–/– mice (Van Woerden et al., 2009; Bachstetter et al., 2014), nor in neuronal 
cultures obtained from Camk2b–/– mice (Borgesius et al., 2011), thus it is unclear how a 
germ-line deletion of Camk2b can be so profoundly affected.
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Locomotion deficits can be caused by dysfunction of several different brain areas (as 
reviewed by (Lalonde and Strazielle, 2007)). Using lesion studies it was shown that the 
cerebellum and thalamus are important in rotarod behaviour (Caston et al., 1995; Jeljeli 
et al., 2000; 2003), but lesioning the dorsal striatum did not cause motor impairments on 
the rotarod (Thullier et al., 1996). As for the motor cortex, some lesion studies have been 
performed, but the effect of the lesions was not assessed by the rotarod task. However, 
a recent pharmacological study showed that mGluR5 inhibition in primary motor 
cortex affected rotarod performance, which was not observed upon mGluR5 inhibition 
in dorsolateral striatum (Guimaraes et al., 2015). In contrast, deletion of the Nmdar1 
gene from P8 onwards using Rgs9-cre mice in the striatum resulted in performance 
and learning deficits on the rotarod (Dang et al., 2006). Taken together, these studies 
all indicate that, depending on the lesion or genetic change, several specific brain areas 
could potentially be responsible for deficits in motor performance as measured with 
the rotarod. 
Surprisingly, restricted deletion of CAMK2B in the major motor areas of the brain did 
not reveal a specific brain area or cell type to be responsible for the severe rotarod 
phenotype observed in the Camk2b–/– mice. In these groups we not only assessed motor 
performance, but also motor learning by testing the mice over 5 consecutive days. Even 
though there are small variations in performance and learning in the control groups 
between the different experiments, the effects of Camk2b deletion on locomotion was 
only marginal compared to the profound phenotypes seen in Camk2b–/–, Camk2b∆ex2/∆ex2 
and Camk2bA303R/A303R mice. There are three possible explanations for our findings. First, 
onset of Camk2b gene deletion in our mutants is likely to be too late. Three of the cre-
lines used in this study start cre expression after onset of CAMK2B expression (L7-cre 
starts expression at P1 (Barski et al., 2000), Gabaα6-cre starts expression at P5-P7 (Aller 
et al., 2003), and Rgs9-cre expression is seen as early as P8 (Dang et al., 2006)). Thus, 
these lines start off with normal embryonic CAMK2B expression. Since we do not know 
the critical time window for CAMK2B in rotarod behaviour, it could be that in these 
mice CAMK2B is deleted too late in these separate brain regions or cell types to cause a 
significant effect on rotarod behaviour, comparable to Camk2bf/f;CAG-CreER mice, where 
adult deletion resulted only in a mild phenotype when CAMK2B was deleted throughout 
the brain. Only the Emx-cre line, which expresses cre from E10.5 (Iwasato et al., 2004), 
induces deletion of Camk2b before onset of CAMK2B expression (E12.5). Interestingly, 
deletion in this cre-line resulted in enhanced, instead of impaired performance. Second, 
Camk2b deletion in thalamus, brainstem and the deep cerebellar nuclei is only obtained 
in the Camk2b∆ex2/∆ex2 mice. Since it has been shown that these areas are involved in 
locomotion (Lalonde and Strazielle, 2007), there is a possibility that the motor deficits 
arise from those areas. Third, the severity of the locomotion deficits observed in the 
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Camk2b–/– mice (Van Woerden et al., 2009) could indicate a distributed role for CAMK2B 
in several brain areas and cell types, each one of them contributing a little to the deficit. 
For example, we cannot exclude that deleting Camk2b in Purkinje-cells and cerebellar 
granule cells simultaneously would have an effect on locomotion. Additionally, even 
though the different cre-lines used in this study were very effective at deleting Camk2b 
throughout multiple brain areas and cell types (as judged by immunuhistochemstry 
and Western blot), we cannot exclude the possibility that a small number of cells did not 
undergo deletion, and prevented the lack of a severe phenotype. 
Taken together we conclude that the nature of severe the locomotion deficits observed 
in the Camk2b–/– is predominantly of developmental origin and cannot be attributed to 
one specific motor area or cell type in the brain. Moreover we conclude that the Calcium/
Calmodulin-dependent activation of CAMK2B is essential for normal locomotion, but 
that the autonomous activity of CAMK2B is largely dispensable for normal locomotion. 
These findings are in sharp contrast to the role of CAMK2A in spatial learning, where 
loss of CAMK2A in adult mice recapitulates the phenotype of Camk2a–/– mice, where 
selective loss of CAMK2A in the hippocampus causes spatial learning deficits, and where 
loss of autonomous CAMK2A activity causes severe spatial learning deficits (Giese et al., 
1998; Achterberg et al., 2014).
MATERIALS AND METHODS
Animals
Camk2bA303R/A303R and Camk2bT287A/T287A mice were tested in a 129P2-C57Bl/6OlaHsd 
F2 hybrid background. Camk2b∆ex2/∆ex2 mice were backcrossed > 16 times into 
C57Bl/6JOlaHsd background. All conditional mice used in this study were backcrossed 
10-12 times into the C57BL/6JOlaHsd background and crossed with cre lines maintained 
in the C57BL/6JOlaHsd background. Mice were genotyped when they were 7-10 days 
old, and re-genotyped after the mice were sacrificed. Genotyping records were obtained 
and kept by a technician not involved in the experimental design, performance and 
analysis. All mice were tested between 2-3 months of age, except the Camk2bf/f;Rgs9-cre 
group, which was tested between 3-5 months of age. All mice were kept group-housed 
in IVC cages (Sealsafe 1145T, Tecniplast) with bedding material (Lignocel BK 8/15 from 
Rettenmayer) on a 12/12 h light/dark cycle in 21°C (±1°C), humidity at 40-70% and with 
food pellets (801727CRM(P) from Special Dietary Service) and water available ad libitum. 
For all experiments mutants were compared to WT or cre-negative homozygous floxed 
littermates. All groups were matched for age and sex and all experiments were done 
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during daytime. Experimenters were blind for genotype throughout experiments and 
data analysis. All research was performed in accordance with and approved by a Dutch 
Animal Ethical Committee (DEC) for animal research.
Generation of Camk2bA303R/A303R and Camk2bT287A/T287A mice
Generation of the Camk2bA303R/A303R mice has been described previously (Borgesius et al., 
2011). The Camk2bT287A targeting construct to generate Camk2bT287A/T287A mice was generated 
as follows. The Camk2b genomic sequence (ENSMUSG00000057897) was obtained from 
a public database (Ensembl) and used to design the primers for the targeting constructs. 
PCR fragments encompassing exon 6-11 using 5’ primer: 5’-GGTACCTGAGGAAGGTGCC
AGCTCTGTCCC-3’ and 3’ primer: 5’–GTCGACCAGGGTAGTCACGGTTGTCC-3’ (5.3 Kb; exon 
denotation according to ENSMUST00000019133) and exon 11-12 using 5’ primer: 5’-GC
GGCCGCCTGTTAAAGGAATGGTTCTC-3’ and 3’ primer: 5’-ATGCATCTAAAAGGCAGGCAGG
ATGATCTGC-3’ (6 Kb) were amplified using High Fidelity Taq Polymerase (Roche) on ES 
cell genomic DNA and cloned on either site of a PGK-Neomycin selection cassette. All 
exons were verified by sequencing. Site directed mutagenesis was used to introduce the 
Thr287Ala point mutation, which induced a TspRI restriction site (Figure 1). For counter 
selection, a gene encoding Diphtheria toxin chain A (DTA) was inserted at the 5’ end 
of the targeting construct. The targeting construct was linearized and electroporated 
into E14 ES cells (derived from 129P2 mice). Cells were cultured in BRL cell conditioned 
medium in the presence of Leukaemia inhibitory factor (LIF). After selection with G418 
(200 mg/ml), targeted clones were identified by PCR (long-range PCR from Neomycin 
resistance gene to the region flanking the targeted sequence). A clone with normal 
karyotype was injected into blastocysts of C57Bl/6 mice. Male chimeras were crossed 
with female C57Bl/6 mice (Harlan). The resulting F1 heterozygous mice (in the 129P2-
C57Bl/6 background) were subsequently inter-crossed to obtain F2 129P2-C57Bl/6 
hybrid mice to generate homozygous mutants and wild-type littermate controls. 
Generation of floxed Camk2b and Camk2b∆ex2/∆ex2 mice
The floxed Camk2b targeting construct was generated as follows. The Camk2b genomic 
sequence (ENSMUSG00000057897) was obtained from a public database (Ensembl) and 
used to design the primers for the targeting constructs. PCR fragments encompassing 
intron 1 using 5’ primer: 5’-TTTGGTACCGCATTGTGGGCATCTATGAAG-3’ and 3’ primer: 
5’–AAAGGATCCAGTCAGCTGGAATGAGACGTG-3’ (2.6 Kb; intron and exon denotation 
according to ENSMUST00000019133), exon 2 using 5’ primer: 5’-TTTATGCATGATAGACC
TGGGTGTTACACAG-3’ and 3’ primer: 5’-AAAGTCGACCTTCAGGTCTGGGACAGAG-3’ (583 
bp) and intron 2 using 5’ primer: 5’-TTTGCGGCCGCAGAAGTCCTCATATTGGGGAGG-3’ 
and 3’ primer: 5’-AAACCGCGGTGACTCCTAATGCAGAAGACACC-3’ (4 kb) were amplified 
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using High Fidelity Taq Polymerase (Roche) on ES cell genomic DNA. The 5’ fragment 
containing part of intron 1 was inserted before the first LoxP site whereas exon 2 and 
part of intron 2 were cloned on either site of a PGK-Neomycin selection cassette, which 
is flanked by frt and LoxP sites (for the schematics see Figure 2). Exon 2 and flanking 
intronic sequences were sequenced to verify that the absence of secondary mutations. 
For counter selection, a gene encoding Diphtheria toxin chain A (DTA) was inserted at the 
5’ of the targeting construct. The targeting construct was linearized and electroporated 
into E14 ES cells (derived from 129P2 mice). Cells were cultured in BRL cell conditioned 
medium in the presence of Leukaemia inhibitory factor (LIF). After selection with G418 
(200 mg/ml), targeted clones were identified by PCR (long-range PCR from Neomycin 
resistance gene to the region flanking the targeted sequence). To delete the Neomycin 
resistance cassette and obtain the conditional construct, the correctly targeted clones 
were transiently transfected with an flp recombinase (Figure 2). Finally, a clone with 
correct karyotype was injected into blastocysts of C57Bl/6 mice. Male chimeras were 
crossed with female C57BL/6JOlaHsd mice (Harlan). The resulting F1 heterozygous 
Camk2bf/+ mice, which were backcrossed 10-12 times with C57BL/6JOlaHsd mice before 
generating the brain region and temporally restricted mutants as described below. To 
obtain the Camk2b∆ex2/∆ex2 mice, the Camk2bf/+ mice were crossed with transgenic Cag-
cre mice (Sakai and Miyazaki, 1997). The Camk2b∆ex2/+ heterozygous offspring were 
backcrossed >16 times in C57BL/6JOlaHsd to obtain a congenic line. 
Generation of Camk2bf/f conditional mutants
For the generation of conditional mutants, female Camk2bf/f mice (backcrossed 10-12 
times with C57BL/6JOlaHsd) were crossed with male transgenic Cre lines maintained 
in C57BL/6JOlaHsd. To obtain temporal control, Camk2bf/f mice were crossed with CAG-
CreER mice (RRID:IMSR_JAX:004682; (Hayashi and McMahon, 2002)). F1 heterozygous 
floxed female Camk2bf/+ mice were then crossed with male heterozygous floxed mice 
expressing CAG-CreER to obtain the desired F2 genotypes: homozygous floxed Camk2bf/
f;CAG-CreER with transgenic expression of CAG-CreER (mutants) and Camk2bf/f without 
CAG-CreER expression (controls). A similar crossing was performed to obtain Purkinje cell 
specific deletion of CAMK2B, using L7/pcp-2 cre transgenic mice (RRID:IMSR_JAX:004146; 
(Oberdick et al., 1990; Barski et al., 2000), and to obtain glutamatergic and telencephalic-
restricted deletion of CAMK2B, using Emx1-cre transgenic mice (RRID:IMSR_RBRC01345; 
(Iwasato et al., 2004)). Deletion of Camk2b in cerebellar granule cells was obtained by 
crossing Camk2bf/f mice with Gabaa6-cre transgenic mice (Aller et al., 2003). To generate 
striatal specific deletion of CAMK2B we crossed Camk2bf/f mice with Rgs9-cre mice (Dang 
et al., 2006). 
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Tamoxifen injections
Adult Camk2bf/f and Camk2bf/f;CAG-CreER mice (8-10 weeks of age) were injected with 
Tamoxifen intraperitoneally (Sigma-Aldrich) (0.1mg/gr of bodyweight) for 4 consecutive 
days. To keep the dose of Tamoxifen constant throughout injection days we kept a tight 
injection scheme, injecting mice 24+/ –1 hour after the previous injection. Tamoxifen 
was dissolved in sunflower oil (20mg/ml). Behavioural testing was assessed 4 weeks 
after the first injection. Even though Tamoxifen does not have an effect on emotional 
reactivity, neurological functioning or learning (Vogt et al., 2008) we injected both 
Camk2bf/f and Camk2bf/f;CAG-CreER mice to control for any possible effects of Tamoxifen. 
Rotarod
The accelerating rotarod (Ugo Basile, Comerio Varese, Italy, 7650) contains a cylinder 
3cm in diameter and can train 5 mice at the same time. Rotarod speed starts at 4 r.p.m., 
which increases to 40 r.p.m. at 270 seconds. The experiment stopped at 300 seconds. 
Latency to fall was measured in seconds after a mouse (i) fell of, (ii) clung to the rod for 
3 consecutive rotations or (iii) clung to the rod for 2 rotations twice within 10 seconds. 
Mice were trained with an inter-trial interval of 45 minutes. We used two different 
paradigms on the accelerating rotarod. For motor performance (which we define as 
locomotion throughout the text) we used 5 consecutive trials with naïve mice (1 day 
paradigm). To assess motor learning we took the average of the first two trials of the first 
day and continued training the mice for another 4 consecutive days with 2 trials per day 
(5 day paradigm). 
Immunohistochemistry and immunofluorescence
Mice were anaesthetized with pentobarbital and perfused transcardially with PBS 
followed by freshly prepared 4% paraformaldehyde solution (PFA, Sigma). Brains were 
taken out after perfusion and post-fixed for 1.5 hours in PFA and afterwards kept in 
30% sucrose solution overnight. Immunohistochemistry was performed on free-
floating 40μm thick sagittal cryostat sections. Sections were washed in PBS once and 
afterwards primary antibodies were added (anti-CAMK2B, 1:2000, #ab34703, Abcam) 
diluted in PBS containing 2% NHS, 0.5% Triton-X 100 and 150mM bovine serum 
albumin (BSA) and kept at 4°C overnight for 48 hours. Two days later sections were 
washed 3 times with PBS and then secondary antibodies were added (biotinylated 
goat anti-rabbit IgG antibody, Vector Laboratories, Burlinghame, CA; 1:200) diluted in 
PBS containing 2% NHS, 0.5% Triton-X 100 and 150mM bovine serum albumin (BSA) 
for 1 to 2 hours on room temperature. For diaminobenzidine (DAB) staining, sections 
were processed using a standard avidin-biotin-immunoperoxidase complex method 
(ABC, Vector Laboratories, USA) and 0.05% DAB as the chromogen. Sections were 
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mounted on slices using chrome(3)potassiumsulfatedodecahydrate and left to dry. 
The next day, slides were dehydrated in alcohol, cleared with xylene and covered using 
Permount (Fisher Scientific, USA). For immunofluorescence, the same CAMK2B was used 
as in immunohistochemistry (1:1000) and we used Cy3 rabbit (1:200) as a secondary 
antibody. After 1-2 hours incubation of the secondary antibody at room temperature 
sections were washed four times in PB (0.05M) and mounted on slices using chrome(3)
potassiumsulfatedodecahydrate and left to dry. Finally, sections were covered using 
Mowiol (Sigma-Aldrich).
Western blot
Mice were anaesthetized using isoflurane and sacrificed by decapitation. Brain samples 
were taken out quickly and stored in liquid nitrogen. Upon protein determination lysates 
were first prepared and brain samples were homogenized in lysis buffer (10mM Tris-
HCl 6.8, 2.5% SDS, 2mM EDTA). Protein concentration in the samples was determined 
and then lysate concentrations were adjusted to 1mg/ml. Western blots were probed 
with primary antibodies against either CAMK2A (6G9, 1:40.000, Abcam), CAMK2B 
(CB-β1, 1:10.000, Invitrogen), Actin (MAB1501R, 1:20.000, Chemicon) or Ph-T286/T287 
(autophosphorylated αCaMKII and CAMK2B antibody; #06-881; 1:5000; Upstate Cell 
Signaling Solutions) and secondary antibodies (goat anti-mouse and/or goat anti-
rabbit, both 1:3000, AffiniPure #115-007-003 and #111-007-003). Blots were stained 
with Enhanced ChemoLuminescence (ECL) (#32106, Pierce) or stained and quantified 
using LI-COR Odyssey Scanner and Odyssey 3.0 software. Quantification of western blot 
in ECL was done using ImageJ. 
Data analysis and statistics
All experiments and analyses were performed blind to genotype. All behavioural tests 
were analysed using a 2-WAY repeated measures ANOVA to determine the performance 
and learning of the genotypes, with genotype as the between subjects factor and 
the repeated measures as within subject factor. α was set at 0.05. All values represent 
average +/- SEM. Group sizes for each genotype are depicted in the figure legends. All 
statistics were performed in Graphpad Prism. *p < 0.05, ***p < 0.001.
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Ca2+/Calmodulin-dependent protein kinase II (CAMK2) is a key player in synaptic 
plasticity and memory formation. Mutations in either Camk2a or Camk2b, cause 
intellectual disability in humans, and severe plasticity and learning deficits in mice, 
indicating the presence of unique functions for each isoform. However, considering 
the high homology between CAMK2A and CAMK2B, it is conceivable that for critical 
functions, one isoform compensates for the absence of the other isoform, and that the 
full functional spectrum of neuronal CAMK2 remains to be revealed. 
Here we show that deletion of both CAMK2 isoforms at germline or adult age is lethal. 
Moreover, Ca2+-dependent activity as well as autonomous activity of CAMK2 is crucial 
for survival. Together, these results reveal an essential role for CAMK2 signalling in early 
postnatal development as well as in adulthood, and indicate that the full spectrum of 
CAMK2 requirements is masked due to partial overlapping functions of CAMK2A and 
CAMK2B.
Significance statement:
CAMK2A and CAMK2B have been studied for over 30 years for their role in neuronal 
functioning. However, most studies were performed using single knockout mice. Since 
the two isoforms show high homology with respect to structure and function, it is 
likely that some redundancy exists between the two isoforms, meaning that for critical 
functions CAMK2B compensates for the absence of CAMK2A and vice versa, leaving 
these functions to uncover. In this study, we generated CAMK2A/CAMK2B double-
mutant mice, and observed that loss of CAMK2, as well as the loss of Ca2+-dependent 
and Ca2+-independent activity of CAMK2 is lethal. These results indicate that despite 
30 years of research the full spectrum of CAMK2 functioning in neurons remains to be 
unraveled.   
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INTRODUCTION
Since the discovery of the CAMK2 protein family in the 1970s, more than 2000 papers 
have been published in which the function of CAMK2A or CAMK2B, the most abundant 
CAMK2 isoforms in the brain, has been studied. The generation of different Camk2a 
mutants (of which the knockout was already published 25 years ago (Silva et al., 1992a; 
1992b)) and Camk2b mutants, greatly contributed to the understanding of the role of 
these 2 isoforms in neuronal functioning, learning and plasticity in mice (Mayford et 
al., 1995; Giese et al., 1998a; Elgersma et al., 2002; Borgesius et al., 2011; Achterberg et 
al., 2014; Kool et al., 2016). Very recently, the important role of CAMK2A and CAMK2B 
for normal human neurodevelopment was shown (Küry et al., 2017; Stephenson et al., 
2017; Akita et al., 2018). 
CAMK2 forms a holoenzyme of approximately 12 subunits, which can consist of both 
CAMK2A and CAMK2B subunits. This CAMK2 holoenzyme is able to convert a short high 
frequency signal into a long-term change in synaptic strength (for review see (Lisman 
et al., 2002; Hell, 2014)). Upon calcium influx Ca2+/Calmodulin binds CAMK2 in the 
regulatory domain (Vallano, 1989). This binding allows the release of a pseudosubstrate 
region of the protein from the catalytic domain. When two adjacent subunits within 
the holoenzyme are activated by Ca2+/Calmodulin, one subunit can phosphorylate the 
neighboring subunit on Thr286 (CAMK2A) or Thr287 (CAMK2B) leaving this subunit 
autonomously active (Ca2+-independent activity) when calcium levels drop to baseline 
(Miller and Kennedy, 1986; Hanson et al., 1994). However, upon detachment of Ca2+/
Calmodulin from CAMK2, Thr305/Thr306 (CAMK2A) or Thr306/Thr307 (CAMK2B) within 
the calmodulin binding region can be phosphorylated thereby preventing future 
binding of Ca2+/Calmodulin (thus Ca2+-dependent activity). 
The importance of these autophosphorylation events for CAMK2 function, was shown 
by generating CAMK2 point mutants, in which the Thr286 or Thr305/Thr306 were 
mutated to either phosphomimic residues (e.g. Thr305Asp), or phosphodead residues 
(e.g. Thr286Ala). All of these mutations resulted in learning and plasticity phenotypes 
(Mayford et al., 1995; Giese et al., 1998a; Elgersma et al., 2002). Besides an important 
enzymatic function, there are also studies showing that CAMK2A and CAMK2B play 
important structural roles. For example, CAMK2A has been shown to play an important 
structural role in the pre-synapse in short-term plasticity (Hojjati et al., 2007) and 
CAMK2B plays an important structural role in determining the localization of CAMK2A 
during hippocampal plasticity, through its F-actin binding domain (Borgesius et al., 
2011). Thus, taken together many studies have shown unique functions for CAMK2A 
and CAMK2B in neuronal functioning. However, CAMK2A and CAMK2B are highly 
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homologous, thus it is conceivable that there is substantial redundancy in function, and 
that these functions of CAMK2 are missed when studying the Camk2a or Camk2b single 
mutants. 
In this study we tried to reveal novel CAMK2 functions by studying different Camk2a 
/Camk2b double mutants. We found that Camk2a/Camk2b double knockout mice 
(Camk2a–/–;Camk2b–/–) die immediately after birth. Surprisingly, blocking Ca2+-
dependent (Camk2aT305D/T305D;Camk2bA303R/A303R) as well as Ca2+-independent (Camk2a286A/2
86A;Camk2b287A/287A) activity in both CAMK2A and CAMK2B is also lethal, since these mice 
also die immediately after birth. Additionally, not only germline deletion of Camk2, but 
also loss of both CAMK2A and CAMK2B in adulthood is lethal, with a median survival of 
37 days after gene deletion initiation. When looking at neuronal function in the absence 
of CAMK2 in the inducible Camk2a/Camk2b double knockout mice (Camk2af/f;Camk2bf/
f;CAG-CreESR), we found that loss of both isoforms in adult animals leads to a complete 
abolishment of CA3-CA1 LTP but that the absence of both CAMK2 isoforms does not 
affect basal synaptic strength. To investigate whether pre- or postsynaptic CAMK2 is 
essential for this loss of LTP, we used a mouse model with a genetic ablation of Camk2a 
and Camk2b specifically in the excitatory neurons of the CA3 area. This revealed that 
presynaptic CAMK2A and CAMK2B are not required for LTP. Taken together we show that 
CAMK2 is crucial for survival during early postnatal development as well as adulthood. 
This indicates that despite the enormous wealth of literature on CAMK2 functions, its 
full spectrum is still not uncovered and that the role of CAMK2 signaling in neurons is 
much more important than was previously thought.
MATERIAL AND METHODS
Animals
In this study the following mice were used: Camk2a–/– (Camk2atm3Sva, MGI:2389262) 
and Camk2b –/– mice to generate Camk2a+/+;Camk2b+/+ (WT mice); Camk2a+/–;Camk2b–/– 
(mice heterozygous for Camk2a and knockout for Camk2b); Camk2a–/–;Camk2b+/– (mice 
knockout for Camk2a and heterozygous for Camk2b); Camk2a–/–;Camk2b–/– (Camk2a 
and Camk2b double knockout mice); Camk2aT286A/T286A (Camk2atm2Sva, MGI:2158733) and 
Camk2b T287A/T287A mice to generate Camk2a+/T286A;Camk2bT287A/T287A (mice heterozygous for 
a T286A knock-in mutation in Camk2a and homozygous for a T287A knock-in mutation 
in Camk2b); Camk2aT286A/T286A;Camk2b+/T287A (mice homozygous for T286A in Camk2a and 
heterozygous for T287A in Camk2b); Camk2aT286A/T286A;Camk2bT287A/T287A (homozygous 
T286A and T287A knock-in mutations in Camk2a and Camk2b respectively); Camk2aT305D/
T305D (Camk2atm5Sva, MGI: 2389272) and Camk2b A303R/A303R (Camk2btm2.1Yelg, MGI:5285573) 
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mice to generate Camk2a+/T305D;Camk2bA303R/A303R (mice heterozygous for a T305D 
knock-in mutation in Camk2a and homozygous for a A303R knock-in mutation in 
Camk2b); Camk2aT305D/T305D;Camk2b+/A303R (mice homozygous for T305D in Camk2a and 
heterozygous for A303R in Camk2b); Camk2aT305D/T305D;Camk2bA303R/A303R (homozygous 
T305D and A303R knock-in mutations in Camk2a and Camk2b respectively); Camk2af/
f;Camk2bf/f (homozygous floxed Camk2a (Camk2atm1.1Yelg, MGI:5662417) and Camk2b 
mice with no Cre expression; controls); Camk2af/f;Camk2bf/f;CAG-CreESR (homozygous 
floxed Camk2a and Camk2b mice with transgenic Cre expression throughout the body 
after injection with tamoxifen (Tg(CAG-cre/Esr1*)5Amc; MGI:2182767) and Camk2af/
f;Camk2bf/f;CA3-Cre (knockout mutants for Camk2a and Camk2b specifically in the CA3 
region of the hippocampus (Grik4tm1.1(cre)Slab; MGI: 4398684). 
All mice were backcrossed >16 times in a C57BL/6J background and were group-housed 
in IVC cages (Sealsafe 1145 T, Tecniplast) with bedding material (Lignocel BK 8/15 from 
Rettenmayer) on a 12/12 h light/dark cycle in 21 °C (±1 °C), humidity at 40–70% and with 
chow (No 1 maintenance autoclave pellets, Special Diets Services) and water available 
ad libitum. Experimenters were blind to all genotypes throughout experiments and 
data analysis. Mice were genotyped when they were 7 days old, and re-genotyped after 
the mice were sacrificed. Genotyping records were obtained and kept by a technician 
not involved in the experimental design, performance and analysis. All experiments 
were done during the light phase, with animals between 2 and 4 months of age. All 
experiments were done with approval of the local Dutch Animal Ethical Committee 
(DEC) for animal research and were in accordance with the European Communities 
Council Directive (86/609/EEC).
Generation of mouse mutants
The generation of both the floxed and knockout Camk2a (Elgersma et al., 2002; 
Achterberg et al., 2014) and Camk2b (Borgesius et al., 2011; Kool et al., 2016) mouse 
mutants has been described previously. All knock-in mutants used in this study have 
been published before as well: Camk2aT286A (Giese et al., 1998a); Camk2aT305D (Elgersma 
et al., 2002); Camk2bT287A (Kool et al., 2016); Camk2aA303R (Borgesius et al., 2011). To 
generate a CA3 specific deletion of the Camk2a and Camk2b genes we crossed Camk2af/
f;Camk2bf/f mice with Grik4-Cre-Neo (Grik4tm1.1(cre)Slab; MGI: 4398684, kindly provided by 
Ralf Schoepfer and York Rudhard) (Filosa et al., 2009) (in this study referred to as CA3-Cre 
mice). CA3-Cre expression starts as early as P5 and is predominantly restricted to the 
CA3 area of the hippocampus. To make sure that full deletion of the gene of interest had 




Adult Camk2af/f;Camk2bf/f, and Camk2af/f;Camk2bf/f;CAG-CreESR mice (8-10 weeks of age) 
were intraperitoneally injected with Tamoxifen (Sigma-Aldrich) (0.1mg/g of bodyweight) 
for 8 consecutive days. To keep the dose of Tamoxifen constant throughout injection 
days we kept a tight injection scheme, injecting mice 24+/ –1 hour after the previous 
injection. Tamoxifen was dissolved in sunflower oil (20mg/ml). For electrophysiological 
experiments we sacrificed adult mice (12-16 weeks old) 25 days after the 1st Tamoxifen 
injection. Though Tamoxifen is not known to have an effect on emotional reactivity, 
neurological functioning or learning (Vogt et al., 2008) we injected both Camk2af/
f;Camk2bf/f and Camk2af/f;Camk2bf/f;CAG-CreESR mice to control for any possible effects of 
Tamoxifen. 
EEG recordings
The surgical procedure for EEG recordings have been described previously (Abs et al., 
2013). At the onset of measurements, mice were connected to a wireless EEG recorder 
(NewBehavior AG, Zurich, Switzerland) and recorded for approximately 16 hours. 
Recordings were analysed by an observer blind to genotype and were only checked for 
the onset of seizures, a pattern of repetitive spike discharge followed by a progressive 
evolution in spike amplitude, which were not observed in any of our recordings.  
Electrophysiology
Mice were sacrificed after being anesthetized with isoflurane (Nicholas Piramal (l) 
Limited, London) and the brain was taken out quickly and submerged in ice-cold 
oxygenated (95%) and carbonated (5%) artificial cerebrospinal fluid (ACSF) (<4.0°) 
containing the following substances (in mM): 120 NaCl, 3.5 KCl, 2.5 CaCl2, 1.3 MgSO4, 
1.25 NaH2PO4, 26 NaHCO3 and 10 D-glucose. Using a vibratome 400-μm-thick sagittal 
slices were made for CA3-CA1 experiments and 400-μm-thick coronal slices for CA3-CA3 
experiments. Hippocampal sections were dissected out afterwards and maintained at 
room temperature for at least 1.5 hours in an oxygenated and carbonated bath to recover 
before experiments were initiated. At the onset of experiments hippocampal slices were 
placed in a submerged recording chamber and perfused continuously at a rate of 2 ml/
min with ACSF equilibrated with 95% O2, 5% CO2 at 30°C. Extracellular recording of 
field EPSP (fEPSPs) and stimulation were done using bipolar platinum (Pt)/iridium (Ir) 
electrodes (Frederick Haer Companu, Bowdoinham, ME). Stimulus duration of 100μs 
for all experiments was used. In CA3-CA1 measurements, the stimulating electrode and 
recording electrode were placed on the CA3-CA1 Schaffer collateral afferents and apical 
dendrites of CA1 pyramidal cells (both 150-200μm from s. pyramidale) respectively. In 
CA3-CA3 measurements both the stimulating electrode and recording electrode were 
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placed on the stratum radiatum of the CA3 area. The stratum lucidum was carefully 
avoided. Upon placement of the electrodes slices were given 20-30 minutes to rest 
before continuing measurements. All paired-pulse facilitation (PPF) experiments were 
stimulated at one-third of slice maximum. Varying intervals were used in PPF: 10, 25, 
50, 100, 200 and 400ms. CAMK2-dependent LTP was evoked using four different tetani: 
(i) 100 Hz (1 train of 1 second at 100 Hz, stimulated at one-third of slice maximum), (ii) 
200 Hz (4 trains of 0.5 seconds at 200 Hz, spaced by 5s), stimulated at one-third of slice 
maximum), (iii) Theta burst (2 trains of 4 stimuli at 100 Hz, 200 ms apart, stimulated at 
two-thirds of slice maximum) and (iv) CA3-CA3 LTP (2 trains of 1 second at 100 Hz 10 
seconds apart, stimulated at one-third of slice maximum). A possible caveat in fEPSP 
measurements in the CA3 area is distinguishing between the mossy fiber pathway and 
the commissural (CA3-CA3) pathway. Therefore, we took several measures to make sure 
we recorded from the commissural pathway. First, we used antidromic stimulation in 
the CA3 area. Second, we made use of the electrophysiological parameters PPF and 1 Hz 
frequency facilitation that differ between these two pathways. Mossy fiber transmission 
shows very strong facilitation (± 215% for PPF and ± 250% for 1 Hz) (Scanziani et al., 1997), 
hence, we chose an upper limit of 180% for PPF and 130% for 1Hz, and excluded all slices 
exceeding those limits. Finally, at the end of all experiments we used a pharmacological 
approach using DCG-IV (3mM) to distinguish between both pathways. DCG-IV (3mM) 
is known to reduce mossy fiber transmission by 80% (Kirschstein et al., 2004). This way, 
we felt confident that we only included data from experiments where we specifically 
stimulated CA3-CA3 synapses. Chemical LTD was induced using a 5-minute wash-in of 
DHPG (100 μM; TOCRIS Biosciences) 20 mins after establishing a stable baseline. For 
PKA-dependent LTP a similar baseline was established before chemical induction. We 
added picrotoxin (50uM) to the ACSF throughout the experiment and LTP was induced 
chemically (cLTP) by bath application of picrotoxin (50uM), Forskolin (50uM) and 
Rolipram (0.1uM) for 15 minutes, after which bath circulation was returned to ACSF with 
only picrotoxin (50uM). During LTP slices were stimulated once per minute. Potentiation 
was measured as the normalized increase of the mean fEPSP slope for the duration of 
the baseline. During induction of chemical  LTP slices were stimulated at half of slice 
maximum. Only stable recordings were included and this judgment was made blind 
to genotype. Average LTP was defined as the mean last 10 minutes of the normalized 
fEPSP slope.
Western Blot
Mice were anaesthetized using isoflurane and sacrificed by decapitation. Brain samples 
(or acute hippocampal slices in the case of the western blots after the electrophysiology 
experiments) were taken out quickly and stored in liquid nitrogen. Lysates were then 
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first prepared and brain samples were homogenized in lysis buffer (10mM Tris-HCl 6.8, 
2.5% SDS, 2mM EDTA). Protein concentration in the samples was determined and lysate 
concentrations were adjusted to 1mg/ml. Western blots were probed with primary 
antibodies against either CAMK2A (6G9, 1:40.000, Abcam), CAMK2B (CB-β1, 1:10.000, 
Invitrogen) or Actin (MAB1501R, 1:20.000, Chemicon) and secondary antibodies (goat 
anti-mouse and/or goat anti-rabbit, both 1:3000, AffiniPure #115-007-003 and #111-
007-003). Blots were stained either with Enhanced ChemoLuminescence (ECL) (#32106, 
Pierce) or stained and quantified using LI-COR Odyssey Scanner and Odyssey 3.0 
software. Quantification of western blot in ECL was done using ImageJ. 
Immunohistochemistry and immunofluorescence
First mice were anaesthetized with pentobarbital and perfused transcardially with PBS 
followed by freshly prepared 4% paraformaldehyde solution (PFA, Sigma). Brains were 
taken out after perfusion and post-fixed for 1.5 hours in PFA and afterwards kept in 
30% sucrose solution overnight. Free floating 40 µm thick frozen sections were made 
and for immunohistochemistry, a standard avidin-biotin-immunoperoxidase complex 
method (ABC, Vector Laboratories, USA) with CAMK2A (MAB3119, 1:10,000; Chemicon) 
as the primary antibody and diaminobenzidine (0.05%) as the chromogen was used. 
For immunofluorescence, free floating 40 µm thick sections were washed in PBS once 
and afterwards primary antibodies were added (anti-CAMK2B, 1:1000, #ab34703, 
Abcam for immunofluorescence; anti-CAMK2A, 1:10,000, MAB3119, Chemicon for 
immunohistochemistry) diluted in PBS containing 2% NHS, 0.5% Triton-X 100 and 
150mM bovine serum albumin (BSA) and kept at 4°C overnight for 48 hours. Two days 
later sections were washed 3 times with PBS and secondary antibodies were added 
(Cy3 rabbit, 1:200 for immunofluorescence) diluted in PBS containing 2% NHS, 0.5% 
Triton-X 100 and 150mM bovine serum albumin (BSA). After 1-2 hours incubation of the 
secondary antibody at room temperature sections were washed four times in PB (0.05M) 
and mounted on slides using chrome(3)potassiumsulfatedodecahydrate and left to dry. 
Finally, for immunofluorescence, sections were covered using Mowiol (Sigma-Aldrich). 
For immunohistochemistry, the slices were, after drying, dehydrated in alcohol, cleared 
with xylene and covered using Permount (Fisher Scientific, USA). 
Half-life calculations
For the protein degradation curves, mice received Tamoxifen injections and were killed 
4, 8, 10, 12, 15, 18, 21 and 24 days after the start of the experiment (n=2 for each time 
point). Protein levels were measured using Western Blot and data was plotted using 
Prism data analysis software (Prism Inc.).
113
CAMK2-dependent signaling in neurons is essential for survival
4
Data analysis and statistics
All statistical tests were performed using a 2-WAY repeated measures ANOVA to 
determine the effect of genotype in the experiments. In LTP experiments, the last 10 
data points were used for comparison. α was set at 0.05. All values represent average 
+/- SEM. Group sizes can be found in the figure legends. All values are based on number 
of slices measured. Each experimental group contained at minimum 4 different mice. 
All statistical tests were performed either using Graphpad Prism or SPSS Statistics v22.0. 
RESULTS
Loss of both CAMK2A and CAMK2B results in neonatal death
To unravel the full spectrum of CAMK2 functions, the CAMK2A/CAMK2B double 
heterozygous mice (Camk2a–/+;Camk2b–/+) were intercrossed to obtain F2 CAMK2A/
CAMK2B double knockout mice (Camk2a–/–;Camk2b–/–)(see Methods). Genotyping 
performed at day 7 on 222 pups, revealed 0 Camk2a–/–;Camk2b–/– double mutants, 
whereas 14 pups were expected based on a Mendelian distribution (Figure 1a), indicating 
that the double mutant might be lethal. Moreover, all of the Camk2a+/–;Camk2b–/– mice 
died within 42 days after birth, whereas only 28% of the Camk2a–/–;Camk2b+/– died 
within the same period, indicating that complete loss of CAMK2B is less well tolerated 
than complete loss of CAMK2A. Importantly, other genotypes obtained by this breeding 
(such as Camk2a+/–;Camk2b+/– mice, data not shown) appeared just as vital as wild-type 
mice. To understand whether the lethality of Camk2a–/–;Camk2b–/– mice was pre- or 
postnatal, mice were monitored immediately from birth on. We observed that a small 
number of the born pups died within the first day after birth, which all appeared to be 
Camk2a–/–;Camk2b–/– upon genotyping. Taken these pups into account, we found that 
6 out of 100 pups were Camk2a–/–;Camk2b–/– double mutants, which is the expected 
number of double mutants, indicating that the Camk2a–/–;Camk2b–/– mutants are born 
at normal frequency (c2: 9.4, p=0.31), but die within one day after birth. When observing 
the pups directly after birth it was not possible to predict which pup would die, since the 
Camk2a–/–;Camk2b–/– pups did not show notable growth retardation or morphological 
changes, and a milk spot was visible in the abdomen, indicating that it was not lack of 
food intake that killed the pups. Additionally, immunohistochemistry showed no gross 
morphological changes in brains of pups on P0 (data not shown). Taken together, this 
shows that simultaneous loss of both CAMK2A and CAMK2B results in neonatal death, 
indicating a critical role of CAMK2 during this period, which cannot be revealed by 



































































Figure 1: Multiple Camk2a mutants crossed with Camk2b mutants and their survival in 
percentage of their total group size. a, Double knockout mice for both Camk2a and Camk2b 
(Camk2a–/–Camk2b–/–) die on P0. Homozygosity for Camk2b (with one functioning allele of 
Camk2a; Camk2a+/–Camk2b–/–, n=18) has a more severe impact on survival than homozygosity for 
Camk2a (and one functioning allele of Camk2b; Camk2a–/–Camk2b+/–, n=25). Camk2a+/+Camk2b+/+ 
were used as controls (n=16). b, Homozygous loss of Ca2+-dependent activity of both CAMK2A 
and CAMK2B (Camk2aT305D/T305DCamk2bA303R/A303R, n=2) results in early death. Homozygosity 
for a A303R knock-in mutation in Camk2b and a heterozygous T305D knock-in mutation for 
Camk2a (Camk2a+/T305DCamk2bA303R/A303R, n=18) has a more severe impact on survival than a 
homozygous knock-in mutation for Camk2a and a heterozygous A303R knock-in mutation 
for Camk2b (Camk2aT305D/T305DCamk2b+/A303R, n=15). Camk2a+/+Camk2b+/+ were used as controls 
(n=4). c, Homozygous loss of autonomous activity of both CAMK2A and CAMK2B (Camk2aT286A/
T286ACamk2bT287A/T287A, n=12) results in early death. Again, homozygosity for a T287A knock-in 
mutation in Camk2b (and a heterozygous T286A knock-in mutation for Camk2a; Camk2a+/
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T286ACamk2bT287A/T287A, n=34) has a more severe impact on survival than a homozygous knock-in 
mutation for Camk2a (and a heterozygous T287A knock-in mutation for Camk2b; Camk2aT286A/
T286ACamk2b+/T287A, n=20). Camk2a+/+Camk2b+/+ were used as controls (n=14). With the exception 
of 1 mouse in the first experiment (a), all Camk2a+/+Camk2b+/+ mice survived a minimum of 
up to 50 days postnatally. d, Model showing the effect of the different mutations used on the 
activity of the holoenzyme for the survival experiments. Green = CAMK2A, red = CAMK2B and 
yellow = Calcium/Calmodulin. 
Loss of Ca2+-independent and Ca2+-dependent activity of CAMK2 results in 
neonatal death
Activity of CAMK2 is governed by multiple phosphorylation sites, of which the Thr286 
(Thr287 in CAMK2B) is important for Ca2+-independent activity (Figure 1d, bottom 
panel) and Thr305/Thr306 (Thr306/Thr307 in CAMK2B) for the Ca2+-dependent activity 
(Figure 1d, middle panel), since they are located within the Ca2+/Calmodulin binding site 
on CAMK2. Considering the phenotypes of the Camk2a and Camk2b single mutants, 
we know that the CAMK2A phosphomimic mutation at Thr305 (CAMK2A-T305D), which 
blocks Ca2+/Calmodulin binding and keeps CAMK2 in its inactivated state, is more 
detrimental than not having CAMK2A at all (Elgersma et al., 2002). This is also the case 
for a similar mutation in CAMK2B (CAMK2B-A303R) with respect to locomotion (Kool et 
al., 2016), although this is not the case for hippocampal learning (Borgesius et al., 2011). 
Hence, we expected that a double mutant of CAMK2A-T305D and CAMK2B-A303R 
might be lethal as well. Indeed, when intercrossing Camk2a+/T305D;Camk2b+/A303R double 
mutant mice we found that upon P7, only 2 Camk2aT305D/T305D;Camk2bA303R/A303R mutants 
were found in a total of 126 pups (number expected was 8). The 2 pups that survived 
until P7 still died a premature death within 16-23 days after birth (Figure 1b). Similar to 
the CAMK2A;CAMK2B double mutants, homozygous mutations in the Ca2+/Calmodulin 
binding of CAMK2B were less well tolerated than comparable mutations in CAMK2A 
(Figure 1b). 
We then tested whether Ca2+-independent activity (also known as autonomous 
activity) was essential for life. To that end, we intercrossed Camk2a+/T286A;Camk2b+/T287A 
double mutant mice, such that autophosphorylation of both CAMK2A and CAMK2B 
at the Thr286/287 site is prevented (Giese et al., 1998a; Kool et al., 2016). Surprisingly, 
despite the fact that these mice still have Ca2+-dependent activity, we found that the 
Camk2aT286A/T286A;Camk2bT287A/T287A mice started dying from P11 onwards and had all died 
by P33 (Figure 1c). Again homozygous mutations in CAMK2B were less well tolerated 
than comparable mutations in CAMK2A. This indicates that CAMK2 autonomous activity 
is essential for survival. 
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Adult deletion of CAMK2A and CAMK2B is lethal
The premature death observed in the various CAMK2A/CAMK2B double mutants 
described above, indicate a crucial role for CAMK2-dependent signaling during 
development. Using inducible Camk2a and Camk2b knockout mice, we have recently 
shown that CAMK2-dependent signaling is also important after brain development 
(Achterberg et al., 2014; Kool et al., 2016). Notably, the phenotypes observed when 
deleting the Camk2a gene in adult mice are as severe as when deleting the gene at 
germline (Achterberg et al., 2014). Therefore we postulated that deletion of both 
CAMK2A and CAMK2B could potentially also be lethal in adult mice. We generated 
inducible Camk2af/f;Camk2bf/f;CAG-CreESR mice which were injected with Tamoxifen at 
8 weeks of age to induce deletion of both Camk2a and Camk2b. Up till 4 days after 
the first injection, the protein levels remained the same, after that time point the levels 
reduced exponentially. Both CAMK2A and CAMK2B showed similar half-lives and decay 
constants in the cortex (CAMK2A: half-life: 3.5 days; CAMK2B: half-life: 2.8 days) as well 
as in the hippocampus (CAMK2A: half-life: 5.3 days; CAMK2B: half-life: 4.4, Figure 2a). 
Immunohistochemical stainings at 21 days after gene deletion showed that despite a 
few CAMK2A or CAMK2B positive cells, most brain areas were devoid of CAMK2 staining 
(Figure 2b). Around 15-19 days (depending on the brain region) after the first injection, 
the levels of CAMK2A and CAMK2B dropped below 10%, after which the Camk2af/
f;Camk2bf/f;CAG-CreESR mice started to die. All injected Camk2af/f;Camk2bf/f;CAG-CreESR mice 
died within 24-53 days, with a median survival of 37 days (Figure 2c). When observing 
the mice we found that the mice did not show any obvious alterations in behavior 
until their last 24 hours, during which they would stop moving, eating and drinking. 
Figure 2: Adult loss of CAMK2A and CAMK2B is lethal but does not lead to epileptic 
activity. (A) Western blot of cortical (top) and hippocampal (bottom) lysates using antibodies 
targeted against CAMK2A and CAMK2B. Actin was used as loading control. Days after first 
injection are indicated above the blots. Lower left graph: non-linear regression curve showing 
protein degradation in cortex, showing faster protein degradation of both CAMK2A and 
CAMK2B than in the hippocampus (n=2 for each time point). Lower right graph: non-linear 
regression curve showing protein degradation in hippocampus, where CAMK2B degradation is 
faster than CAMK2A degradation. (B) Immunohistological stainings showing effective loss after 
Tamoxifen injections of CAMK2A (Top) and CAMK2B (Bottom) in Camk2af/f;Camk2bf/f;CAG-CreESR 
mice 21 days after gene deletion. (C) Loss of both CAMK2A and CAMK2B (Camk2af/f;Camk2bf/
f;CAG-CreESR) in adulthood is lethal. Both groups of mice (Camk2af/f;Camk2bf/f;CAG-CreESR (n=9) 
versus Camk2af/f;Camk2bf/f (n=8)) received Tamoxifen injections (see Methods). (D) Example 
traces of EEG recordings of Camk2af/f;Camk2bf/f;CAG-CreESR and Camk2af/f;Camk2bf/f control mice. 
Despite the changing activity pattern in Camk2af/f;Camk2bf/f;CAG-CreESR mice, no seizure activity 
was detected in any recordings. The bottom trace is of a Camk2af/f;Camk2bf/f;CAG-CreESR mouse 
that died less than 24 hours later. 
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Importantly, Camk2af/f;Camk2bf/f mice without CAG-CreESR (control group) all survived. 
Even though we did not observe any seizures in the Camk2af/f;Camk2bf/f;CAG-CreESR mice, 
we performed continuous EEG recordings on a subset of the mice, to monitor epileptic 
activity more carefully. None of the tested mice showed epileptic activity in their EEG 
recordings (Figure 2d), also not just before death (Figure 2d, lower panel). Analysis of 
these brains obtained just after death did not reveal any gross morphology changes 
(Figure 2b). These data indicate that also in adult mice, CAMK2-dependent signaling is 
crucial for survival.
Loss of CAMK2A and CAMK2B completely abolishes LTP
We tested the effect of the combined loss of CAMK2A and CAMK2B on basal synaptic 
transmission and LTP. Thus far, previous reports on conventional and inducible Camk2a 
and Camk2b single knockout mice showed an impairment of LTP upon Camk2 gene 
deletion with approximately 50% of residual LTP left compared to wild-type levels 
(Hinds et al., 1998; Elgersma et al., 2002; Borgesius et al., 2011; Achterberg et al., 2014). 
It is likely that the remaining fraction of LTP present in these mutant mice is provided 
by the remaining isoform present (CAMK2B in the case of Camk2a mutant mice and 
vice versa). To test this, we injected 8 week-old mice and chose 25 days after the first 
injection as the moment of sacrifice and electrophysiological testing, corresponding to 
Figure 3: CAMK2A and CAMK2B are essential for CA3-CA1 LTP. (A) Timeline showing the loss 
of CAMK2A and CAMK2B upon induction of genomic deletion with Tamoxifen injections (see 
Methods). Mice were sacrificed 25 days after the first injection to conduct electrophysiological 
experiments. (B) Camk2af/f;Camk2bf/f;CAG-CreESR mice (fiber volley: (n=30, from 11 mice), fEPSP 
slope: (n=42, from 11 mice)) show normal basal synaptic transmission compared to Camk2af/
f;Camk2bf/f mice (fiber volley: (n=29, from 15 mice), fEPSP slope: (n=50, from 15 mice)). (C) Inset: 
Schematic overview of LTP induction in the CA3-CA1 pathway (also, see Methods). stim = 
stimulating electrode; rec = recording electrode; DG = dentate gyrus. Figure: Camk2af/f;Camk2bf/
f;CAG-CreESR mice (n=40, from 11 mice) show normal PPF compared to Camk2af/f;Camk2bf/f 
mice (n=51, from 15 mice). (D) Camk2af/f;Camk2bf/f;CAG-CreESR mice (n=16, from 6 mice) show 
a complete loss of 100Hz LTP compared to Camk2af/f;Camk2bf/f mice (n=21, from 9 mice). (E) 
Camk2af/f;Camk2bf/f;CAG-CreESR mice (n=11, from 4 mice) show a complete loss of 200Hz LTP 
compared to Camk2af/f;Camk2bf/f mice (n=9, from 5 mice). (F) Camk2af/f;Camk2bf/f;CAG-CreESR 
mice (n=28, from 7 mice) show impaired Forskolin/Rolipram-induced (50uM/0.1uM) LTP 
compared to Camk2af/f;Camk2bf/f mice (n=29, from 7 mice). FSK = Forskolin; RPM = Rolipram; 
PTX = Picrotoxin (G) Camk2af/f;Camk2bf/f;CAG-CreESR mice (n=9, from 5 mice) show normal 
DHPG-induced (100uM) LTD compared to Camk2af/f;Camk2bf/f mice (n=13, from 6 mice). (H) 
Western blot showing efficient loss of both CAMK2A and CAMK2B in the acute hippocampal 
slices of Camk2af/f;Camk2bf/f;CAG-CreESR mice with normal CAMK2A and CAMK2B expression 
in Camk2af/f;Camk2bf/f mice. Actin levels are shown as loading control. Numbers depicted in 
brackets represent number of slices, followed by number of mice. Error bars indicate SEM.
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the moment when CAMK2 levels have dropped to a minimum but well before most of 
these mice start dying, to keep confounding effects of dying on the LTP measurements 
to a minimum (Figure 3a). We measured basal synaptic transmission, paired-pulse 
facilitation (PPF), LTP and DHPG-induced LTD in the well-studied CA3-CA1 Schaffer 
collateral pathway in acute hippocampal slices. In agreement with the lack of gross 
brain morphology changes, Camk2af/f;Camk2bf/f;CAG-CreESR mice still showed normal 
basal synaptic transmission as fiber volley amplitude, fEPSP slope and their ratio did not 
differ significantly between both Camk2af/f;Camk2bf/f;CAG-CreESR and Camk2af/f;Camk2bf/f 
mice (effect of genotype: fiber volley: F1,57=0,53, p=0.47; fEPSP slope: F1,90=0.74, p=0.39; 
repeated measures ANOVA; Figure 3b). Subsequently PPF was not impaired in Camk2af/
f;Camk2bf/f;CAG-CreESR mice (effect of genotype: PPF: F1,89=0.34, p=0.56; repeated 
measures ANOVA; Figure 3c). We then tested LTP by giving a 100Hz tetanus and found 
a complete abolishment of LTP 50 minutes after induction in Camk2af/f;Camk2bf/f;CAG-
CreESR mice. (effect of genotype: 100Hz LTP: F1,35=19.86, p<0.001; repeated measures 
ANOVA; Figure 3d). We then tested a much stronger LTP induction protocol (4 trains 
of 200Hz for 0.5 seconds, spaced 5 seconds apart) known to activate different pools 
of CAMK2 in the spines (Lee et al., 2009). This LTP induction protocol yields normal LTP 
in Camk2b–/– mice and only partially reduces LTP in Camk2a–/– mice (Borgesius et al., 
2011). However, like in the 100 Hz LTP protocol, Camk2af/f;Camk2bf/f;CAG-CreESR mutants 
showed complete absence of LTP in the in the 4 x 200Hz protocol (effect of genotype: 
200Hz LTP: F1,18=27.19, p<0.001; repeated measures ANOVA; Figure 3e). To investigate 
if other LTP inducing pathways were similarly affected, we tested PKA-dependent 
plasticity, using a 15-minute wash-in of Forskolin (50uM) and Rolipram (0.1uM) in the 
presence of Picrotoxin (50uM) to induce LTP chemically (cLTP). We found that also 
this LTP pathway was affected in the Camk2af/f;Camk2bf/f;CAG-CreESR mice, although 
considerable potentiation was still observed  (effect of genotype: PKA LTP: F1,55=9.75, 
p<0.01; repeated measures ANOVA;  Figure 3f ). Finally, we found no involvement of 
CAMK2A and CAMK2B in DHPG-induced LTD (effect of genotype: DHPG LTD: F1,20=1.05, 
p=0.32; repeated measures ANOVA; Figure 3g). As a control for the efficiency of gene 
deletion, we performed western blot analysis on the acute hippocampal slices used 
in these experiments. As expected, the slices of Camk2af/f;Camk2bf/f;CAG-CreESR mice 
showed a clear absence of CAMK2A and CAMK2B (Figure 3h).
Presynaptic CAMK2 is dispensable for CA3-CA1 LTP
CAMK2 was originally found as a presynaptic protein, involved in the phosphorylation 
of Synapsin I (DeLorenzo et al., 1979; Kennedy and Greengard, 1981; Kennedy et al., 
1983). Additionally, more recent literature shows involvement of CAMK2A in vesicle 
release and short-term presynaptic plasticity as well as a role for presynaptic CAMK2 in 
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LTP in culture conditions (Llinás et al., 1985; Lin et al., 1990; Nichols et al., 1990; Chapman 
et al., 1995; Hinds et al., 2003; Ninan and Arancio, 2004; Lu and Hawkins, 2006; Hojjati 
et al., 2007; Jiang et al., 2008; Pang et al., 2010; Achterberg et al., 2014). Therefore, it is 
likely that loss of both presynaptic as well as postsynaptic CAMK2 contributes to the 
LTP deficits described above. To investigate the requirement of presynaptic CAMK2 
for LTP induction, we deleted Camk2 in the CA3 region of the hippocampus, without 
affecting CAMK2 expression in the other hippocampal regions, by crossing Camk2af/
f;Camk2bf/f mice with a Cre-line in which Cre is under the control of the GRIK4 promotor 
(Glutamate Ionotropic Receptor Kainate Type Subunit 4). This gene is highly expressed 
in CA3 neurons, but absent in CA1 neurons (Filosa et al., 2009). We confirmed the 
specificity of this cre-line in Camk2af/f;CA3-Cre and Camk2bf/f;CA3-Cre mice. These mice 
showed specific deletion of CAMK2A and CAMK2B in the pyramidal cells of the CA3 
region of the hippocampus at the age of 8 weeks, with no deletion in other parts of 
the hippocampus (Figure 4a). Note that the mossy fibers coming from the dentate 
gyrus still express CAMK2A and can now be readily observed crossing through the 
CA3 area. We used immunofluorescence to confirm the deletion of CAMK2B in these 
mice. Although confirmation of the deletion of CAMK2B is complicated by the residual 
expression of CAMK2B in oligodendrocytes (Cahoy et al., 2008; Waggener et al., 2013) 
and interneurons (Lamsa et al., 2007), we could still observe a decrease in fluorescence 
in the stratum pyramidale of the CA3 region of the hippocampus (Figure 4a). 
As we observed in the Camk2af/f;Camk2bf/f;CAG-CreESR mice, synaptic transmission and 
PPF were not affected in the absence of presynaptic CAMK2A and CAMK2B (effect 
of genotype: fiber volley: F1,39=0.15, p=0.70; fEPSP: F1,39=0.89, p=0.35; PPF: F1,83=0.89, 
p=0.35; repeated measures ANOVA; Figure 4b and c). As different LTP induction protocols 
rely on different molecular pathways (Grover and Teyler, 1990; Cavuş and Teyler, 1996; 
Raymond and Redman, 2002) and are reported to differ in their dependence on 
presynaptic CAMK2A (Lu and Hawkins, 2006), we tested 100Hz as well as theta burst 
(2 Theta, see methods) LTP-induction protocols. Surprisingly, both the 100Hz and theta 
burst LTP-inducing protocols resulted in normal LTP in Camk2af/f;Camk2bf/f;CA3-Cre mice 
(effect of genotype: 100Hz LTP: F1,32=0.002, p=0.96; Theta burst LTP: F1,17=0.001, p=0.98; 
repeated measures ANOVA; Figure 4d and e), indicating that presynaptic CAMK2A and 
CAMK2B are not required for LTP at the CA3-CA1 synapse of the hippocampus. Thus the 
complete loss of high-frequency stimulation (HFS) induced LTP in Camk2af/f;Camk2bf/























































































Figure 4: Presynaptic CAMK2A and CAMK2B are not necessary for CA3-CA1 LTP. (A) 
Specific deletion of CAMK2A (Top) and CAMK2B (Middle and Bottom) in the CA3 area of the 
hippocampus. Immunohistochemical stainings showing deletion of CAMK2A in the CA3 area 
in Camk2af/f;CA3-Cre mice (Upper Right). Note the absence of CAMK2A staining in all layers of 
the CA3 area except for mossy fibers coming from the dentate gyrus that still express CAMK2A. 
Immunofluorescent images showing deletion of CAMK2B in the CA3 area in Camk2bf/f;CA3-Cre 
mice (Bottom right). Note that interneurons, oligodendrocytes and mossy fibers coming from 
the dentate gyrus still express CAMK2B. The middle and bottom right pictures are enlarged 
images of boxed areas. Arrowheads show CA3 pyramidal cell somas in Camk2bf/f mice (middle 
right) and absence of fluorescence in cell somas in Camk2bf/f;CA3-Cre mice (bottom right). (B) 
Camk2af/f;Camk2bf/f;CA3-Cre mice (fiber volley: (n=19, from 6 mice), fEPSP slope: (n=19, from 6 
mice)) show normal basal synaptic transmission compared to Camk2af/f;Camk2bf/f mice (fiber 
volley: (n=22, from 6 mice), fEPSP slope: (n=22, from 6 mice)). (C) Camk2af/f;Camk2bf/f;CA3-
Cre mice (n=41, from 6 mice) show normal PPF compared to Camk2af/f;Camk2bf/f mice (n=44, 
from 6 mice). (D) Camk2af/f;Camk2bf/f;CA3-Cre mice (n=20, from 6 mice) show normal 100Hz 
LTP compared to Camk2af/f;Camk2bf/f  mice (n=14, from 6 mice). (E) Camk2af/f;Camk2bf/f;CA3-Cre 
mice (n=9, from 4 mice) show normal theta burst LTP compared to Camk2af/f;Camk2bf/f mice 
(n=10, from 4 mice). Numbers in brackets represent number of slices, followed by number of 
mice. Error bars indicate SEM.
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Role of CAMK2A and CAMK2B in plasticity at the CA3-CA3 synapse
Control over gene deletion in the CA3 area of the hippocampus does not only provide 
a great tool for investigating a presynaptic role in the well-studied CA3-CA1 synapse, 
it can also be used to investigate the role of CAMK2A and CAMK2B both pre- and 
postsynaptically in the associational/commissural pathway (CA3-CA3 synapse). The 
CA3-CA3 synapse in the hippocampus has been widely proposed to play a pivotal role 
in spatial processing and previous studies have shown that LTP at this synapse is NMDA-
dependent (Debanne et al., 1998). Therefore, we examined the role of CAMK2A and 
CAMK2B in the properties of the CA3-CA3 synapse in our Camk2af/f;Camk2bf/f;CA3-Cre 
mutant. 
Although CA3-CA3 basal synaptic transmission and PPF were not affected in the 
Camk2af/f;Camk2bf/f;CA3-Cre mice (effect of genotype: fiber volley: F1,45=0.18, p=0.68; 
fEPSP slope: F1,49=0.03, p=0.87; PPF: F1,36=0.92, p=0.34, repeated measures ANOVA; 
Figure 5a, b and c), deletion of both CAMK2A and CAMK2B in the CA3 region of the 
hippocampus resulted in a significant impairment of LTP at the CA3-CA3 synapse (effect 
of genotype: F1,32=6.89, p=0.01; repeated measures ANOVA; Figure 5d). Pyramidal 
neurons in the CA3 region of the hippocampus receive inputs from different pathways. 
The major source of inputs originates from the CA3 itself through the commissural 
pathway (CA3-CA3 synapse), but also the mossy fibers coming from the dentate gyrus 
(DG-CA3 synapse) form an important source. To distinguish between these different 
pathways, we used three different approaches: (i) antidromic stimulation (Figure 
5a), (ii) differences in physiological characteristics of 1Hz facilitation and PPF and (iii) 
differences in sensitivity to DCG-IV (see Methods). Importantly, 1Hz stimulation did not 
show any facilitation (1Hz facilitation (10th stimulus): Camk2af/f;Camk2bf/f;CA3-Cre 106.8 
± 2.1 vs Camk2af/f;Camk2bf/f 103.8 ± 2.3; 1Hz Facilitation (10 stimuli, not shown): effect 
of genotype: F1,40=1.56, p=0.22, repeated measures ANOVA). Furthermore, 3mM DCG-IV 
reduced transmission by less than 20% in our experiments (81.9 ± 2.7% and 78.1 ± 3.3% 
transmission in the last 10 minutes for Camk2af/f;Camk2bf/f and Camk2af/f;Camk2bf/f;CA3-
Cre respectively; DCG-IV: t=1.12, p=0.27; unpaired two tailed t-test; Figure 5e). Therefore, 
we are confident that we selectively stimulated CA3-CA3 connections. 
Notably, the phenotype observed in the Camk2af/f;Camk2bf/f;CA3-Cre mice appeared 
to be the result of the combined deletion of CAMK2A and CAMK2B and not due to 
absence of CAMK2A or CAMK2B alone, as the same parameters were not affected in 
the Camk2af/f;CA3-Cre or Camk2bf/f;CA3-Cre mice, in which only CAMK2A or CAMK2B is 
deleted from the CA3 region of the hippocampus (effect of genotype: Camk2af/f;CA3-
Cre LTP: F1,43=0.43, p=0.52; Camk2b
f/f;CA3-Cre LTP: F1,50=0.004, p=0.95, repeated measures 

























































































































Figure 5: Redundancy of CAMK2A and CAMK2B in CA3-CA3 LTP. (A) Schematic overview 
of LTP induction in the CA3-CA3 pathway (also, see Methods). stim = stimulating electrode; 
rec = recording electrode; DG = dentate gyrus. (B) Camk2af/f;Camk2bf/f;CA3-Cre mice (fiber 
volley: (n=27, from 4 mice), fEPSP slope: (n=23, from 4 mice)) mice show normal basal synaptic 
transmission compared to Camk2af/f;Camk2bf/f mice (fiber volley: (n=24, from 4 mice) fEPSP 
slope: (n=24, from 4 mice)). (C) Camk2af/f;Camk2bf/f;CA3-Cre (n=17, from 4 mice) mice show 
normal PPF compared to Camk2af/f;Camk2bf/f (n=21, from 4 mice) mice. (D) Camk2af/f;Camk2bf/
f;CA3-Cre (n=16, from 4 mice) show reduced 100Hz LTP compared to Camk2af/f;Camk2bf/f (n=18, 
from 4 mice) mice. (E) DCG-IV only minimally blocks the fEPSP signal in both Camk2af/f;Camk2bf/
f;CA3-Cre (n=21, from 4 mice) and Camk2af/f;Camk2bf/f (n=21, from 4 mice) mice. (F) Camk2af/
f;CA3-Cre (n=29, from 8 mice) show normal 100Hz LTP compared to Camk2a+/+ (n=16, from 5 
mice) mice. (G) Camk2bf/f;CA3-Cre (n=28, from 8 mice) show normal 100Hz LTP compared to 
Camk2bf/f (n=24, from 8 mice) mice. Numbers in brackets represent number of slices, followed 
by number of mice. Error bars indicate SEM.
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CAMK2A in Camk2af/f animals without Cre in comparison with wild-type mice (data not 
shown), we used the wild-type littermate Camk2a+/+ mice as the control group for one 
of these experiments (Figure 5f ). Importantly, basal synaptic transmission and PPF were 
both not significantly different and the control experiments for mossy fiber stimulation 
1Hz facilitation and DCG-IV wash-in were all within normal range and not significantly 
different for both Camk2af/f;CA3-Cre and Camk2bf/f;CA3-Cre mice (data not shown). Taken 
together, these data show that either CAMK2A or CAMK2B needs to be expressed at the 
CA3-CA3 synapse for normal CA3-CA3 LTP. Hence, this confirms the notion that some 
functions of CAMK2 cannot be uncovered using Camk2a or Camk2b single mutants. 
DISCUSSION
CAMK2A and CAMK2B are the most abundant proteins in the brain and are shown to be 
crucial for learning, memory and plasticity in mice and for normal neurodevelopment 
in humans (Silva et al., 1992a; 1992b; Van Woerden et al., 2009; Borgesius et al., 2011; 
Li et al., 2013; Küry et al., 2017; Stephenson et al., 2017; Akita et al., 2018). Due to the 
high homology in their structure, we contemplated that the full spectrum of CAMK2 
functions has yet to be revealed, since crucial functions can potentially be masked, due 
to compensation by the non-deleted isoform. In this study we confirm this hypothesis 
with the following findings. 1) Loss of CAMK2A and CAMK2B simultaneously is lethal 
both during development as well as in adult mice. 2) Loss of the combined CAMK2A and 
CAMK2B Ca2+-dependent or Ca2+-independent activity is lethal. 3) Simultaneous loss of 
CAMK2A and CAMK2B results in complete absence of LTP at the CA3-CA1 synapse in 
the hippocampus. 4) Simultaneous loss of CAMK2A and CAMK2B but not of CAMK2A 
or CAMK2B alone results in LTP deficits at the CA3-CA3 synapse. Taken together these 
results show that there is quite some redundancy in the CAMK2A and CAMK2B isoform 
function, and that crucial functions of CAMK2 remain to be uncovered.
It remains to be investigated why absence or dysregulation of CAMK2 function results 
in lethality. CAMK2 is critical for NMDA receptor-dependent signaling, and it is known 
that absence of the NR1 subunit of the NMDA receptor also results in neonatal death 
due to respiratory failure in these mice (Forrest et al., 1994). CAMK2 activity mediates 
the emergence and maintenance of synchronous activity in the preBötzinger complex, 
a center in the brainstem important for respiratory motor output (Mironov, 2013). 
Thus respiratory distress could underlie the lethality seen in the Camk2a–/–;Camk2b–/– 
mutants. Also NR2B null mutants are not viable (Kutsuwada et al., 1996), which is due 
to a defect in the suckling response. Indeed lethality was rescued when the pups were 
hand-fed (Kutsuwada et al., 1996). We do not think that a similar mechanism underlies 
the lethality seen in our mice, since all pups had milk in their stomach just before they 
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died. Moreover, when looking at the catalytically inactive Camk2aT305D/T305D;Camk2bA303R/
A303R mice, it seems unlikely that either feeding or breathing deficits are the cause of 
death, since some of these mice survive until P17 or later. These findings further indicate 
that enzymatic activity of CAMK2 is dispensable in the first 2 weeks after birth and that 
the survival of these mice depends solely on the presence of an enzyme that cannot be 
activated by Ca2+/Calmodulin. This may point out an essential structural role of CAMK2. 
It is also interesting that Camk2aT286A/T286A;Camk2bT287A/T287A mice die, indicating that the 
autonomous (Ca2+-independent) activity of the CAMK2 holoenzyme is required for life. 
However, it is notable that no gross brain morphology differences were found in our 
double mutants nor in the NR1 or the NR2B null mutants (Forrest et al., 1994; Kutsuwada 
et al., 1996), which is consistent with the finding that the brain does not need CAMK2-
NMDA receptor dependent plasticity or functional synapses to develop anatomically 
(Verhage et al., 2000; Sando et al., 2017; Sigler et al., 2017).
The complete loss of HFS-induced LTP upon deletion of both CAMK2A and CAMK2B is 
perhaps not surprising considering the impairments both Camk2a–/– (Hinds et al., 1998; 
Elgersma et al., 2002) and Camk2b–/– (Borgesius et al., 2011) mice show in this kind of LTP. 
The complete loss of LTP in Camk2af/f;Camk2bf/f;CAG-CreESR mice strongly suggests that 
the residual LTP left in the single knockout mice is mediated by the remaining isoform. 
This is further strengthened by the observation that single amino acid mutations in 
Camk2a mutant mice such as Camk2aT286A (Giese et al., 1998b) and Camk2aT305D (Elgersma 
et al., 2002) have more detrimental effects on LTP than the loss of the Camk2a isoform 
as a whole. This could well be explained by the dominant-negative effects of these 
Camk2a point mutations on the proper functioning of the heteromeric CAMK2A-
CAMK2B holoenzyme. 
In contrast to impaired LTP, basal synaptic transmission and PPF in the CA3-CA1 area 
were unaffected in absence of both CAMK2A and CAMK2B. Given the clear abundance 
of CAMK2 in synapses both pre- and postsynaptically and its major role in AMPA 
phosphorylation, GluN2B binding and AMPA insertion (reviewed in (Lisman et al., 
2012)), it is surprising that in the absence of these major isoforms synaptic strength stays 
intact. This suggests that synaptic strength in the CA3-CA1 synapse can be maintained 
independently of CAMK2A and CAMK2B. 
Forskolin-induced LTP has been shown to be primarily PKA-dependent (Sokolova et al., 
2006), but also NMDA-dependent components have been described (Otmakhov et al., 
2004). Thus the impairment seen in cLTP in our Camk2af/f;Camk2bf/f;CAG-CreESR could be 
caused by the selective loss of the NMDA (CAMK2)-dependent pathway while leaving 
the PKA-dependent pathway intact. 
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The finding that presynaptic CAMK2 is dispensable for LTP at the CA3-CA1 synapse 
is surprising, considering that CAMK2 was first discovered as a presynaptic protein 
(DeLorenzo et al., 1979; Kennedy and Greengard, 1981; Kennedy et al., 1983). Indeed, 
CAMK2A has long been shown to play a role in presynaptic plasticity and regulation of 
neurotransmitter release at the CA3-CA1 synapse in brain slices (Llinás et al., 1985; Lin et 
al., 1990; Nichols et al., 1990; Chapman et al., 1995; Hinds et al., 2003; Hojjati et al., 2007; 
Jiang et al., 2008; Pang et al., 2010; Achterberg et al., 2014). Additionally, a previous 
study reported a role for presynaptic CAMK2 in LTP in dissociated hippocampal neurons 
(Ninan and Arancio, 2004). In this study, the role of presynaptic CAMK2 was assessed 
using different CAMK2 inhibitors, which when applied resulted in reduced LTP. Thus, in 
light of these studies, we expected to find a requirement for presynaptic CAMK2A and 
CAMK2B in synaptic transmission and LTP at the CA3-CA1 synapse. However, we found 
that presynaptic CAMK2 is completely indispensable for LTP at the Schaffer collateral 
pathway. There are a few reasons to explain the discordance between literature and 
our findings. First, in our model CAMK2 is already absent from as early as postnatal day 
5. We cannot exclude that the lack of effect in our experiments is due to presynaptic 
compensatory mechanisms during this phase of development. Second, to study the 
role of presynaptic CAMK2 in LTP in hippocampal cultures, CAMK2 inhibitors were 
used to block presynaptic CAMK2 activity. These are general CAMK2 blockers, blocking 
not only CAMK2A or CAMK2B, but also CAMK2D and CAMK2G. It could be that in our 
experiments that CAMK2D and CAMK2G are compensating for the absence of CAMK2A 
and CAMK2B. Taken together, it is clear that complete understanding of the precise role 
of presynaptic CAMK2 at the CA3-CA1 Schaffer collateral synapse is still lacking. 
CA3-CA3 LTP shares many characteristics with Schaffer collateral (CA3-CA1) LTP. Most 
notably, both CA3-CA3 and CA3-CA1 LTP depend on NMDA receptor activation and 
a postsynaptic rise in Ca2+ (Bradler and Barrionuevo, 1990; Zalutsky and Nicoll, 1990; 
Debanne et al., 1998; Bains et al., 1999; Debanne et al., 1999; Smith and Swann, 1999; 
Pavlidis et al., 2000; Kakegawa et al., 2004). We show here that CA3-CA3 LTP is impaired 
when deleting both CAMK2A and CAMK2B, but not upon deletion of either CAMK2A or 
CAMK2B, indicating that one of the 2 CAMK2 isoforms needs to be present to support 
normal LTP. These results are in agreement with a previous study using a pharmacological 
approach, which described a pre- and postsynaptic role for CAMK2 in LTP at the CA3-
CA3 synapse (Lu and Hawkins, 2006). Using a CAMK2 synthetic peptide (281-309) 
CAMK2 inhibitor, on organotypic slice cultures the authors saw a decrease of 50% in 
theta burst LTP when CAMK2 was blocked pre- or postsynaptically. This inhibitor does 
not distinguish between the 4 different CAMK2 isoforms, leaving the question which 
CAMK2 isoform is responsible for the LTP deficit open. Here we showed that the loss of 
either CAMK2A or CAMK2B isoform does not affect LTP, but that only the simultaneous 
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absence of both CAMK2A and CAMK2B causes a CA3-CA3 LTP deficit. Interestingly, 
whereas CA3-CA1 LTP is completely abolished in absence of CAMK2, CA3-CA3 LTP is 
only reduced indicating that there are some fundamental differences underlying CA3-
CA1 LTP compared to CA3-CA3 LTP.
Taken together, our results show that despite our vast knowledge about CAMK2, there 
are many aspects of CAMK2 function that remain to be uncovered.
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The mammalian Ca2+/calmodulin-dependent protein kinase II (CAMK2) family consists 
of 4 different CAMK2 genes, encoding CAMK2A, CAMK2B, CAMK2D and CAMK2G, which 
have high structural homology. CAMK2A and CAMK2B are abundantly expressed in the 
brain; they play a unique role in proper neuronal functioning, since both CAMK2A and 
CAMK2B knockout mice show several behavioural and cellular phenotypes. However, 
our recent finding that deletion of both CAMK2A and CAMK2B is lethal indicates that 
they also have overlapping functions and that the full spectrum of CAMK2 function in 
neurons, for example excitability and synaptic transmission, remains to be uncovered. 
In order to get more insight into the full spectrum of CAMK2 functions in neurons, we 
performed whole-cell patch clamp experiments in CA1 pyramidal neurons of inducible 
Camk2a/Camk2b double knockout mice, as well as CAMK2A and CAMK2B knockout 
mice. We found that whereas deletion of CAMK2A or CAMK2B alone did not change 
evoked firing rate, deletion of both CAMK2A and CAMK2B resulted in a decrease in 
evoked firing rate 10 days after deletion, which reversed to an increased evoked firing 
rate 21 days after deletion. Additionally, loss of both CAMK2A and CAMK2B resulted in a 
decreased frequency of both miniature excitatory and inhibitory postsynaptic currents 
(mEPSCs and mIPSCs) 21 days after deletion, but not 10 days after deletion, an effect 
not seen in the single mutants. Our results indicate that CAMK2 is critically important 
to maintain normal excitability of hippocampal CA1 pyramidal cells, as well as normal 
inhibitory and excitatory synaptic transmission. Together, these results provide new 
insights in the regulation of neuronal function by CAMK2 and highlight the importance 
of having both CAMK2A and CAMK2B expressed in high levels in the brain.
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INTRODUCTION 
The mammalian Ca2+/calmodulin-dependent protein kinase II (CAMK2) family consists 
of 4 different CAMK2 genes, encoding CAMK2A, CAMK2B, CAMK2D and CAMK2G, which 
all share high homology in their structure (Tobimatsu and Fujisawa, 1989). CAMK2A and 
CAMK2B are both expressed in high abundance in neurons, accounting for up to 2% 
of total brain protein (Erondu and Kennedy, 1985). Studies using Camk2a or Camk2b 
mutant mice indicate that these proteins fulfil unique functions in the brain (Silva et al., 
1992a; 1992b; Hojjati et al., 2007; Van Woerden et al., 2009; Borgesius et al., 2011; Kool 
et al., 2016). However, these isoforms may also have overlapping functions. In support 
for this hypothesis we recently found that simultaneous deletion of both CAMK2A and 
CAMK2B is lethal, indicating that critical functions of CAMK2 are masked in the single 
mutants due to isoform compensation and or redundancy (Kool et al., submitted). Here 
we set out to identify these functions at the single cell and network level. 
The role of CAMK2A and CAMK2B in neuronal function and synaptic plasticity has 
been extensively studied using Camk2a–/– and/or Camk2b–/– mice (Silva et al., 1992b; 
Van Woerden et al., 2009; Borgesius et al., 2011; Achterberg et al., 2014), as well as by 
studying mutant mice with knock-in missense mutations (Mayford et al., 1996; Giese 
et al., 1998; Elgersma et al., 2002). In addition, pharmacological approaches have been 
used that interfere with kinase function of both isoforms. Inhibiting CAMK2 activity 
in vestibular nucleus neurons (Nelson et al., 2005) and medium spiny neurons in the 
striatum (Klug et al., 2012) resulted in increased intrinsic excitability. Consistent with this 
finding, expression of constitutive active CAMK2 in CA1 pyramidal neurons decreases 
neuronal excitability (Varga et al., 2004), whereas the CAMK2A-T286A mouse mutant, 
in which the autonomous activity of CAMK2A is blocked, shows increased excitability 
(Sametsky et al., 2009), suggesting that CAMK2 activity is needed to regulate neuronal 
excitability. Indeed, blocking CAMK2 activity in cultured cortical neurons for >4 hours 
increases excitability and eventually leads to cell death (Ashpole et al., 2012). 
At the synaptic level most studies have focussed either on CAMK2A alone or used a 
broad pharmacological approach to investigate the role of CAMK2 in basal synaptic 
transmission. For example, in hippocampal CA1 pyramidal cells and piriform cortex 
pyramidal cells, CAMK2 has been shown to increase the amplitude of spontaneous 
or miniature inhibitory postsynaptic currents (sIPSC or mIPSC), most likely through 
phosphorylation of the GABAA receptor (Wei et al., 2004; Ghosh et al., 2015). CAMK2 
mediates a glutamate-induced increase in miniature excitatory postsynaptic currents 
(mEPSC) frequency in cultured hippocampal neurons (Ninan and Arancio, 2004). Infusion 
of activated CAMK2 in hippocampal CA1 pyramidal cells also increases the amplitude 
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of evoked EPSCs (Lledo et al., 1995), whereas knockdown of CAMK2A in dissociated 
hippocampal cultures decreased mEPSC amplitude, but not frequency (Barcomb et al., 
2014). Only one study investigated the differential effect of CAMK2A and CAMK2B on 
mEPSC frequency; upon overexpression in neurons opposing effects on basal synaptic 
strength were found, indicating that the ratio of CAMK2A and CAMK2B is important 
for activity-dependent synaptic homeostasis (Thiagarajan et al., 2002). Recently 
another study found that CAMK2A activity is essential for maintaining basal synaptic 
transmission and that loss of CAMK2A, but not CAMK2B, diminishes AMPA-receptor and 
NMDA-receptor currents (Incontro et al., 2018).
Since the majority of the above-mentioned studies used CAMK2 inhibitors, it is 
difficult to disentangle whether CAMK2A, CAMK2B or both are responsible for the 
observed effects. In this study we set out to investigate the contribution of CAMK2A 
and CAMK2B, alone or in combination, on neuronal excitability and basal synaptic 
transmission at the single cell level. To that end, we made use of single Camk2a–/– and 
Camk2b–/– mutants to study the role of each of these isoforms separately, as well as 
inducible Camk2af/f;Camk2bf/f knockout mice to understand how simultaneous loss of 
both isoforms affects neuronal function. Using whole-cell electrophysiology we found 
that only deletion of both CAMK2A and CAMK2B affects intrinsic excitability and basal 
synaptic transmission. We further show that induced deletion of both isoforms results 
in remarkable temporary changes. Whereas deletion of both CAMK2 isoforms initially 
results in decreased neuronal intrinsic excitability, this shifts to a marked increase in 
intrinsic excitability in just 10 days. The increase in intrinsic excitability coincides with a 
decrease of both miniature excitatory as well as inhibitory postsynaptic currents in the 
inducible Camk2af/f;Camk2bf/f knockout mice, suggesting that the increase in excitability 
could be a homeostatic response of the cell to maintain its basal functions. 
MATERIAL AND METHODS
Animals
Camk2a–/–, Camk2b–/– and Camk2af/f;Camk2bf/f;Cag-CreER mice were tested in a 
C57Bl/6JOlaHsd background and backcrossed >16 times. Mice were genotyped 
between 7-10 days of age and re-genotyped after the mice were sacrificed. Genotyping 
records were obtained and kept by a technician not involved in the design, execution or 
analysis of the experiments. 
Electrophysiological recordings in Camk2a–/– and Camk2b–/– mice were performed 
between 17 and 30 days of age. Camk2af/f;Camk2bf/f;Cag-CreER mice were older when 
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tested. Tamoxifen injections began at the age of 21 days until a maximum age of 30 
days. Three groups were used: D10 (10 days after the first tamoxifen injection), D15 (15 
days after the 1st Tamoxifen injection) and D21 (21 days after the 1st Tamoxifen injection). 
In absolute age, these time points corresponded with 31-40 days of age for mice of the 
D10 group, 36-45 days of age for mice of the D15 group and 42-50 days of age for mice 
of the D21 group.
All mice were kept group-housed in IVC cages (Sealsafe 1145T, Tecniplast) with bedding 
material (Lignocel BK 8/15 from Rettenmayer) on a 12/12 h light/dark cycle in 21°C 
(±1°C), humidity at 40-70% and with food pellets (801727CRM(P), Special Dietary 
Service) and water available ad libitum. For all experiments, mutants were compared 
to either WT or Cre–negative homozygous floxed littermates. Groups were matched 
for age and sex. All experiments were done during daytime and experimenters were 
blind for genotype throughout experiments and data analysis. All research has been 
performed in accordance with and approved by a Dutch Animal Ethical Committee 
(DEC) for animal research. 
Generation of Camk2a–/–, Camk2b–/– and Camk2af/f;Camk2bf/f;Cag-CreER 
mice 
The generation of Camk2a–/– and Camk2b–/– mice has been described previously 
(Elgersma et al., 2002; Kool et al., 2016) Camk2af/f;Camk2bf/f;Cag-CreER mice were 
generated by crossing Camk2af/f (Achterberg et al., 2014) and Camk2bf/f  (Kool et al., 
2016) mice. 
Tamoxifen injections
Camk2af/f;Camk2bf/f and Camk2af/f;Camk2bf/f;Cag-CreER mice (as early as P21) were 
injected with 0.1mg/gr of bodyweight Tamoxifen (Sigma-Aldrich) intraperitoneally for 4 
consecutive days. To keep Tamoxifen dose constant throughout injection days we kept a 
tight injection scheme, injecting mice 24±1 hour after the previous injection. Injections 
were given each day around noon. Tamoxifen was dissolved in sunflower oil (20mg/ml). 
Even though Tamoxifen is not known to have an effect on physiology, we injected both 
Camk2af/f;Camk2bf/f and Camk2af/f;Camk2bf/f;Cag-CreER mice with Tamoxifen to control for 
any possible effects. 
Electrophysiology 
Brain slices were prepared from mice using standard techniques. Briefly, mice were 
decapitated under deep isoflurane anaesthesia, brains were quickly removed and 320 
μm thick transverse slices were cut using a vibratome (HM650V; Microm) in ice-cold 
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cutting solution, containing (in mM): 126 Choline Chloride, 2.5 KCl, 1.25 NaH2PO4, 10 
MgSO4, 0.5 CaCl2, 16.7 glucose, 26 NaHCO3 bubbled with 95% O2 and 5% CO2. After 
cutting, slices were stored in the same cutting solution for 30 seconds at 35°C and then 
transferred to 35°C artificial cerebrospinal fluid (ACSF) containing (in mM): 126 NaCl, 2.5 
KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 glucose, 2 MgSO4, 2 CaCl2 bubbled with 95% O2 and 
5% CO2 (osmolarity between 300-310 mOsm/kg H2O). Afterwards, slices were kept in 
ACSF at room temperature for a minimum of 1 hour before onset of experiments.  
Whole-cell patch-clamp recordings were made from pyramidal neurons from area CA1 
in the hippocampus. Neurons were visualized using differential interference contrast 
(DIC) and infrared video microscopy optics on an Olympus BX51W1 microscope. Pipettes 
were pulled from borosilicate glass capillaries and had a resistance of 3-5 MΩ when filled 
with intracellular solutions containing (in mM): 120 K-gluconate, 10 KCl, 10 HEPES, 4 Mg-
ATP, 10Na2-Phosphocreatine, 0.3 GTP (pH adjusted to 7.3 with KOH) and 0.5% biocytin 
(osmolarity between 275-280 mOsm/kg H2O). Pyramidal neurons were identified based 
on their firing pattern, morphology under the microscope as well as their morphology 
after biocytin staining. Recordings were made with a patch-clamp amplifier (Multiclamp 
700B; Axon Instruments, Foster City, CA, USA). Signals were low-pass filtered at 2 kHz 
and digitized at 10 kHz. Only cells with series resistance under 30 MOhm were included. 
Series resistance was monitored during the experiments and not compensated for. Cells 
were rejected when series resistance changed by more than 20%. Resting membrane 
potential was measured in bridge mode (I=0). Other passive membrane properties 
(membrane resistance, access resistance, membrane capacitance and tau values) 
were measured immediately after obtaining whole-cell access using the membrane 
test in Clampex (Axon Instruments). Firing pattern, action potential characteristics 
and threshold were analysed using Clampfit 10.3 (Axon Instruments). Physiological 
responses were evoked using a series of depolarizing constant-current pulses of 750 ms 
duration at 30 pA intervals from a holding potential of -68 mV or by using 1 ms, 1 or 1.5 
nA constant-current pulses given at 10 Hz for 750 ms. Firing rate was measured as the 
number of action potentials elicited during the 750ms long constant-current pulse for 
each current step, calculated in Hertz and action potentials were identified and counted 
by the researcher in Clampfit. Action potential characteristics were measured on the 
1st and 3rd action potential at the first step that induced action potentials. The action 
potential amplitude was calculated as the difference between threshold and peak. 
For rise and decay kinetics of the action potentials, maximum rise and decay slope 
were calculated. Action potential half width was calculated as the width of the action 
potential at half of the maximum amplitude. Action potential threshold was calculated 
taking the first derivative of the action potential, and measuring the corresponding 
voltage when the derivative exceeded 2 mV/ms. Membrane potentials were corrected 
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for a (calculated) liquid junction potential of -8 mV. KN62 (Tocris Bioscience) was used in 
a concentration of 20 µM and autocamtide-2 related inhibitory peptide II (AIP-II; Merck 
Millipore) at 4 µM.
Miniature synaptic currents (mEPSCs and mIPSCs) were analysed using Mini Analysis 
(Synaptosoft Inc, Decatur, GA, USA). Events were detected with a threshold criterion 
of 3 times root-mean-square (RMS) of baseline noise. After detection, recordings were 
manually checked for false positive or missed events while the experimenter was still 
blind for genotype. mEPSCs were pharmacologically isolated using tetrodotoxin (TTX) 
(1 μM) and picrotoxin (50 μM). mIPSCs were isolated using TTX (1 μM), 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) (10 μM) and D,L-2-amino-5-phosphopentanoic acid 
(AP5; 50 μM). Cells were held at -70 mV when measuring miniature events. For mIPSCs 
a high chloride internal solution was used, containing (in mM): 2 NaCl, 141 KCl, 1 CaCl2, 
10 EGTA, 2 Mg-ATP, 0.3 Na-GTP, 10 HEPES, 10 Na-phosphocreatine (pH 7.25, 295 mOsm/
kg H2O).
Western blot
Western blot analysis was done as described previously (Kool et al., 2016). In short, 
western blots were probed with primary antibodies against CAMK2A (6G9, 1:40.000, 
Abcam), CAMK2B (CB-β1, 1:10.000, Invitrogen) and actin (MAB1501R, 1:20.000, 
Chemicon) and secondary antibodies (goat anti-mouse and/or goat anti-rabbit, both 
1:3000, Affinipure #115-007-003 and #111-007-003). Blots were stained and quantified 
using LI-COR Odyssey Scanner and Odyssey 3.0 software. 
Immunofluorescence
Immunofluorescence has been done as described previously (Kool et al., 2016). 
Data analysis and statistics
All excitability tests were analysed using a 2-way repeated measures ANOVA to 
determine a main effect of genotype. For all miniatures, averages were compared using 
a Student’s t-test. α was set at 0.05. All values represent average ± SEM. Number of mice 
and number of slices are depicted in the figure legends. All statistics were performed in 




Absence of either CAMK2A or CAMK2B does not change the intrinsic 
excitability of CA1 pyramidal neurons  
In order to decipher the role of CAMK2A and/or CAMK2B in neuronal excitability, we 
measured the physiological responses upon depolarizing current stimulations in CA1 
pyramidal neurons in the hippocampus of both Camk2a –/– and Camk2b–/– mice. For 
both mutants we found no difference in passive membrane properties such as input 
resistance, capacitance and resting membrane potential compared to their littermate 
controls (see Table 1). Additionally, we found no changes in excitability in both mutants 
(Camk2a–/–: effect of genotype: F(1,42)=0.06, p=0.81; Camk2b
–/–: effect of genotype: 
F(1,60)=0.22, p=0.64; 2way repeated measures ANOVA; Figure 1).
Table 1: An overview of all passive membrane properties of all mice used in Figure 1 and 2. 





Cm (pF)  
Vm (mV) 
WT (12) KO (10) WT (11) KO (20)p-value p-value
Camk2b–/–
Camk2af/f;Camk2bf/f;CAG-CreER




















































































































































































Figure 1: Loss of only CAMK2A and CAMK2B does not change excitability in hippocampal 
pyramidal CA1 neurons. (A) Excitability is unchanged in pyramidal neurons in Camk2a–/– 
(n=23) compared to Camk2a+/+ (n=21) mice. (B) Excitability is unchanged in pyramidal neurons 
in Camk2b–/– (n=34) compared to Camk2b+/+ (n=28) mice. N indicates the number of neurons 
measured. Scale bars indicate time (x) = 200ms and voltage (y) = 40mV.
Absence of both CAMK2A and CAMK2B causes a bidirectional change in 
excitability over time  
Since we recently showed clear redundancy in some functions for CAMK2A and CAMK2B 
(Kool et al., submitted), we considered the possibility that also at the level of neuronal 
excitability, loss of CAMK2A is compensated for by CAMK2B and vice versa. Therefore, 
we decided to measure excitability in mice lacking both CAMK2A and CAMK2B. Because 
Camk2a–/–;Camk2b–/– mice die at P1, we made use of our inducible homozygous floxed 
Camk2af/f;Camk2bf/f mice (Kool et al., submitted). Simultaneous deletion of Camk2a and 
Camk2b in adult mice results in lethality 24-53 days after onset of deletion. Hence we 
decided to measure the neuronal changes over time in the three weeks following gene 
deletion but before the mice become clearly affected. We injected Camk2af/f;Camk2bf/
f;Cag-CreER mice with Tamoxifen from postnatal day 21 (P21) onwards for 4 consecutive 
days and measured neuronal excitability on three different time points: 10 days (D10), 
15 days (D15) and 21 days (D21) after the 1st injection. Western blot analysis of prefrontal 
cortex tissue of the brains used for the whole cell experiments showed a 60% decrease of 
CAMK2A and an 85% decrease of CAMK2B protein on D10, which was further decreased 
on D15. Maximal reduction of protein level was obtained on D21 with <14% of CAMK2A 
and <5% of CAMK2B left in lysates (Figure 2A). First, we compared passive membrane 
properties, including input resistance, capacitance and resting membrane potential, of 
hippocampal CA1 pyramidal neurons at the different time points. Overall, we detected 
no differences in passive membrane properties on D10, D15 and D21 (see Table 1). Next, 
we measured voltage responses in CA1 pyramidal neurons upon depolarizing current 
injections. On D10, Camk2af/f;Camk2bf/f;Cag-CreER mice showed a decrease in excitability 
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pyramidal neurons on D15, excitability was no longer significantly different between 
the Camk2af/f;Camk2bf/f;Cag-CreER mutants and controls (effect of genotype: F(1,16)=0.02, 
p=0.89; 2way repeated measures ANOVA; Figure 2C), whereas on D21 Camk2af/f;Camk2bf/
f;Cag-CreER pyramidal neurons showed an increase in excitability compared to controls 
(effect of genotype: F(1,31)=15.25, p<0.001; 2-way repeated measures ANOVA; Figure 
2D). Importantly, Camk2af/f;Camk2bf/f;Cag-CreER mice injected with vehicle (sunflower oil 
without Tamoxifen) showed no changes in excitability both 10 and 21 days after the first 
vehicle injection (D10: effect of genotype: F(1,25)=0.94, p=0.34; D21: effect of genotype: 
F(1,23)=0.95, p=0.34; 2-way repeated measures ANOVA; Figure 2E and F). Taken together, 
whereas excitability was not changed in Camk2a –/– and Camk2b–/– single knockout mice, 
simultaneous deletion of both CAMK2A and CAMK2B initially induced a decrease in 
excitability followed by an increase in excitability.
CAMK2 is known to have both a catalytic as well as a structural role in neurons (Giese et 
al., 1998; Elgersma et al., 2002; Hojjati et al., 2007; Borgesius et al., 2011). To distinguish 
between the structural and catalytic role of CAMK2 in the observed phenotypes, 
excitability was measured again in CA1 pyramidal neurons of Camk2af/f;Camk2bf/
f;Cag-CreER mice; this time not after injection with Tamoxifen, but in the presence or 
absence of two types of CAMK2 inhibitors: the calmodulin-binding competitor KN62 
and substrate-binding competitor AIP-II (autocamtide-2 related inhibitory peptide II). 
Neither wash-in of 20uM KN62, nor 2.5h incubation of AIP-II affected excitability in CA1 
Figure 2: Loss of both CAMK2A and CAMK2B causes a bidirectional change in excitability 
in time (A) CAMK2A and CAMK2B protein quantification using Western Blot of prefrontal cortex 
of Camk2af/f;Camk2bf/f-CAG-CreER mice (Cre+) versus Camk2af/f;Camk2bf/f mice (Cre–) 10, 15 and 
21 days after the first Tamoxifen injection. Quantification of all Cre+ samples was compared to 
normalized Cre– samples from the same age (set at 100%). Statistics: Cre- vs Cre+: CAMK2A; 
D10: t=1.8, p=0.14; D15: t=9.2, p<0.001; D21: t=5.2, p<0.0001; CAMK2B; D10: t=3.2], p=0.032; 
D15: t=6.3, p<0.01; D21: t=9.8, p<0.0001; unpaired two tailed t-test. Actin was used as a loading 
control and number of samples is depicted in the bars. (B) Cre+ mice (n=10) show decreased 
excitability 10 days after onset of gene deletion compared to Cre– mice (n=13). (C) Cre+ 
mice (n=10) show no change in excitability 15 days after onset of gene deletion compared to 
Cre– mice (n=8). (D) Cre+ mice (n=18) show increased excitability 21 days after onset of gene 
deletion compared to Cre– mice (n=15). (E) Cre+ mice (n=14) show no change in excitability 
10 days after injection of vehicle compared to Cre– mice (n=13). (F) Cre+ mice (n=13) show 
no change in excitability 21 days after injection of vehicle compared to Cre– mice (n=12). N 
indicates the number of neurons measured, except for A. Scale bars in B-F indicate time (x) = 
200ms and voltage (y) = 40mV.
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pyramidal cells (KN62: effect of genotype: F(1,26)=0.24, p=0.63; AIP-II: effect of genotype: 
F(1,20)=0.08, p=0.79; 2-way repeated measures ANOVA; Figure 3A and B), suggesting that 








































































Figure 3: Blocking CAMK2 activity for several hours does not change excitability. (A) KN62 
wash-in for 10 minutes does not change excitability in CA1 pyramidal (n=14) compared to 
control conditions with no KN62 (n=14). (B) Incubation of Autocamtide-2 related inhibitory 
peptide II (AIP-II) for 2.5 hours does not change excitability in CA1 pyramidal neurons (n=10) 
compared to control conditions with no AIP-II (n=12). In these experiments Camk2af/f;Camk2bf/
f;Cag-CreER mice who received no Tamoxifen injections were used and were therefore used as 
controls. N indicates the number of neurons measured. Scale bars indicate time (x) = 200ms and 
voltage (y) = 40mV.
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Absence of CAMK2 changes action potential threshold 
Changes in excitability could result from changes in the active properties of CA1 
neurons. Thus we analysed the action potential properties including the threshold, 
maximum amplitude, rise and decay slopes, and half-width. We analysed the properties 
of the first and the third action potential at the first step that induced action potentials 
from mice on D10 and D21. We found no changes in amplitude, maximum rise slope, 
maximum decay slope or action potential half-width on D10 (Figure 4). However, the 
threshold at which the action potential was generated on D10 for the first and third 
action potential was significantly more positive (Figure 4D). However, 21 days after 
onset of deletion, we found that mice lacking CAMK2 had a significantly more negative 
threshold, with no changes in amplitude, maximum rise slope, maximum decay slope 
or action potential half-width (Figure 5). Also, using a more physiological approach to 
elicit action potentials using high current squared pulses for 1 ms at 10Hz, we still found 
a more negative threshold in Camk2af/f;Camk2bf/f;Cag-CreER mice on D21 (Cre- vs Cre+: 
t=2.3, p=0.29; unpaired two tailed t-test; Figure 5G). Taken together, loss of CAMK2 
significantly changed the action potential threshold first to a more positive level, which 
then shifted to a more negative level. 
Reduction of both inhibitory and excitatory inputs upon loss of CAMK2
Hypo- and hyperexcitability of neurons is often caused by changes in the inhibition to 
excitation ratio (Isaacson and Scanziani, 2011; Zhou and Yu, 2018). CAMK2A and CAMK2B 
are highly expressed at the synapse, regulating functional as well as structural plasticity 
(Lee et al., 2009; Kim et al., 2015) and changes in the ratio of CAMK2A and CAMK2B are 
shown to influence unitary synaptic strength as well as mEPSC frequency (Thiagarajan 
et al., 2002). Thus, it is plausible that loss of one or both CAMK2 isoforms affects the 
inhibitory and/or excitatory input a neuron receives, resulting in changes in excitability. 
Therefore, we measured both miniature excitatory and inhibitory postsynaptic currents 
(mEPSCs and mIPSCs) in hippocampal pyramidal cells of both Camk2a–/– and Camk2b–/– 
mice. Importantly, mEPSC and mIPSC frequency and amplitude were unaffected in both 
Camk2a–/– and Camk2b–/– mice (Camk2a–/–: mEPSC frequency: t=0.01, p=0.99; mEPSC 
amplitude: t=0.27, p=0.79; mIPSC frequency: t=0.05, p=0.96; mIPSC amplitude: t=0.51, 
p=0.62; Camk2b–/–: mEPSC frequency: t=0.37, p=0.71; mEPSC amplitude: t=0.78, p=0.45; 
mIPSC frequency: t=1.98, p=0.06; mIPSC amplitude: t=0.66, p=0.51; unpaired two tailed 
t-test; Figure 6). We then hypothesized that redundancy could play a role on the level 
of mEPSC and mIPSC frequency and amplitude similar as in excitability. We measured 
Camk2af/f;Camk2bf/f;Cag-CreER mice on the two time points at which excitability was 
changed: 10 days (D10) and 21 days (D21) after the 1st injection. Surprisingly, on D10, 
mEPSCs and mIPSCs showed no difference in frequency and amplitude between 
148
Chapter 5
Camk2af/f;Camk2bf/f;Cag-CreER mice and Camk2af/f;Camk2bf/f control littermates (Cre- 
vs Cre+: mEPSC frequency: t=0.65, p=0.52; mEPSC amplitude: t=1.66, p=0.11; mIPSC 
frequency: t=1.0, p=0.31; mIPSC amplitude: t=0.32, p=0.75; unpaired two tailed t-test; 
















































































































Figure 4: Action potential characteristics 10 days after onset of gene deletion of Camk2a 
and Camk2b in Camk2af/f;Camk2bf/f;Cag-CreER mice. (A) (Left) Average action potential 
for Camk2af/f;Camk2bf/f;Cag-CreER mice (Cre+; red) and Camk2af/f;Camk2bf/f mice (Cre–; black). 
Averages were taken from the first action potential at the first depolarizing step that induced 
action potentials. Scale bar indicates time (x) = 2ms and absolute voltage is shown on the 
y-axis. (Right) Same averages as left, but now overlapped to allow easier comparison for overall 
shape. (B) No difference in amplitude of action potentials in the first and third action potential 
between Cre+ and Cre– mice. (C) No difference in the half width of action potentials in the first 
and third action potential between Cre+ and Cre– mice. (D) Cre+ mice show a significantly 
more depolarized action potential threshold in the first and third action potential compared 
to Cre– mice. (E) No difference in maximum rise slope of action potentials in the first and third 
action potential between Cre+ and Cre– mice. (F) No difference in maximum decay slope of 
action potentials in the first and third action potential between Cre+ and Cre– mice. For all 
graphs: Cre+ (n=10), Cre– (n=13). N indicates number of neurons measured.
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frequency but not in amplitude (Cre- vs Cre+: mEPSC frequency: t=2.14, p=0.0398; 
mEPSC amplitude: t=0.71, p=0.48; mIPSC frequency: t=3.49, p<0.01; mIPSC amplitude: 
t=1.2, p=0.22; unpaired two tailed t-test; Figure 7C and D). To understand whether the 
reduced frequency was due to loss of synapses, neurons were filled with biocytin and 
the number of spines as well as their shape was analysed. Whereas there was no change 
in the density of spines per 10 micron length of dendrite, primary dendrites, branches 
































































































































Figure 5: Action potential characteristics 21 days after onset of gene deletion of Camk2a 
and Camk2b. (A) (Left) Average action potential for Camk2af/f;Camk2bf/f;Cag-CreER mice (Cre+; 
red) and Camk2af/f;Camk2bf/f mice (Cre–; black). Averages were taken from the first action 
potential from the first depolarizing step that induced action potentials. Scale bar indicates time 
(x) = 2ms and absolute voltage is shown on the y-axis. (Right) Same averages as left, but now 
overlapped to allow easier comparison for overall shape. (B) No difference in amplitude of action 
potentials in the first and third action potential between Cre+ and Cre– mice. (C) No difference 
in the half width of action potentials in the first and third action potential between Cre+ and 
Cre– mice. (D) Cre+ mice show a significantly more hyperpolarized action potential threshold 
in the first and third action potential compared to Cre– mice. (E) No difference in maximum rate 
of rise of the first or the third action potential between Cre+ and Cre– mice. (F) No difference 
in maximum decay slope of action potentials in the first and third action potential between 
Cre+ and Cre– mice. For all graphs (A-F): Cre+ (n=18), Cre– (n=11). (G) a more physiological 
protocol using 1ms squared pulses at 10Hz instead of continuous depolarization still show a 
significantly more hyperpolarized action potential threshold in Cre+ (n=22) compared to Cre– 
















































































































































Figure 6: No changes in mEPSC and mIPSC frequency and amplitude of Camk2a–/– and 
Camk2b–/–. (A) Representative traces (top) and frequency and amplitude (bottom) of miniature 
excitatory postsynaptic currents (mEPSC) measured from CA1 pyramidal cells. Camk2a–/– mice 
(n=21) show no change in frequency (Camk2a+/+ vs Camk2a–/–: 0.44 vs 0.44 Hz) and amplitude 
(Camk2a+/+ vs Camk2a–/–: 15.9 vs 15.7 pA) compared to Camk2a+/+ mice (n=17). (B) Representative 
traces (top) and frequency and amplitude (bottom) of miniature inhibitory postsynaptic 
currents (mIPSC) measured from CA1 pyramidal cells. Camk2a–/– mice (n=18) show no change 
in frequency (Camk2a+/+ vs Camk2a–/–: 5.17 vs 5.21 Hz)  and amplitude (Camk2a+/+ vs Camk2a–/–: 
43.03 vs 41.42 pA) compared to Camk2a+/+ mice (n=15). (C) Representative traces (top) and 
frequency and amplitude (bottom) of miniature excitatory postsynaptic currents (mEPSC) 
measured from CA1 pyramidal cells. Camk2b–/– mice (n=13) show no change in frequency 
(Camk2b+/+ vs Camk2b–/–: 0.54 vs 0.50 Hz) and amplitude (Camk2b+/+ vs Camk2b–/–: 18.26 vs 17.03 
pA) compared to Camk2b+/+ mice (n=8). (D) Representative traces (top) and frequency and 
amplitude (bottom) of miniature inhibitory postsynaptic currents (mIPSC) measured from CA1 
pyramidal cells. Camk2b–/– mice (n=14) show no change in frequency (Camk2b+/+ vs Camk2b–/–: 
3.95 vs 5.71 Hz) and amplitude (Camk2b+/+ vs Camk2b–/–: 47.97 vs 45.65 pA) compared to 
Camk2b+/+ mice (n=8). Scale for all mEPSCs indicates time (x) = 100ms and current (y) = 10pA: 
Scale for all mIPSCs indicates time (x) = 100ms and current (y) = 30pA. N indicates number of 
neurons measured.
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Figure 7: A decrease in mEPSC and mIPSC frequency 21 days after onset of gene deletion 
of Camk2a and Camk2b. (A) Representative traces (top) and frequency and amplitude 
(bottom) of miniature excitatory postsynaptic currents (mEPSC) measured from CA1 pyramidal 
cells 10 days after onset of gene deletion. Camk2af/f;Camk2bf/f;Cag-CreER mice (Cre+; n=11) show 
no change in frequency (Cre+ vs Cre–: 0.23 vs 0.25 Hz) and amplitude (Cre+ vs Cre–: 14.13 vs 
12.35 pA) compared to Camk2af/f;Camk2bf/f mice (Cre–; n=14). (B) Representative traces (top) 
and frequency and amplitude (bottom) of miniature inhibitory postsynaptic currents (mIPSC) 
measured from CA1 pyramidal cells 10 days after onset of gene deletion. Camk2af/f;Camk2bf/
f;Cag-CreER mice (Cre+; n=13) show no change in frequency (Cre+ vs Cre–: 5.73 vs 4.90 Hz) and 
amplitude (Cre+ vs Cre–: 32.1 vs 31.1 pA) compared to Camk2af/f;Camk2bf/f mice (Cre–; n=15). 
(C) Representative traces (top) and frequency and amplitude (bottom) of mEPSCs measured 
from CA1 pyramidal cells 21 days after onset of gene deletion. Camk2af/f;Camk2bf/f;Cag-CreER 
mice (Cre+; n=18) show a decrease in frequency (Cre+ vs Cre–: 0.32 vs 0.66 Hz) but not in 
amplitude (Cre+ vs Cre–: 14.82 vs 15.51 pA) of mEPSCs compared to Camk2af/f;Camk2bf/f mice 
(Cre–; n=16). (D) Representative traces (top) and frequency and amplitude (bottom) of mIPSCs 
measured from CA1 pyramidal cells 21 days after onset of gene deletion. Camk2af/f;Camk2bf/
f;Cag-CreER mice (Cre+; n=12) show a decrease in frequency (Cre+ vs Cre–: 4.70 vs 7.28 Hz) but 
not in amplitude (Cre+ vs Cre–: 40.40 vs 44.97 pA) of mIPSCs compared to Camk2af/f;Camk2bf/f 
mice (Cre–; n=15). Scale for all mEPSCs indicates time (x) = 100ms and current (y) = 10pA: Scale 




























































































Figure 8: Loss of CAMK2A and CAMK2B causes an increase of immature spines (filopodia). 
(A) No change in the density of spines per 10 micron length of dendrite in Camk2af/f;Camk2bf/
f;Cag-CreER mice compared to Camk2af/f;Camk2bf/f mice. (B) Camk2af/f;Camk2bf/f;Cag-CreER mice 
show significantly more immature spines than Camk2af/f;Camk2bf/f mice. For (A) and (B) 544 
spines/filopodia from 4 neurons from 3 different Camk2af/f;Camk2bf/f;Cag-CreER mice were used 
versus 540 spines/filopodia from 3 neurons from 3 different Camk2af/f;Camk2bf/f mice. (C) No 
change in the number of primary dendrites in Camk2af/f;Camk2bf/f;Cag-CreER mice compared 
to  Camk2af/f;Camk2bf/f mice. (D) No change in the number of neuronal branches in Camk2af/
f;Camk2bf/f;Cag-CreER mice compared to  Camk2af/f;Camk2bf/f mice. (E) No change in the total 
neurite length in Camk2af/f;Camk2bf/f;Cag-CreER mice compared to  Camk2af/f;Camk2bf/f mice. For 
graphs (C-E) 3 neurons were analysed from 3 different Camk2af/f;Camk2bf/f;Cag-CreER mice and 5 
neurons from 4 different Camk2af/f;Camk2bf/f mice.
Figure 8A, C-E), we did find a trend towards more immature spines (filopodia) in the 
Camk2af/f;Camk2bf/f;Cag-CreER mice (filopodia vs. spines: t=3.29, p=0.046; unpaired two 
tailed t-test; Figure 8B). Taken together, these results imply that the hypo-excitability 
seen in the Camk2af/f;Camk2bf/f;Cag-CreER mice at day 10 after induction of gene deletion, 
is not caused by initial changes in the inhibition to excitation ratio. 
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DISCUSSION
Here we made use of the Camk2a–/–, the Camk2b–/– as well as the Camk2af/f;Camk2bf/
f;Cag-CreER mice to study the effect of loss of either CAMK2A or CAMK2B or both 
simultaneously on neuronal excitability in hippocampal CA1 pyramidal neurons. 
Whereas loss of only CAMK2A or CAMK2B did not change the excitability, simultaneous 
loss of CAMK2A and CAMK2B resulted in a bidirectional change in excitability over time. 
Upon acute loss of both CAMK2 isoforms, excitability of hippocampal CA1 pyramidal 
cells decreased, but over time this was converted to an increase in excitability. These 
changes are accompanied by an initial increase of action potential threshold followed 
by a decrease in the threshold for which the underlying mechanisms are unknown. The 
changes in excitability seem not to be caused by changes in inhibition and excitation, 
since initially these inputs are not affected in our mini analysis; only at the latest time 
point a decrease was found in the frequency of both inhibitory and excitatory synaptic 
inputs. 
It is interesting that an effect on excitability was observed only when CAMK2A 
and CAMK2B are both absent. This indicates that either one of them can fulfill the 
function needed to maintain normal intrinsic neuronal excitability. Several studies 
showed involvement of the kinase activity of CAMK2 in neuronal excitability, most 
of which indicate that CAMK2 functions to inhibit neuronal excitability. In vestibular 
nucleus neurons, loss of CAMK2 activity results in an increase of intrinsic excitability 
mediated through BK-type calcium-activated potassium channels (Nelson et al., 2005). 
In Drosophila, CAMK2 was found to phosphorylate the ether à go-go (EAG) potassium 
channel, and inhibition of CAMK2 results in hyper-excitability (Wang et al., 2002). The 
Kv4.2 channel is also a substrate for CAMK2, and increased CAMK2 activity results 
in a decrease in excitability (Varga et al., 2004). In cardiac tissue and the axon initial 
segment of Purkinje cells, bIV-spectrin-dependent targeting of CAMK2 to Nav1.5 allows 
for phosphorylation of Nav1.5 on S571, altering excitability (Hund et al., 2010). 
Surprisingly, we find a bidirectional change in excitability over time, starting with hypo-
excitability. There are several explanations for this switch: i) dose-dependence; we find at 
10 days after gene deletion still 40% of CAMK2A and 15% of CAMK2B left in the prefrontal 
cortex. Since we have recently shown that the half-life in the hippocampus is slightly 
longer than in the cortex (Kool et al., submitted), the expression levels of CAMK2 in the 
hippocampus at this time point are likely somewhat higher than what we measured in the 
prefrontal cortex. This would mean that in total a fair amount of the kinase is still present 
when we see the decrease in excitability. However, the Camk2a–/– or Camk2b–/– mice, in 
which there is still 50% of CAMK2 present, did not show any change in excitability. It is 
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possible that adult deletion in our mouse model prohibits the neuron to compensate 
for loss of 50% of the most abundant protein, possibly showing the direct involvement 
of CAMK2 in neuronal excitability. Upon further decrease of CAMK2 levels, perhaps the 
neuron tries to compensate for the total loss of CAMK2 and the accompanying loss of 
input on the synapses by homeostatically increasing the excitability at the soma. ii) 
subcellular localization of CAMK2 loss; CAMK2 is present in the soma, in dendrites as 
well as in spines. Additionally, there is a pool of CAMK2A mRNA present in the dendrites 
(Burgin et al., 1990; Benson et al., 1992). Depending on which pool of CAMK2 is depleted 
first upon acute gene deletion, different channels and pathways will be affected, initially 
resulting in a more positive threshold for action potential firing, hence hypo-excitability. 
Upon loss of CAMK2 in more subcellular locations, other pathways get involved, resulting 
eventually in a decrease in action potential firing, hence hyper-excitability. Interestingly, 
when applying 2 different CAMK2 inhibitors we did not find any change in excitability, 
indicating that acute inhibition in slices does not directly affect neuronal excitability. 
Thus, whether the shift from hypo- to hyper-excitability seen in our Camk2af/f;Camk2bf/
f;Cag-CreER mice is caused by a structural or kinetic function of CAMK2 or maybe a 
combination of both is subject for future research. 
We observed a decrease in the frequency but not in the amplitude of miniature 
excitatory and inhibitory postsynaptic currents only 21 days after deletion of CAMK2A 
and CAMK2B, which is not seen in Camk2a–/ – and Camk2b–/– mice. However, at 10 days 
after gene deletion, no changes in mPSCs are observed. This indicates that the changes 
in excitability are not caused by changes in inhibitory and excitatory input. 
At 21 days, it is possible that the neuron tries to compensate for the synaptic loss of 
CAMK2A and CAMK2B and the accompanying decrease in mPSC input by decreasing 
the action potential threshold. Loss of CAMK2B has already been associated with a 
decreased volume of spines and the conversion of mature spines into immature spines 
(Okamoto et al., 2007). Moreover, CAMK2 activity has been shown to be involved 
in unsilencing silent synapses (Liao et al., 2001). Our observation of more immature, 
filopodia-shaped synapses in the Camk2af/f;Camk2bf/f;Cag-CreER mice indeed supports 
the idea that CAMK2 is important for synapse formation and/or maintenance and 
indicates that the neuron tries to compensate for the loss of CAMK2 at the synapse by 
increasing somatic excitability. However, we cannot exclude the opposite possibility, in 
which the neuron compensates for the hyperexcitability by decreasing mPSC frequency. 
Furthermore, it is still possible that the changes in mPSCs and in excitability are 2 
independent mechanisms, caused by deletion of CAMK2A and CAMK2B simultaneously. 
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The mouse models used in our study have a different onset of gene deletion. The 
Camk2af/f;Camk2bf/f-CAG-CreER mice develop normal CAMK2 expression up to the 
moment of Tamoxifen injections, usually starting at P21. However, Camk2a–/– and 
Camk2b–/– mice lack CAMK2A or CAMK2B from germline. This could mean that differences 
observed can also be explained by differences during (embryological) development. 
However, for CAMK2A it was recently shown that adult deletion results in similar LTP 
and hippocampal-dependent learning deficits as germline deletion (Achterberg et 
al., 2014). Furthermore taking into account the late onset of CAMK2A expression (P1) 
(Bayer et al., 1999), it is unlikely that CAMK2A plays a role during the embryological 
development. Its role in early postnatal development remains to be uncovered. CAMK2B 
starts to be expressed at E12.5 (Karls et al., 1992; Bayer et al., 1999), and is therefore more 
likely to play an important role early in development. Indeed, for locomotion, germline 
deletion of Camk2b is more disruptive than deletion of Camk2b in adulthood (Kool et 
al., 2016), indicating an important role for CAMK2B in development for locomotion 
If this is also true for other phenotypes remains to be investigated. However, it is still 
possible that the lack of effect we see in the Camk2a–/ – and Camk2b–/– single mutants 
is not only due to compensation of the other CAMK2 isoform still being present, but 
through other compensatory mechanisms kicking in during early development, and 
that adult deletion of CAMK2A or CAMK2B in inducible single mutants would cause 
similar changes in excitability and unitary synaptic transmission as seen in the inducible 
double Camk2a/Camk2b mutants studied here. 
Taken together our data show critical involvement in neuronal excitability as well as 
synapse formation and shed new light on the full spectrum of CAMK2 function in 
neurons. Additionally, our data indicates that acute deletion of a gene can uncover 
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The aim of this thesis was to further elucidate the roles of CAMK2A and CAMK2B, both 
their individual as well as their collective role, in neuronal and cognitive functioning.
Throughout the chapters in this thesis the Cre-LoxP system has played a central role to 
investigate protein functioning in the different mouse mutants. The Cre-LoxP system 
has the advantage to explore functions of the gene of interest in both a temporal as 
well as a spatial manner. We first used this technique to target Camk2a and Camk2b 
separately in Chapter 2 and 3. We explored both the spatial and temporal roles of these 
proteins and compared them to phenotypes that have been observed in the global 
Camk2a and Camk2b knockout models.
In Chapter 2 we focussed specifically on CAMK2A. We generated a floxed mouse model 
and investigated the spatiotemporal role of CAMK2A in spatial and contextual learning 
and LTP. We found that forebrain specific deletion of CAMK2A impairs learning but 
cerebellar specific deletion does not. Furthermore, adult deletion of CAMK2A results 
in impaired LTP at the Schaffer-collateral pathway, similar as in conventional Camk2a 
knockout mice. These results highlight the necessity of CAMK2A in the forebrain but not 
in cerebellar Purkinje cells in spatial and contextual learning. Furthermore, these results 
showed that the presence of CAMK2A at the time of learning is an absolute requirement. 
In Chapter 3 we used a similar approach. We used several Camk2b mouse mutants, 
two of which were new, and tested them on the accelerating Rotarod. Already CAMK2B 
was known for its important role in locomotion, as conventional Camk2b knockout 
mice show profound locomotion deficits on the Rotarod (Van Woerden et al., 2009; 
Bachstetter et al., 2014). We further tested the molecular, temporal and region-specific 
requirements for this deficit. First, we found that autonomous activity of CAMK2B 
(using CAMK2B-T287A mice) is dispensable for locomotion. In sharp contrast, loss of 
Ca2+-dependent activity in CAMK2B-A303R mice has a severe impact on locomotion 
performance. Second, onset of deletion in adulthood resulted in a relatively mild 
impairment in locomotion, suggesting that the locomotion deficit in Camk2b –/– mice, is 
mainly of developmental origin. Third, with respect to spatial requirements, early onset 
of gene deletion in cerebellum, striatum or forebrain did not recapitulate this deficit, 
arguing that this deficit cannot be attributed to a single brain area.
The findings of these two chapters can be discussed both on a temporal and spatial 
level. On a temporal level, we gained more information on the role of the separate 
isoforms in development. The phenotypes we found in Chapter 2 in the Camk2af/f mice 
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are remarkably consistent with previous research performed in Camk2a–/– mice (Silva et 
al., 1992a; 1992b; Elgersma et al., 2002). These findings make it unlikely that CAMK2A 
plays an important role in (postnatal) brain development necessary to sustain normal 
LTP and hippocampal-dependent learning. Additionally, the late onset expression of 
CAMK2A at P1 (Bayer et al., 1999) and the dependency of neonatal LTP on PKA but not on 
CAMK2 (Yasuda et al., 2002) further suggest that CAMK2A does not have an important 
developmental role. However, to definitively exclude a developmental role for CAMK2A, 
another approach using the Cre-LoxP system could be used. Instead of flanking exon 
2 of Camk2a with LoxP sites, as has been done in the Camk2af/f mice, the Camk2a gene 
could be preceded by a Stop-cassette flanked by LoxP sites. Hence, expression of the 
gene is withheld until the moment of Tamoxifen injection. This way, mice could reach 
adulthood mimicking the knockout condition and upon deletion of the Stop-cassette 
expression of CAMK2A is restored. The interesting question then becomes whether LTP is 
fully reinstated and if the phenotypes in hippocampal-dependent learning are rescued. 
If this is indeed the case, then a developmental role for CAMK2A could be excluded in 
LTP and hippocampal-dependent learning. A similar approach using this technique has 
recently been used for Angelman syndrome, which showed that rescue of behavioural 
phenotypes (but not LTP) required gene reinstatement early in life (Silva-Santos et al., 
2015). These experiments would require a new set of mutant Camk2 mice, but these 
rescue experiments answer a fundamentally important question for the treatment of 
intellectual disability in humans, in particular for individuals where malfunctioning of 
CAMK2 is directly causing intellectual disability (Küry et al., 2017 and Akita et al., 2018).
In contrast to CAMK2A, we did find a developmental role for CAMK2B in locomotion. In 
Chapter 3 we showed that the adult onset of Camk2b deletion resulted in a locomotion 
phenotype which was rather mild compared to Camk2b–/– mice. This implies that 
CAMK2B has a more substantial role during development than in adulthood. We have 
chosen to delete CAMK2B 8-10 weeks postnatally. Since expression starts already at 
embryonic day 12.5 (Bayer et al., 1999) this means that the brain in these mice has been 
allowed to mature in the presence of CAMK2B for a substantial amount of time before it 
was deleted. It could be expected that earlier onset of deletion will result in a stronger 
locomotion phenotype. Conversely, the same could hold if time between Camk2b 
deletion and testing of locomotion increases. This would mean that the longer CAMK2B 
is absent in our mouse model, the more detrimental the locomotion phenotype will be. 
Whether this hypothesis is true, would be worth investigating.
Earlier I discussed the possibility of reinstating CAMK2A expression in adulthood using 
Stop-cassettes flanked by LoxP sites. A similar approach could be used for the locomotion 




deficits? And would early reinstatement have a more profound rescue effect than late 
reinstatement? Some of the Camk2b patients that were recently identified (Küry et al., 
2017) showed delayed gross motor development. Again, these rescue experiments 
could provide us with crucial information on whether reinstating normal CAMK2B 
expression in patients would be feasible to treat these impairments in the future. 
On a spatial level we gained more information which brain regions are involved in the 
phenotypes present in the global knockout mice. For example, in Chapter 2 we found 
that CAMK2A in the forebrain but not in the cerebellum is important for LTP and spatial 
learning. However, considering the size of the forebrain we still targeted a relatively 
broad area in the brain. Future research could further dissect the role of CAMK2A in 
different smaller brain areas or within different subfields of these brain areas. For 
example, different areas in the hippocampus are known for different functions. The 
CA3 area has been postulated in pattern recognition and therefore essential in spatial 
learning, partially due to the recurrent connections between different CA3 pyramidal 
cells (Marr, 1971). Would loss of CAMK2A in this area underlie the spatial learning 
deficits? A previous study using knockout mice for NMDA-receptor subunit NR1 
specifically in CA3 have already shown an important role for NMDA-receptor dependent 
LTP in pattern recognition and completion (Nakazawa et al., 2002). 
When we deleted CAMK2B in different brain regions in Chapter 3, we failed to locate 
a single brain area responsible for the locomotion deficit observed in Camk2b –/– mice. 
It might be possible that we missed this either because (i) the promoters driving the 
Cre in our mouse models start expressing Cre too late allowing normal embryonic 
development, (ii) we failed to target the brain area involved in the locomotion deficit 
or (iii) we missed it because we only targeted CAMK2B in one brain region at a time 
whereas the locomotion deficit might arise from the summation of relative small deficits 
in multiple brain regions. In order to distinguish between these options, we could 
either switch using new Cre-driver lines or cross already existing Cre-lines to expand 
the deletion over multiple brain regions. An example of the former could be to use 
Cre-lines targeting other brain regions not used in our study important for locomotion, 
such as the thalamus or deep cerebellar nuclei. An example of expanding the deletion 
over multiple brain regions would be using the GABAa6-Cre and L7-Cre simultaneously, 
thereby targeting a bigger part of the cerebellum. However, considering the inter-
experimental variation present when using the Rotarod, one could argue whether 
exploring these options using the Rotarod will be feasible.
Next to dissecting temporal and spatial roles of the different isoforms, in Chapter 3 we 
also focussed on the molecular requirements of CAMK2B in the locomotion phenotype. 
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We found that binding of Ca2+/Calmodulin to CAMK2B is crucial for locomotion (as seen 
in Camk2b A303R/A303R mice), whereas subsequent autophosphorylation is not (as seen in 
Camk2b T287A/T287A mice). However, upon binding of Ca2+/Calmodulin two events occur: 
CAMK2B becomes active and the protein detaches from actin. Even though this occurs 
subsequently, they can still be seen as two separate events. Using Camk2b A303R/A303R mice 
we could not distinguish whether it is the impairment in activating CAMK2B or whether 
it is the inability to detach from actin that underlies the locomotion deficit. 
In Chapters 4 and 5 we continued using the Cre-LoxP system now targeting Camk2a and 
Camk2b simultaneously. Considering the remarkable similarity on genetic and protein 
level, we hypothesized that certain functions could be carried out by both CAMK2A 
and CAMK2B. Targeting both genes allowed us to explore redundancy between the two 
isoforms. Below, our findings will be further discussed in the light of this redundancy. 
In Chapter 4 we explored potential redundancy and uncovered new functions of CAMK2 
by deleting or mutating Camk2a and Camk2b simultaneously. Complete loss of CAMK2A 
and CAMK2B is lethal both during development as well as in adulthood. Moreover, loss 
of Ca2+-dependent and Ca2+-independent activity is lethal. On a physiological level, 
loss of CAMK2A and CAMK2B in adulthood causes a complete loss of LTP at the CA3-
CA1 synapse in the hippocampus. This could not be attributed to a presynaptic role of 
CAMK2A and CAMK2B in this synapse, as presynaptic deletion of these two proteins 
did not impair LTP expression. Finally, we found that simultaneous deletion of CAMK2A 
and CAMK2B at the CA3-CA3 synapse impairs LTP, whereas deletion of only CAMK2A or 
CAMK2B does not. Taken together, these results show yet unknown roles for CAMK2A 
and CAMK2B that were masked in previous studies by redundancy of the isoform still 
present in the single knockout models.
In Chapter 5 we continued exploring the redundancy of CAMK2A and CAMK2B in our 
inducible Camk2af/f;Camk2bf/f mouse model. We investigated the role of CAMK2A and 
CAMK2B in neuronal excitability and unitary synaptic transmission on a single cell level 
in CA1 pyramidal cells using whole-cell electrophysiology. We found a bidirectional 
change in excitability in time in CA1 pyramidal cells upon loss of CAMK2A and CAMK2B. 
Loss of CAMK2A and CAMK2B decreased neuronal excitability 10 days after onset of 
deletion, which was absent 15 days after onset of deletion and subsequently followed 
by an increase in excitability 21 days after onset of deletion. At the synaptic level, loss 
of CAMK2A and CAMK2B resulted in a decrease in mIPSC and mEPSC frequency and 




changes in excitability and mEPSC and mIPSC frequency and amplitude were not found 
in conventional Camk2a–/– and Camk2b–/– mice. Finally, the decrease in mEPSC and mIPSC 
frequency was accompanied by higher percentage of immature spines (filopodia).
These results further emphasize the redundancy of CAMK2A and CAMK2B. Only upon 
simultaneous deletion of CAMK2A and CAMK2B could these phenotypes be uncovered. 
This redundancy could be explained by the evolutionary origins of the Camk2a and 
Camk2b genes. As mentioned in the introduction of this thesis, it is very likely that 
Camk2a and Camk2b share a common ancestral gene. As assessed in rats, different 
CAMK2 isoforms have a 89-93% sequence homology in the catalytic and regulatory 
domain (Tobimatsu and Fujisawa, 1989). Therefore, it is not surprising that they can 
have an overlap in substrates. This is exemplified by CAMK2’s role in survival, CA3-CA3 
LTP, neuronal excitability and unitary synaptic transmission, where single Camk2a or 
Camk2b knockout mice show no phenotypes. These findings argue for more studies 
on CAMK2 double knockout or knock-in mouse models for CAMK2 to explore novel 
functions that were previously hidden in single knockout or knock-in mice. 
Unfortunately, we were not able to identify the cause of death in our mouse mutants. 
We can however speculate, based on studies performed investigating proteins closely 
related to CAMK2. For example, knockout animals for NMDA-receptor subunits such as 
NR1 and NR2B, die shortly after birth (Forrest et al., 1994; Kutsuwada et al., 1996), similar 
as our Camk2a–/–;Camk2b–/– mice. These mouse models have been found to die from 
respiratory failure and impaired suckling response, respectively. An impaired suckling 
response is unlikely, given that we found milk in the stomachs of P0 pups. However, it 
is possible that respiratory failure could be the cause of death for Camk2a–/–;Camk2b–/– 
mice. Indeed, a role for CAMK2 in the emergence and maintenance of synchronous 
activity in the preBötzinger complex (preBotC), a respiratory center in the brainstem 
important for the motor output of respiration, was found (Mironov, 2013). In this study, 
blocking CAMK2 activity using KN93 attenuated bursting activity of the preBotC. 
Another reason why respiratory failure is a likely cause of death in Camk2a–/–;Camk2b–/– 
mice is based on the importance of a well-functioning respiratory system after birth. In 
utero the organism is not depending on respiration. After birth however, respiration is 
critical for sustaining life. It is not unlikely that in the absence of CAMK2 in the preBotC 
in these mice the induction of a respiratory rhythm fails. For adult mice however, this 
argument is harder to defend, mainly since some mice lived more than 50 days after 
the induction of deletion, well after levels of CAMK2 in the brain have dropped to a 
minimum. Still, loss of CAMK2 in the preBotC could dysregulate the synchronous activity 
in the preBotC in such a way that the mice can sustain for multiple days, but eventually 
will die because of this dysregulation.
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In addition to a new-found role for CAMK2 in survival, our electrophysiological findings 
in the hippocampus shed some important light on the role of CAMK2 in plasticity 
throughout the brain. The finding that loss of CAMK2A and CAMK2B completely 
eliminated LTP elicited by high frequency stimulation at the CA3-CA1 synapse, while 
it was only partially impaired in the CA3-CA3 synapse underscores the differences that 
are present in the brain in mechanisms underlying LTP on a spatial level. The CA3-CA1 
synapse may be an example of a synapse where CAMK2 has a greater role for expression 
of LTP, whereas in the CA3-CA3 synapse other protein kinases such as PKA, PKG or PKC 
(as suggested by Lu and Hawkins, 2006) may act in concert with CAMK2 to express 
LTP. However, we have shown that PKA-dependent LTP is also present at the CA3-CA1 
synapse and is only partially impaired there when CAMK2A and CAMK2B are absent. 
Also on a temporal level plasticity is known to be regulated differently. For example in 
the CA3-CA1 synapse, early expression of LTP (<9 postnatal days) is not regulated by 
CAMK2 but by PKA (Yasuda et al., 2002). Thus, whereas the CA3-CA1 synapse could well 
be the most-studied synapse in the mammalian brain, scientists should be cautious in 
extrapolating observations from the CA3-CA1 synapse taken from one developmental 
stage to other synapses in the brain or other developmental stages.
When we performed whole-cell electrophysiology on a single cell level, we found a 
bidirectional change in excitability over time. What is the reason for this change over time? 
One explanation could be that the effect of excitability is dose-dependent. For example, 
on day 10 when there is a decrease in excitability, levels of CAMK2A and CAMK2B are at 
60% and 15%, respectively. Upon day 21 when there is an increase in excitability, levels 
have dropped to 14% for CAMK2A and less than 5% for CAMK2B. Another explanation 
could be that the loss of CAMK2 directly triggers this decrease in excitability, which is 
later homeostatically (over)compensated by an increase in excitability. The difference 
between these two scenarios is that in the former the hyperexcitability of D21 is directly 
related to the loss of CAMK2, whereas in the latter the hyperexcitability is an indirect 
(compensatory) effect.
Loss of CAMK2A and CAMK2B also leads to a decrease in unitary synaptic transmission 
21 days after onset of gene deletion. Interestingly, this loss of unitary synaptic 
transmission in Chapter 5 (decrease in frequency of mEPSCs and mIPSCs) precedes the 
basal synaptic transmission tested in field electrophysiology on day 25 in Chapter 4, 
where we observed normal synaptic transmission. These two observations seem hard 
to reconcile. In whole-cell electrophysiology we selectively measured input on a single 
hippocampal pyramidal cell in the presence of tetrodotoxin (TTX), thereby blocking 
action potential-induced vesicle release. In field electrophysiology we measure a 




release of presynaptic vesicles. There are multiple explanations for this discrepancy in 
outcome between these two experimental approaches: (i) the effects we measure using 
whole-cell electrophysiology are relatively small and dissipate when measured using 
field electrophysiology or (ii) the effects are only noticeable when action potentials 
are blocked (i.e. during unitary synaptic transmission), but are compensated by action 
potential-dependent release. Future research could try to distinguish between these 
options and find an explanation for this seeming inconsistency. 
The change in excitability in time in Chapter 5 highlights the importance of working 
with inducible knockout mice. By using inducible knockout mice, we kept track of the 
changes occurring in time, demonstrating that the increase in excitability on day 21 is 
preceded by a decrease in excitability on day 10. It is conceivable that similar changes 
occur in conventional knockout mice as well, as a response of the neuron to the absence 
of one of its crucial proteins. However, this could easily be missed by researchers since 
these compensatory mechanisms are likely to kick in already during development and 
most experiments are done after that time window. Therefore, certain phenotypes in 
conventional knockout mice could be directly attributed to the loss of the gene whereas 
the notion that the phenotype could also be a compensatory mechanism (i.e. an indirect 
effect) will be missed. For example, in our double knockout mice the hyperexcitability 
at day 21 could be a compensatory mechanism for the initial hypo-excitability on 
day 10. The point that needs to be stressed here is that any phenotype can thus be 
a direct consequence of the loss of a protein or it can be caused as a compensatory 
reaction towards the absence of the protein. Therefore, when researchers are exploring 
phenotypes they should be cautious for indirect effects when investigating conventional 
knockout models and be aware of compensatory mechanisms. One way to better track 
changes occurring upon loss of a protein is by studying inducible knockout mouse 
models and follow the changes over time.
During the years when our insight in CAMK2A and CAMK2B function accumulated using 
animal models, the question has always been: are there human patients with CAMK2 
mutations? Now, nearly 25 years after the generation of the first knockout mouse for 
Camk2a in 1992 (Silva et al., 1992a; 1992b) we are starting to find point mutations or 
haploinsufficiency in humans (Iossifov et al., 2014; Vincent et al., 2014; Küry et al., 2017; 
Akita et al., 2018). Compared to other genes causing intellectual disability however, it 
took a significant amount of time before the first human patients with mutations in one 
of the CAMK2 genes were found. On the contrary, in other diseases causing intellectual 
disability (e.g. FMRP in Fragile X or UBE3A in Angelman Syndrome) the underlying 
genetic cause is already known for quite some time. One reason could be that these 
genetic diseases present a typical cluster of symptoms making them easier to recognize 
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clinically. Another potential reason is that genetic screening is very expensive, which 
could make clinicians reluctant to perform these tests when the symptoms at hand 
cannot be treated with drugs or surgically, symptoms such as intellectual disability 
or delay in motor development. At present however, prices of sequencing a human 
genome have plummeted ever since 2007 (Hayden, 2014), now reaching prices under 
$1000 per genome and prices are expected to drop even further for the coming years. 
This creates great opportunities to genetically screen vast numbers of patients with 
intellectual disability. Most certainly, some of these patients will have mutations in one 
of the CAMK2 genes. When more patients are found, it will be easier to cluster these 
patients. This could be done according to which CAMK2 gene is affected or according to 
the effect of the mutation (for example, whether it is a loss or gain of function mutation) 
or even the localization of the mutation (which domain is affected). Beyond doubt, this 
will further increase our understanding of CAMK2 in cognitive functioning in humans.
Conclusively, the research in this thesis increases our understanding of Ca2+/calmodulin-
dependent protein kinase II in the brain both on a spatial as well as a temporal level. 
CAMK2A and CAMK2B are two majorly abundant proteins in the mammalian brain, 
controlling a great deal of different processes. For example, on the basis of this thesis 
CAMK2 can be found to control processes ranging from locomotion and spatial 
navigation on a behavioural level to excitability at a somatic level and LTP at a synaptic 
level. As noted in the previous paragraph, with the recent discovery of humans with 
mutations in CAMK2, future research is expected to start investigating human patients 
alongside animal models. The next decades will be very promising in terms of describing 
the full spectrum of clinical features in which CAMK2 mutations can present themselves. 
We might still be a long way from curing patients with a CAMK2 mutation, but one small 
step at a time, we will get closer to obtaining a therapy that can benefit patients with a 
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In the field of learning and memory, CAMK2 is one of the most studied proteins. In 
addition, CAMK2 is also one of the most abundant proteins in the mammalian brain. 
Over 30 years of research has established a clear role for CAMK2 in learning, memory 
and long-term potentiation (LTP). This thesis focuses on CAMK2A and CAMK2B, the two 
major brain isoforms that can form a CAMK2 dodecamer. Specifically, the spatial and 
temporal roles of CAMK2A and CAMK2B individually were investigated, as well as the 
redundancy of CAMK2A and CAMK2B.
In Chapter 2 we investigated the spatial and temporal requirements of CAMK2A in 
spatial and contextual learning. We generated a new mouse model in which genetic 
deletion of CAMK2A could either be induced in specific parts of the brain or globally 
in adulthood. We found that CAMK2A expressed in forebrain, but not in the cerebellar 
Purkinje cells, is essential for spatial learning. Moreover, adult deletion of CAMK2A 
impaired spatial learning and LTP at a similar level as in conventional Camk2a knockout 
mice. These results highlight the importance of CAMK2A at the moment of learning and 
LTP expression.
A similar approach was used for CAMK2B in Chapter 3. Here we investigated the 
spatiotemporal requirements of CAMK2B in locomotion, since the conventional 
Camk2b–/– mutant has a severe locomotion deficit. Additionally, we used two point 
mutants to study the molecular requirements for locomotion. Starting with the 
molecular requirements, we found that autonomous activity of CAMK2B (using CAMK2B-
T287A mice) is dispensable, whereas loss of Ca2+-dependent activity of CAMK2B (using 
CAMK2B-A303R mice) is detrimental for normal locomotion. On a temporal level, loss of 
CAMK2B in adulthood results in a relatively mild impairment in locomotion, suggesting 
a developmental role for CAMK2B in locomotion. On a spatial level we could not 
recapitulate the locomotion deficit by deleting CAMK2B in single brain regions such as 
cerebellum, striatum or forebrain arguing that this deficit does not arise from a single 
brain region. 
In Chapter 4 we targeted both CAMK2A and CAMK2B simultaneously. This allowed us 
to uncover new functions of CAMK2 which were masked by redundancy of CAMK2A 
in Camk2b–/– mutant mice and CAMK2B in Camk2a–/– mutant mice. One of these new 
functions we unmasked was a role for CAMK2 in survival. We found that deletion of 
CAMK2A and CAMK2B simultaneously either from germline or at the adult age is lethal. 
Moreover, loss of autonomous and Ca2+-dependent activity of CAMK2 is lethal. On a 
physiological level, we found that LTP at the CA3-CA1 synapse was completely absent 
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upon genetic deletion of Camk2a and Camk2b in adulthood. This was not due to the loss 
of CAMK2A and CAMK2B in the presynaptic neuron, as genetic deletion presynaptically 
did not alter LTP. Finally, we found that at the CA3-CA3 synapse plasticity rules are 
governed differently as compared to the CA3-CA1 synapse with respect to CAMK2. 
Only upon loss of CAMK2A and CAMK2B simultaneously is LTP impaired at the CA3-
CA3 synapse. This is in contrast with the CA3-CA1 synapse, where loss of only CAMK2A 
or CAMK2B already partially impairs LTP. Together these results show that CAMK2A 
and CAMK2B can compensate for each other for some critical functions and that 
investigating single knockout mutants is not sufficient to apprehend the full spectrum 
of CAMK2A and CAMK2B.
We went one step further in Chapter 5 by investigating new functions of CAMK2 on a 
single cell level. There we explored the loss of CAMK2A and CAMK2B and the subsequent 
effect on neuronal excitability and unitary synaptic transmission in hippocampal CA1 
pyramidal cells. We found a bidirectional change in excitability following CAMK2A 
and CAMK2B deletion. 10 days after deletion we found a decrease in excitability when 
CAMK2A and CAMK2B were deleted. This effect was gone at 15 days after onset of 
deletion and subsequently followed by an increase in excitability 21 days after onset of 
deletion. At the synaptic level we found that loss of CAMK2A and CAMK2B resulted in 
a decrease of mIPSC and mEPSC frequency and amplitude 21 days after deletion, but 
not yet after 10 days of deletion. All these effects in neuronal excitability and unitary 
synaptic transmission were only present in mice where CAMK2A and CAMK2B were 
deleted simultaneously. When only one of these isoforms was deleted, these effects 
were no longer present.
Together these results further elucidate the mechanisms of CAMK2 in behavior, on 
a network level and on a single cell level. Understanding the mechanisms of CAMK2 
on these different levels will one day provide new insights for treating patients with 





CAMK2 is een van de meest bestudeerde enzymen binnen het veld van leren en 
geheugen en sterk oververtegenwoordigd in het brein van zoogdieren. Meer dan 30 jaar 
fundamenteel onderzoek laat een essentiële rol zien voor CAMK2 in leren, geheugen 
en lange-termijn potentiatie (LTP). Deze fundamentele kennis blijkt nu van onkenbaar 
belang, sinds er dankzij verbeterde en goedkopere DNA-technieken nu CAMK2 mutaties 
gevonden worden in individuen met een (tot nog toe) onverklaarde verstandelijke 
beperking. Echter in dit proefschrift wordt nog met name de fundamentele rol van 
CAMK2A en CAMK2B bestudeerd, twee zeer veel voorkomende isoformen, die in 
het brein samen een CAMK2 enzymcomplex kunnen vormen. Zowel de individuele 
rol van CAMK2A en CAMK2B in verschillende hersengebieden en in verschillende 
ontwikkelingsstadia (de spatiele en temporele rol) als de gezamenlijke rol van CAMK2A 
en CAMK2B komen aan bod.
In hoofdstuk 2 onderzochten we de rol van CAMK2A in verschillende hersengebieden 
en in verschillende ontwikkelingsstadia in ruimtelijk en contextueel leren. We maakten 
een nieuw muis model waarin we CAMK2A genetisch konden verwijderen ofwel in 
specifieke gebieden in het brein of in het gehele brein op volwassen leeftijd. We laten zien 
dat CAMK2A in de voorhersenen essentieel is voor ruimtelijk leren, maar dat CAMK2A 
in de Purkinje cellen van de kleine hersenen (cerebellum) geen rol speelt in dit gedrag. 
Deletie van het gen Camk2a, en daarbij deletie van het enzym CAMK2A, op volwassen 
leeftijd verhinderde het ruimtelijk leren en de expressie van LTP. Dit is vergelijkbaar met 
de conventionele Camk2a knockout muis waarin CAMK2A nooit aanwezig is geweest. 
Deze resultaten tonen aan dat aanwezigheid van CAMK2A belangrijk is op het moment 
van leren en voor het creëren van LTP.
Eenzelfde methode werd gebruikt voor CAMK2B in hoofdstuk 3. Hier onderzochten 
we de spatiele en temporele rol van CAMK2B in motoriek. De conventionele Camk2b 
knockout muismutant heeft hierin een sterk fenotype. Aanvullend maakten we gebruik 
van twee knock-in mutanten om de moleculaire rol van CAMK2B voor motoriek te 
onderzoeken. We vonden dat calcium-onafhankelijk (autonome) activiteit van CAMK2B 
verwaarloosbaar is voor de motorische fenotypes. Daarentegen was de calcium-
afhankelijke activiteit van CAMK2B cruciaal voor normale motoriek. Wat betreft het 
temporele aspect vonden we dat verlies van CAMK2B op latere leeftijd een relatief 
milder fenotype in de motoriek gaf in vergelijking met de conventionele CAMK2B 
knockout muis. Dit betekent dat er een rol voor CAMK2B in motoriek is weggelegd 
in de ontwikkeling. Wanneer we CAMK2B alleen in het cerebellum, striatum of in de 
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voorhersenen weghaalden zagen we geen fenotype in de motoriek. Het lijkt er dus op 
dat de motoriek van de knockout muis niet uit een van deze hersengebieden alleen 
komt, maar waarschijnlijk uit meerdere tegelijkertijd. 
In hoofdstuk 4 onderzochten we zowel CAMK2A als CAMK2B door muizen te 
onderzoeken die beide isoformen niet hadden vanaf de conceptie of op volwassen 
leeftijd verloren. Hierdoor werden we in staat gesteld nieuwe functies van CAMK2 te 
ontdekken. Deze waren eerder mogelijk niet zichtbaar door compensatie van CAMK2A 
in de Camk2b knockout muis of CAMK2B in de Camk2a knockout muis. Een van deze 
nieuwe functies was een cruciale rol voor CAMK2 in de overleving. We vonden dat 
genetische deletie van Camk2a en Camk2b zowel vanaf de conceptie als geïnduceerde 
deletie op volwassen leeftijd resulteerde in vroegtijdige sterfte. Ook het verlies van 
autonome en calcium-afhankelijke activiteit van CAMK2 resulteerde in vroegtijdige 
sterfte. Op elektrofysiologisch niveau vonden we dat LTP compleet afwezig was in de 
CA3-CA1 synaps van de hippocampus in muizen waar Camk2a en Camk2b genetisch 
werden verwijderd op volwassen leeftijd. In een ander muismodel vonden we dat de 
afwezigheid van LTP niet kwam niet door verlies van presynaptisch CAMK2A en CAMK2B. 
Tot slot vonden we dat de regels voor plasticiteit in de CA3-CA3 synaps verschillen van 
die in de CA3-CA1 synaps. Alleen bij verlies van zowel CAMK2A als CAMK2B was er een 
fenotype in LTP-expressie in de CA3-CA3 synaps, niet bij verlies van alleen CAMK2A of 
CAMK2B. Dit is in tegenstelling tot de CA3-CA1 synaps waar verlies van alleen CAMK2A 
of CAMK2B een fenotype in LTP-expressie geeft. Deze resultaten laten zien dat CAMK2A 
en CAMK2B voor elkaar kunnen compenseren voor een aantal cruciale functies zoals 
overleving en LTP. Tevens laten deze resultaten zien dat het onderzoek van alleen 
Camk2a of Camk2b knockout muizen niet voldoende is om het volledige functionele 
spectrum van CAMK2A of CAMK2B te begrijpen.
In hoofdstuk 5 gingen we een stap verder door op zoek te gaan naar nieuwe functies 
van CAMK2 op het niveau van één neuron. Op dat niveau verkenden we het effect 
van verlies van CAMK2A en CAMK2B tegelijk, op de prikkelbaarheid en de synaptische 
transmissie in pyramidale cellen in het gebied CA1 van de hippocampus. We vonden een 
tweezijdig effect op de prikkelbaarheid na het verwijderen van CAMK2A en CAMK2B. 10 
dagen na de genetische deletie vonden we een afname van deze prikkelbaarheid, wat 
niet meer zichtbaar was 15 dagen na de start van de genetische deletie en verschoof 
naar een toename van prikkelbaarheid 21 dagen na genetische deletie. Op synaptisch 
niveau vonden we dat verlies van CAMK2A en CAMK2B resulteerde in een afname in 
de frequentie en amplitude van kleine signalen tussen neuronen (mIPSCs en mEPSCs) 
21 dagen na de start van genetische deletie, maar niet eerder. Al deze effecten in 




tegelijk CAMK2A en CAMK2B werden verwijderd. Deze effecten waren afwezig als alleen 
CAMK2A of CAMK2B werd verwijderd. Deze resultaten laten ook hier zien dat CAMK2A 
en CAMK2B elkaar kunnen compenseren. 
Tezamen dragen deze bevindingen bij aan het begrip van hoe CAMK2 werkt op het 
niveau van gedrag, op netwerkniveau en op het niveau van één enkel neuron. Het 
begrijpen van de mechanismes waarmee CAMK2 werkt op deze verschillende niveaus 
zal in de toekomst nieuwe inzichten leveren in de behandeling van patiënten met een 







Achterberg KG, Buitendijk GHS, Kool MJ, Goorden SMI, Post L, Slump DE, Silva AJ, 
Van Woerden GM, Kushner SA, Elgersma Y (2014) Temporal and Region-Specific 
Requirements of αCaMKII in Spatial and Contextual Learning. Journal of Neuroscience 
34:11180–11187.
Kool MJ, van de Bree JE, Bodde HE, Elgersma Y, Van Woerden GM (2016) The molecular, 
temporal and region-specific requirements of the beta isoform of Calcium/Calmodulin-
dependent protein kinase type 2 (CAMK2B) in mouse locomotion. Scientific Reports 
6:26989.
Kool MJ, Borgesius NZ, van de Bree JE, Elgersma-Hooisma M, Buitendijk GHS, 
Aghadavoud Jolfaei M, Elgersma Y, van Woerden GM. CAMK2-dependent signaling in 
neurons is essential for survival. Under Review in the Journal of Neuroscience
Kool MJ, Rotaru DC, Bodde HE, Elgersma Y, van Woerden GM. Bidirectional changes in 
excitability upon loss of both CAMK2A and CAMK2B. Manuscript in preparation
Other Publications:
Bruinsma CF, Savelberg SMC, Kool MJ, Jolfaei MA, Van Woerden GM, Baarends WM, 
Elgersma Y (2016) An essential role for UBE2A/HR6A in learning and memory and 






Martijn Jacob Kool was born on December 31, 1986 and raised in Rotterdam. After 
graduating from high school at the Erasmiaans Gymnasium in Rotterdam he was 
admitted to medical school in 2006 at the Erasmus University Rotterdam. Parallel to 
medical school, he followed the Erasmus MC research master program in Neuroscience 
under the supervision of prof. dr. Y. Elgersma investigating the molecular mechanisms 
underlying learning and memory. After graduating from the neuroscience master 
program in 2012 he decided to postpone his medical school and started as a PhD-
candidate in the same field as his master thesis under the supervision of dr. G.M van 
Woerden and prof. dr. Y. Elgersma. During his work as a PhD student Martijn was 
member and subsequently chairman of the Science Café committee, an initiative from 
the Erasmus University Rotterdam to bring science to the general public in a series 
of monthly lectures by high-profile scientists. Additionally, Martijn participated in 
ScienceBattle, a cultural initiative to bring science to theatres where PhD-students in 
theatres across the Netherlands compete in trying to sell the relevance of their scientific 
work to a broad audience. Since September 2016 he started with his final two years 
of medical school while finishing his PhD. In September 2018 Martijn graduated from 
medical school and he's currently working at the E.R. of the Franciscus Vlietland Hospital. 






Name:  Martijn Jacob Kool
PhD Period: 2012-2016
Department: Neuroscience
Promotor: Prof.dr. Y. Elgersma
Co-promotor: Dr. G.M. van Woerden
Research School: Graduate School Neurosciences Amsterdam Rotterdam (ONWAR)
1. PhD Training Year
Workload 
(ECTS)
Article 9 Course required for animal research 2012 1.5
Biostatistical methods I: basic principles (NIHES) 2013 5
Interneuron Summer School Amsterdam 2014 1.5
Biomedical English Writing and Communication 2016 4
Conferences
E-Phys Brain Conference, department of Neuroscience 2013-2015 0.5
ONWAR annual PhD meeting, Driebergen (poster presentation) 2012-2013 1
Interneuron Summer School Amsterdam (Conference part) 2014 0.5
Society for Neuroscience annual meeting Chicago (poster presentation) 2015 1.5
Seminars and workshops
Neuroscience department seminar series 2010-2016 2
Seminar at Essen University (presentation) 2017 1
2. Teaching
Medical curriculum “Functional anatomy of the musculoskeletal system” 2013-2016 10
“Anatomy of the eye” classes for medical students 2013 0.5
“General anatomy of the body” classes for medical students 2015 0.5
Workshop Hippocampal Field Recording for Master of Neuroscience students 2012-2016 3
Supervising Masters theses
H.E. Bodde (Master of Neuroscience student) 2015-2016 1.5
Other






Als je denkt dat je het lastigste gehad hebt, komt er nog het dankwoord. Er zijn een 
hoop mensen die ik wil bedanken. 
Laat ik beginnen met mijn copromotor. Geeske, wat vond ik het fijn toen je aan het 
begin van mijn PhD terugkwam in het lab. Je had direct door hoe mijn projecten in 
elkaar staken en wist ze op te delen en goed vervolg te geven. Ik heb altijd met groot 
plezier van je geleerd, met je gediscussieerd en onderdeel uitgemaakt van de CAMK2-
club (inclusief zelfgedrukte T-shirts!). Mijn promotie heeft langer geduurd dan we 
aanvankelijk gepland hadden. Toch ben ik ontzettend blij dat ik je eerste echte PhD 
student was. Dat neemt niemand me meer af.
Ten tweede mijn promotor, prof. dr. Elgersma. Beste Ype, al vroeg tijdens de 
Summerschool wist ik het zeker, bij jouw lab wil ik graag mijn project doen. Een eiwit 
wat zo’n cruciale rol speelt bij het vormen van het geheugen, hoe kan dat nou niet 
interessant zijn. Ik was direct verkocht, ook al zal onze gedeelde passie voor producten 
van Apple daar ook een rol in hebben gespeeld. Bedankt voor de steun, je expertise en 
het handhaven van een goede balans tussen werk en privé op het lab. 
Andere commissieleden, prof. dr. Borst, prof. dr. Kushner en prof. dr. Hoebeek. Beste 
Gerard, bedankt voor het kritisch beoordelen van mijn thesis en voor de vele hulp rondom 
de elektrofysiologie de afgelopen jaren. Beste Steven, bedankt voor alle intrigerende 
discussies en de mooie colleges. Beste Freek, bedankt voor de discussies en de leuke 
tijd in Chicago! Prof. dr. Kessels en dr. Nadif Kasri, bedankt voor het plaatsnemen in de 
commissie.
Lieve collega’s van het Elgersma Lab. Edwin, wat was je een fijne collega en wat mis 
ik je vrolijke blik als je weer eens met een bak ijs terugkwam uit het moleculaire lab 
(“kijk voor je, kl#j%”), de door jou geschetste dilemma’s die elk moment van de dag 
op konden komen en je opgeruimde bureau. Mehrnoush, you have an amazing talent 
for field electrophysiology. It’s always been a great pleasure to work besides you. I can 
still get jealous on how seemingly easy you placed those electrodes and got great 
responses from the slices. Minetta, bedankt dat je altijd met geduld de administratie 
rondom de muizen op je nam, ook als ik op de valreep met wijzigingen kwam waardoor 
de breedings moesten worden omgegooid. Hanna, mijn eerste master-studente! Wat 
heb je het goed gedaan en wat was je al gelijk van belangrijke waarde voor een aantal 
van mijn projecten. Ik vond het heel fijn samenwerken. Jolet, partner in crime binnen 
de CAMK2-club, maar vooral vriendjes na je vertrek uit het lab gebleven. Bedankt voor 
190
Appendix
alle leuke avondjes eten in Rotterdam of Utrecht en de late avonden in de stad. Bedankt 
allen met wie ik heb samengewerkt de afgelopen jaren: Nils, Susan, Caroline, Thijs, Iris, 
Monica, Diana, Guy, Jay, Jaga, Linda, Martina, Myrthe, Sara, Elisabeth, Marielle, Erika, 
Elize and everyone I might forget.
Lieve vrienden: Rochus, Jeff, Olivier, Stephan en Tip. Bedankt voor de avondjes chillen na 
een drukke week op het lab of in het ziekenhuis, voor de provocerende discussies en de 
vele grappen. Iets minder bedankt voor de 300+ aan dagelijkse berichten (FFF), er is wat 
kostbare (onderzoeks)tijd verloren gegaan. Imke, bedankt voor het zojuist aanreiken 
van een glas spa rood tijdens het schrijven van deze alinea, waarbij je expliciet vroeg 
om een vermelding. Thnx chickie!
Lieve Thomas en Laura-anne, leuk dat jullie mijn paranimfen zijn! Thomas, ik snap niet 
hoe je kan kiezen voor motor systems als er ook zoiets moois bestaat als de hippocampus. 
Toch ervaren we nu samen hoe het is om een PhD af te ronden. Ik ben blij dat we dat 
samen doen en niet alleen. Succes met de laatste loodjes! Lieve Laura-anne, ik kan me 
nu moeilijk voorstellen dat je ooit op het lab hebt gewerkt. Je stap uit de wetenschap is 
je zo goed afgegaan. Toch leuk om mijn PhD in de oude stijl af te sluiten, zoals vroegah. 
Bedankt voor de vele avonden eten, dansjes en spelen! 
Lieve schoonfamilie, bedankt voor alle steun over de afgelopen jaren. Jullie hebben 
vanaf de eerste dag al meegeleefd. Jan, bedankt voor de geweldige illustratie van de 
hippocampus die nu op de voorkant van mijn boekje staat. 
Lieve papa en mama, jullie hebben je altijd ingezet voor de beste basis op het gebied 
van onderwijs. Ik ben jullie daar heel dankbaar voor, maar het is nu wel even klaar met 
de diploma’s. Bedankt dat jullie er altijd voor me zijn. Yorick, onze werelden liggen ver 
uit elkaar maar je bent altijd geïnteresseerd in hoe het gaat en wat ik precies doe. Uit 
zelfbescherming houd ik je weg uit de organisatie van mijn feestje, anders verdedig ik 
straks mijn PhD in een cookiemonster pak, na 5 shotjes campari met gelakte nagels. 
Michelle, bedankt voor je kritische blik op mijn steenKool Engels, je weet van wie ik het 
heb.
Tot slot mijn vrouw. Lieve Marieke, bedankt voor je eindeloze geduld als ik in de avonden 
en weekenden verder werkte aan het afronden van dit boekje, terwijl dit ten koste ging 
van tijd met zijn tweetjes. Er komen mooie maanden toeren in Europa aan, waar we 
door niks worden gehinderd om elke dag te doen wat we zelf willen met onze hoofden 
helemaal vrij van verplichtingen.
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